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SUMMARY 
	  
	   	  
iv	  
Summary 
Clostridium difficile is one of the UK’s most common hospital acquired infections and 
there is anecdotal evidence to suggest that the bacteria are sensitive to the antibacterial 
properties of tea. Surprisingly, little research has been undertaken to characterise the 
inhibitory activity of aqueous tea infusions that are representative of traditional drinking 
habits. The antibacterial properties of tea are thought to be due to a group of 
polyphenols called catechins. However, their contribution to the inhibitory activity of 
tea infusions and their mechanism of action is still subject to debate.  
An antimicrobial assay, developed using Staphylococcus aureus as a model organism, 
was used to determine the antibacterial activity of a range of tea infusions against 75 
clinical isolates of C. difficile that represented all the major strain ribotypes over 11 
years.  
Green teas demonstrated more potent antibacterial activity than black teas and their 
activity was positively correlated with antioxidant power, hydrogen peroxide production, 
and catechin content. Furthermore, the country of origin of the tea affected the catechin 
content and subsequent antimicrobial activity of the infusion.  
Detailed chemical analysis using high performance liquid chromatography and counter 
current chromatography suggests that the antibacterial activity of tea is probably the 
result of synergistic interactions between a number of catechins rather than the activity 
of an individual compound. With regards to the mode of action by which tea inhibits C. 
difficile, electron microscopy studies of the bacterium treated with green tea revealed 
distinct changes to the outer cell structures of the bacteria. These changes were  
indicative of cell membrane blebbing, thus supporting the theory that tea compounds 
interact with the bacterial membrane and/or cell wall.  
Overall, this investigation concluded that tea infusions have inhibitory activity against C. 
difficile in vitro and may be useful in the treatment or prevention of C. difficile 
infections in vivo.  
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1. General Introduction 
1.1 Natural Therapeutics Derived from Plants 
Natural products have provided the foundation for many of today’s longstanding 
medicinal treatments. A natural product is defined as a compound or substance 
produced by a living organism, such as plants, bacteriophages and bacteria (G & C. 
Merriam Co., 1913). An example of an important plant derived natural product is 
morphine, a powerful opioid analgesic used worldwide for treating pain. It was isolated 
from the dried sap of un-ripened seedpods of the poppy plant (Papaver rhoeas) in 1804 
by Friedrich Sertürne (Lockermann, 1951). Another good example of a plant derived 
natural product is the cardiac glycoside digoxin, it is used for a variety of heart 
conditions such as atrial fibrillation (Martin, 2013) and was isolated from the foxglove 
plant (from the Digitalis family) (Krikler, 1985). On a global scale, approximately 75% 
of drugs used in infectious diseases and 60% of drugs used in anticancer treatments are 
directly from or derived from natural products (Newman et al., 2003). Furthermore, 
approximately 60% of the world’s population relies almost entirely on plants for 
medication (Harvey, 2000). However, considering the importance of natural products to 
drug discovery, in the last decade major drug companies have reduced the amount of 
capital they invest in natural product research (Beutler, 2009). The extent of this trend 
was evident when the number of approved drugs derived from natural products reached 
a 20-year low in 2002 (Ortholand and Ganesan, 2004). The main reasons for this shift in 
drug discovery was the perception that identifying new clinically-relevant drugs from 
natural products, particularly plants, is a slow process and one that often yields complex 
molecules that are very difficult to synthesise or purify in significant quantities (Beutler, 
2009). When this is combined with the challenge of physically obtaining the biomass 
needed to provide a workable amount of the isolated compound and the tedious pathway 
to take a drug to market, investing in natural product research becomes a difficult 
financial decision. Therefore, pharmaceutical companies have opted for the synthetic 
approach to finding novel drug entities, such as high throughput screening and synthetic 
chemistry to generate ‘hits’ for clinical targets (Koehn and Carter, 2005). These 
techniques are very quick and inexpensive methods of generating large numbers of 
novel compounds. The promise of a seemingly inexhaustible supply of compound 
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libraries precipitated a further shift away from natural products (Ortholand and Ganesan, 
2004).  
Combinatorial chemistry is good example of a high throughput technique that is used 
extensively in drug discovery (Myers, 1997). This technique identifies points of 
diversity in a starting hit compound or pharmacophore. Each point of diversity in the 
molecule is then varied based on an inventory of starting materials and mathematical 
models of drug-target interactions. This will then generate huge libraries of similar but 
structurally different compounds (Furka, 2002). When used alongside automated 
combinational synthesis, thousands of compounds can be physically generated for 
biological screening. However, the initial drawbacks of these methods were small yields, 
poor solubility and low purity of the generated compounds (Beutler 2009). Progress has 
been made to improve on these limitations, but the success rate of producing clinically 
effective novel therapeutics using these techniques has been lower than expected 
(Newman and Cragg, 2007).  
After the implementation of this technology, the number of new chemical entities 
reached a 24 year low of 25 in 2004 (Newman and Cragg, 2007). In the United States of 
America (USA), 487 new drugs were approved by the Food and Drug Administration 
(FDA) from 1998 through to 2003, 378 (78 %) of which were classed by the FDA as 
appearing to have therapeutic qualities similar to those of one or more drugs already in 
the market (Kumar and Singh, 2008). Furthermore, 333 (68 %) of these drugs were not 
new molecular entities, but re-formulated versions of current drugs (Kumar and Singh, 
2008). The expectations of high throughput screening and combinational chemistry in 
its purest form had clearly not come to fruition, as between 1981 and 2006 there was 
only one de novo drug, the multikinase inhibitor sorafenib, approved by the FDA 
(Newman and Cragg, 2007). Although these high throughput techniques have not 
yielded as many new drugs as once thought, they are still important tools in drug 
discovery and seem better placed to expand on existing lead compounds rather than 
inventing new ones (Beutler, 2009).  
It is evident that initial efforts to produce new therapeutics using these techniques were 
not as successful as anticipated, however progress has been made to combine high 
throughput technology with natural product screening (Li and Vederas, 2009) and there 
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has been a slow resurgence of drugs approved by the FDA derived from natural 
products (Newman and Cragg, 2007). This is not surprising, considering that many of 
the novel chemicals isolated from nature are often unique and stereo-chemically 
complex structures (McChesney et al., 2007).  
Generally, natural products are chemically different in their composition in comparison 
with synthetic drugs. They tend to be more oxygen rich, contain less nitrogen atoms and 
contain more chiral centres (Ortholand and Ganesan 2004). This is partially due to the 
complex biosynthetic pathways from which they are derived. These pathways are often 
more efficient than their synthetic counterparts and are usually extremely difficult to 
emulate due to the complexity of the chemistry and the lack of suitable starting 
materials (Ortholand and Ganesan 2004). Although this would prove to be a 
disadvantage to a drug company seeking to mass produce/purify a hit compound, it may 
not pose a problem if a crude extract of the natural product was clinically effective and 
could be produced on a large scale. With this in mind, it raises the question whether 
food grade plants that contain high concentrations of the desired compounds as a result 
of environmental conditions, genetic manipulation or species could be specifically 
selected for clinical application. This would eliminate the need for chemical synthesis 
and complicated extraction techniques. It is a very exciting possibility, especially with 
regard to plants such as Camellia sinensis, a plant that is well accepted as a common 
foodstuff and the leaves of which are infused in water by millions of people worldwide 
(Fernandez-Caceres et al., 2001).  
1.2 Camellia sinensis 
Camellia sinensis (fig 1.1) is an evergreen shrub belonging to the Theaceae plant family. 
There are two major varieties of Camellia sinensis: Chinese Camellia sinensis var. 
sinensis and Camellia sinensis var. assamica (Integrated Taxonomic Information 
System, 2013). Camellia sinensis var. sinensis is hardier than Assam tea and has 
relatively small and narrow leaves (Kew Royal Botanical Gardens, 2013; table 1.1). The 
leaves from this variety are used to produce Chinese green and black tea (Kew Royal 
Botanical Gardens, 2013). The C. sinensis var. assamica variety has larger leaves, 
which have a droopy and leather like appearance. This variety of tea bush is 
predominantly grown to produce Assam and Indian black tea (Kew Royal Botanical 
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Gardens, 2013). Both types of tea bush are cultivated across the world, but mainly in 
tropical and subtropical regions, primarily to be harvested for tea.  
Table 1.1. The taxonomy of Camellia sinensis (adapted from Kew Royal Botanical Gardens, 
2013). 
 
 
Figure 1.1. Artist representation of Camellia sinensis (taken from Koehler’s Medicinal Plants, 
2013). 
Kingdom Plantae
Sub Kingdom Tracheobionta
Division Magnoliopsida
Order Theales
Family Theaceae
Genus Camellia (L.)
Species Camellia sinensis (L.) Kuntze
Main varieties Camellia sinensis var. assamica
Camellia sinensis var. sinensis
Camellia sinensis
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The history of infusing Camellia sinensis leaves in water can be traced back to China in 
2700 BC (Weisburger, 1997). According to legend, Chinese Emperor Shen Nung 
discovered the drink when a few Camellia sinensis leaves accidentally fell into a pot of 
boiling drinking water (Wheeler and Wheeler, 2004). When the Emperor tasted the 
infusion, he was pleasantly surprised by the taste and from then onward the infusion 
became known as the popular drink tea (Wheeler and Wheeler, 2004). Around the 17th 
century, tea was imported into the United Kingdom (UK) from India and became an 
important part of the British culture (Weisburger, 1997). Britain played an important 
role in popularising the drink and during the late 17th Century, it became so popular it 
had value in currency and international trade (Hara, 2001).  
Today tea continues to be one of the most popular drinks worldwide, second only to 
water (Kuhnert, 2010; Park et al., 2012). This is probably due to many different 
varieties of tea and also the versatility of creating different flavoured drinks by altering 
the infusion time (Stahl, 1962). It is estimated that 20 billion cups are consumed daily 
(Fernandez-Caceres et al. 2001). The UK accounts for 165 million of these cups making 
it one of the biggest global consumers of tea worldwide (UK Tea Council, 2013, 2009; 
fig. 1.2).  
Black tea, the most popular variety in the UK is usually consumed with milk, while in 
China and Japan green tea is the most popular tea and is usually consumed neat (Stewart, 
2012). Cold tea drinks are now becoming more popular, especially in the US and Japan. 
In the US nearly 75 % of tea drinks are consumed cold (Weisburger, 1997). Tea extracts 
are also being added to many foodstuffs, such as biscuits, cakes and other confectionary, 
a trend that is prominent in Japan but is slowly moving into other countries around the 
world (Wang et al., 2003). 
With a huge demand for tea worldwide, it is estimated that the annual global production 
is 2.9 million tons (World Green Tea Organisation, 2010), with the biggest producers 
being China, India and Sri Lanka (fig. 1.3).  
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Figure 1.2. The amount of tea (kilograms) consumed per head globally in 2009 (data obtained 
from Food and Agriculture Organisation of the United Nations, FAOSTAT, 2009)  
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Figure 1.3. Amount of tea (tons) produced by country in 2010 (data obtained from Food and 
Agriculture Organisation of the United Nations, FAOSTAT, 2009). 
 
1.3. Tea Leaf Processing 
There are many types and variations of tea available, though the four main types are 
white, green, oolong and black. Teas are primarily differentiated by level of 
fermentation they have undergone, but can also be distinguished by the grade of leaf, 
season of picking, province of tea plant and the position of where the leaves are picked 
from the plant (Hara, 2001). There are four main processing steps involved in producing 
tea, the duration and combination of which will determine the type of tea obtained. An 
overview of the processing steps for the main types of tea can be seen in figure 1.4.  
1.3.1 Withering or Wilting 
Once a leaf is plucked from the tea plant, a small amount of enzymatic oxidation will 
take place and the tea leaf will start to wilt (Roberts, 1958). This is usually done in 
sunlight or a cool room with plenty of air movement to remove water from the leaf. The 
removal of water enhances the breakdown of leaf proteins by peptidases (approximately 
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1.2%) (Hampton, 1992) to free amino acids, which is important in the first stage of 
fermentation (Roberts, 1958). High levels of caffeine are released in this stage and 
polyphenol oxidase is released as the leaf cells become more permeable (Bondarovich 
et al., 1967).  
 
 
 
Figure 1.4. Processing of different types of common teas (taken from Santana-Rios et al., 2001). 
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1.3.2 Leaf Bruising 
After the leaves have dried from wilting, they are bruised to break down the leaf 
structure, which allows the mixing of enzymes and polyphenols promoting oxidation 
(Bondarovich et al., 1967). This is one of the most diverse steps in tea leaf processing 
as the degree leaves are bruised can range from gentle bruising such as shaking and 
tossing to more extreme bruising like rolling, crushing and tearing of the leaf (Varnam 
and Sutherland, 1994). For effective bruising to take place, it is essential that most of 
the moisture from the leaf has been lost during the wilting stage (Hampton, 1992). 
1.3.3 Oxidation (Fermentation) 
In this step the tea leaves are left in a climate controlled room to oxidise or ferment for 
the desired amount of time. During this process, the leaves will darken and the degree of 
bruising and tearing will determine how quickly this process takes place (Bondarovich 
et al., 1967). This step results in many of the major changes in chemical content of the 
tea leaf (Roberts, 1958). 
1.3.4 Drying 
The drying stage is the final step in tea production and takes place immediately after 
oxidation. The drying process can be carried out in many ways, some traditional tea 
producers pan fry the leaves while others use techniques such as sunning and oven 
drying (Graham, 1992). The application of heat in this stage deactivates the oxidising 
enzymes and prevents any further fermentation of the tea leaf (Bondarovich et al., 1967). 
It also removes any remaining moisture in the leaf (Bondarovich et al., 1967). To 
produce green tea, this step is carried out immediately after wilting, whereas in black 
tea the leaf is allowed to ferment completely before drying. Oolong teas are partially 
oxidised before drying, and depending on the type of Oolong tea required, the range of 
oxidation is usually between 5-70% (Bhattacharyya et al., 2007). 
1.4 Chemical Composition of Tea Leaves 
Tea leaves are rich with many different compounds, a summary of their typical 
composition is detailed in table 1.2. 
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Table 1.2. A summary of the main components of dried tea leaves and tea infusions (Graham, 
1992; Hara, 2001). 
 
1Phenolic content largely determined by degree of fermentation (adapted from Graham, 1992 
and Zhang, 2012) 
 
1.4.1 Polyphenols 
For many years, tea consumption has been assigned various health benefits. Scientific 
research has shown that the compounds found in tea possess anticancer (Link et al., 
2010), antimicrobial (Ikigai et al., 1993) and antiviral properties (de Siqueira et al., 
2006). It has also been reported to be cardio-protective (Dreger et al., 2008) and have 
anti-diabetic properties (Chen et al., 2010a). Evidence has indicated that these effects 
may be due to of a group of compounds in tea called polyphenols. 
Class Compounds Average weight in Average weight in
dried tea leaf tea infusions
% (w/w) % (w/v)
Protein - 15 - 20 Trace
Amino acids Theanine, glutamic acid, trytophan, 1 - 4 1 - 3.5
glycine, serine, aspartic acid, tyrosine,
valine, leucine, threonine, arginine 
and lysine 
Fibre Cellulose 26 Trace
Carbohydrates Glucose, sucrose, fructose and pectins 7 4
Lipids Linoleic acids and sterols 7 Trace
Pigments Chlorophylls and carotenoids 2 Trace
Minerals Calcium, magnesium, chromium, 5 4.5
maganese, iron, zinc, copper, selenium,
molybedenum, sodium, phosphorus,
cobalt, strontium, nickel, potassium,
fluorine and aluminium
Alkaloids Methylxanthines (caffeine, theobromine, 3 - 4 7 - 9
theophylline)
Phenolics1 Flavonoids (flavones, flavonols, flavones, 25 - 36 45 - 65
flavanones, isoflavones and anthocyanins),
theaflavins, thearubigins, theasinensins
and phenolic acids
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Polyphenol is a generic term to describe any chemical that is built around two or more 
phenol groups and tea, like most plants, contains many different types of polyphenols 
(Bradfield and Bate-Smith, 1950). The largest group of tea polyphenols by weight is the 
flavonoids (~30 %(w/w)) (Chou et al., 1999). The composition of flavonoids in tea 
leaves varies with the type of processing the tea has undergone. Fresh tea leaves consist 
mainly of monomeric catechins (a subgroup of flavonoids) (Chou et al., 1999). When 
the leaf is picked from the plant, enzymatic oxidation starts to take place (fermentation), 
which converts monomeric catechins into simple theaflavins and multimeric 
thearubigins (Wheeler and Wheeler, 2004). This oxidation process can be stopped by 
heat inactivation of the enzymes (polyphenol oxidases) as described earlier in the 
processing methods (Weisburger, 1997).  
1.4.1.1 Flavonoids 
As discussed, tea is abundant in flavonoids; the types of which are dependent on the 
degree of fermentation. Flavonoids are divided into 7 main classes: flavones, flavanones, 
isoflavones, flavonols, flavanols, chalcones and anthocyanins, based on the structure of 
the heterocyclic oxygen ring (Wang et al., 2000) (fig. 1.5). The main groups found in 
tea are flavonols and flavanols (Wang et al., 2000). The flavonoids are secondary 
metabolites in tea plants, which means they are not known to participate directly in the 
plants growth and development (Croteau et al., 2000). To date their exact function 
within the plant remains unknown. Although their biosynthesis from phenylalanine 
derivatives and malonyl-coenzyme A in tea leaves is well documented (fig. 1.6). 
 
 
Figure 1.5. The chemical backbone of flavonoids (adapted from Wang et al. 2000). 
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Figure 1.6. The biosynthesis of flavonoids from malonyl-coenzyme A (taken from Wheeler and 
Wheeler, 2004). 
 
Despite the uncertainty surrounding the function of flavonoids, a few studies have 
hypothesised that they may be produced to prevent infections (antimicrobials), plant 
signalling or as a general stress response (Winkel-Shirley, 2001). They may also be 
produced to prevent the plant being eaten by predators as some polyphenols, 
particularly catechins and proanthocyanidins, give tea a very bitter taste (Croteau et al., 
2000). 
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Another plausible role of these secondary metabolites is to act as a ‘sunscreen’ for the 
leaves of the plant, which was proposed in a study that looked at the evolution of land 
based plants in response to changes in sunlight (Stafford, 1991). This idea is further 
supported by a study that reported that keeping tea plants in the dark inhibited 
polyphenol production whilst exposing them to excess light increased their 
concentrations (Forrest, 1969). This may be explained by the conjugated electron dense 
ring systems found in flavonoids, which may allow the leaves to absorb and displace the 
energy of excessive Ultraviolet (UV) B radiation (Croteau et al., 2000). One flavonoid 
that has been identified as having this role is the flavonol kaempferol, which is present 
in tea leaves and tea infusions (Croteau et al., 2000).  
1.4.1.2 Catechins 
The major group of flavanols in tea are catechins (fig 1.6). The catechins are 
synthesised within the tea leaf during the daylight hours and then stored in the leaf 
vacuoles (Hara, 2001). Catechins are present in all teas but are at their highest 
concentration in green teas where they form 20 – 30 % of the dry weight of tea leaf  
(Balentine et al., 1997; table 1.3). In black tea leaves, the presence of catechins is much 
lower because of the enzymatic oxidation that takes place during fermentation. 
Therefore, catechins only contribute 3 – 10 % of the total dry weight of black tea leaves 
(Graham, 1992).  
Catechins give rise to the astringency and aroma of tea (Wang et al., 2000). Almost all 
of the characteristics of manufactured tea, including its taste, colour and aroma are 
associated directly or indirectly from modifications to the catechins (Wang et al., 2000). 
An example of this is the de-galloation from ester catechins to non-ester catechins, 
which results in a decrease in bitterness and astringency (Wang et al., 2000). 
Epigallocatechin gallate (EGCG) is one of the most abundant catechins in green tea and 
has been the most widely studied catechin (Schramm, 2013) (fig. 1.7). The amount of 
EGCG present in an average cup of green tea has been shown to be around 90 - 100 mg/ 
cup (Henning et al., 2013).  
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Figure 1.7. The catechins in fresh tea leaves (taken from Wang et al., 2000). 
 
 
Table 1.3. Average weight of catechins in fresh tea leaves. (adapted from Graham, 1992). 
 
 
Catechin Acronym Average dry weight
in fresh tea leaf 
%(w/w)
Catechin C 1 - 2
Epicatechin EC 1 - 3
Epicatechin gallate ECG 3 - 6
Gallocatechin GC 1 - 3
Epigallocatechin EGC 3 - 6
Epigallocatechin gallate EGCG 7 - 13
	  
 
	  
 
GENERAL INTRODUCTION 
	  
	   	  
16	  
1.4.1.3 Flavonols  
Flavonols make up 2 – 3 % of the aqueous extract of tea (Balentine et al., 1997). They 
differ from catechins predominantly by the addition of a ketone group on the C ring (fig 
1.7). The three most abundant flavanols in tea are quercetin, kaempferol and myricetin 
(Wang et al., 2000). The primary structure of non-glycosylated flavonols (aglycones) is 
shown in figure 1.8. However, they are dominantly present as glycosides with sugars 
such as glucose, rhamnose and fructose attached (Wang et al., 2000). The water 
solubility of aglycones is very poor and therefore they are only present in low levels in 
prepared tea drinks compared to glycosylated state (Finger et al., 1991).               
 
 
Figure 1.8. The chemical structure of the flavonols (taken from Wang et al., 2000). 
 
1.4.1.4 Theaflavins, Thearubigins and Theasinensins 
The presence of theaflavins and thearubigins in tea leaves is the result of dimerisation 
and oxidation of monomeric catechins during the fermentation process (Roberts, 1958; 
fig. 1.9). Their concentrations are highest in black teas and are responsible for the dark 
colours in fermented teas (Roberts, 1958). Theaflavins give rise to the orange colours 
while the thearubigins are responsible for the brown pigments (Wang et al., 2000). 
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Thearubigins are heterogeneous polymers of catechins and catechin gallates (Wheeler 
and Wheeler, 2004). Theaflavins possess a characteristic benzotropolone moiety and are 
further oxidised in black tea infusions to bistheaflavins and theanapthoquinone (Tanaka 
et al., 2009a; fig. 1.10). 
 
 
Figure 1.9. Oxidation of catechins to theaflavins (taken from Tanaka et al., 2009a). 
 
The most abundant black tea pigments are the thearubigins, which make up an 
estimated 60 % of the solids in a black tea infusion (Kuhnert, 2010). They are extremely 
complex molecules and since their discovery 50 years ago, efforts to clarify their 
definite structure have been in vain (Kuhnert, 2010). Nevertheless, evidence has shown 
that they range from dimeric catechins to large polymeric structures with molecular 
weights ranging from 700 to 40,000 Daltons. It is hypothesised that the likely 
precursors to thearubigins are ECG and EGCG (Haslam, 2003). Investigations using 
high performance liquid chromatography (HPLC) and C13 nuclear magnetic resonance 
spectra have failed to provide any clarity on the possible structures of thearubigins due 
to the poor separation and low signal to noise ratios (Haslam, 2003). The only signal on 
the chromatograph that characterises the thearubigins is a broad peak that is referred to 
as the ‘thearubigin hump’ (Bailey et al., 1991) (fig. 1.10 (B)).  
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Figure 1.10. Chemical structures of the theaflavins in black tea (taken from Sang et al., 2011). 
A minor group of polyphenols found in tea are the theasinensins (Tanaka et al., 2009b) 
(fig. 1.11 (A)). Theasinensins are colourless compounds formed from the dimerisation 
of two catechins via a carbon-carbon bond on the B rings (Tanaka et al., 2009b). They 
are thought to be the intermediates to some theaflavins and thearubigins. As a result, 
they are found mainly in semi-fermented oolong teas (Hashimoto et al., 1988).  
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Figure 1.11. (A) The structure of the theasinensins (taken from Sang et al., 2011). (B) An HPLC plot 
showing the classic ‘thearubigin hump’  (taken from Kuhnert, 2010). 
1.4.2 Chlorophylls and Carotenoids 
Organic tea pigments, chlorophylls (fig. 1.12) and carotenoids (fig. 1.13), are found in 
both fresh and processed tea leaves. They are poorly soluble in polar solvents, and when 
in isolation they are immiscible with water (Suzuki and Shioi, 2003). However, small 
quantities have been found in hot water tea infusions. This is thought to be due to the 
action of saponins in the tea leaf. Saponins are mild surfactants, which in aqueous 
solution make chlorophylls and carotenoids more miscible (Suzuki and Shioi, 2003).  
 
Figure 1.12. The structures of different chlorophylls found in fresh tea leaves (taken from 
Kohata et al., 1998). 
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Figure 1.13. The structures of different carotenoids found in fresh tea leaves (adapted from 
Suzuki and Shioi, 2003). 
In an average green tea infusion (2.5 g of tea brewed for 5 min at 100 °C), the amount 
of chlorophylls in the infusion will be in the range of 1-11 mmols/g whilst the amount 
of carotenoids is approximately between 1-5 mmols/g (Suzuki and Shioi, 2003). 
Chlorophylls are also present in black tea infusions but at lower levels 0-6 mmols/g, 
while carotenoids are barely detectable (0-1 mmol/g) (Suzuki and Shioi, 2003). 
The main organic pigments found in tea leaves are chlorophyll a, chlorophyll b, 
pheophytin a, pheophytin b, β-carotene and lutein (Higashi-Okai et al., 2001). Like 
monomeric polyphenols, chlorophyll undergoes chemical changes during the tea leaf 
fermentation process. During fermentation, chlorophyll is degraded by chlorophyllase 
β-carotene 
Zeaxanthine 
Antheraxanthine 
α-carotene 
Lutein 
Violaxanthin 
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into pheophorbide and other minor degradation products (Suzuki and Shioi, 2003). 
Unlike polyphenol oxidase, it has been shown that chlorophyllase is not completely 
inactivated by heating, or the firing process in green and black tea manufacture (Kohata 
et al., 1998). Therefore after processing, enzymic degradation of chlorophylls may still 
take place long after the tea leaf has been processed (Kohata et al., 1998).  
1.4.3 Methylxanthines 
Methylxanthines are methylated purine derivatives, which are a subgroup of the 
alkaloid family of compounds (Stavric, 1988). Their presence in nature is limited to 
only a few plants species and can be found in foods such as tea, coffee and chocolate 
(cocoa) (Ashihara et al., 2011). The primary methylxanthines in tea are caffeine, 
theobromine and theophylline (fig 1.14).  
The average tea brew is reported to contain between 50 – 90 mg of caffeine (Astill et al., 
2001). It is the most abundant methylxanthine in tea and is well known for its stimulant 
activity on the central nervous system and the cardiovascular system (Talik et al., 2012). 
Theobromine and theophylline also have similar effects on the body but are found at 
much lower concentrations in tea infusions, 4 mg and 0.3 mg respectively (Stavric, 
1988; UK Food Standards Agency, 2004).  
 
 
Figure 1.14. The structures of the methylxanthines theophylline, caffeine and theobromine 
(adapted from Stavric, 1988). 
Theophylline Caffeine Theobromine 
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1.5 Environmental Factors Affecting the Polyphenol Content of C. sinensis 
As discussed previously, tea is produced in many countries and as a result the tea plants 
would be subjected to different environmental and cultivation conditions. Some studies 
that will be discussed have shown that these factors can affect the levels of polyphenols 
in the tea leaf.  
1.5.1 Seasonal Variation 
The purpose of polyphenol production remains unknown, but it has been shown that 
seasonal differences and the conditions under which the plants grow can alter the 
concentrations of polyphenols they produce (Lin et al., 2003b; Yao et al., 2005). An 
investigation conducted in Australia found that the levels of the principle tea catechins, 
epigallocatechin gallate (EGCG), epigallocatechin (EGC), catechin (C) and combined 
total polyphenols varied greatly between the different seasons (Yao et al., 2005). In the 
warmer months (April and May), there were higher levels of all catechins, while in the 
colder months (July, August and September); the levels were at their lowest (Yao et al., 
2005).  This trend was also observed in Phoenix Mountain Provence, China. Chen et al. 
(2010b) reported that levels of EGC, C, gallocatechin (GC) and simple catechins in the 
tea leaves were significantly higher in the spring months compared to the colder autumn 
months. The seasonal effects observed in these studies imply that changes in 
temperature, humidity and sunlight hours may all contribute to the level of polyphenol 
produced in tea plants. 
1.5.2 Position of Tea Leaves 
The position of the leaf on the tea plant has also been shown to affect the levels of 
polyphenols. The best tea is said be produced using the young leaves (apical bud) or the 
‘flush’, which is made up of the tips of the plant (Wickremasinghe and Perera, 1973; fig 
1.15). A study has shown that the young leaves at the apical bud and the two youngest 
leaves were 2.7 fold more concentrated in polyphenolic compounds than the older 
leaves (Lin et al., 1996). Levels of caffeine and amino acids were also higher in the 
younger leaves (40-60 %) (Wickremasinghe and Perera, 1973). Although unproven, it is 
hypothesised that like un-ripened fruits, the higher levels of polyphenols in younger 
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shoots increase their bitterness, providing protection from predators (Mayer and Harel, 
1979). 
 
Figure 1.15. Diagram of the stem and leaves of the Camellia sinensis plant (taken from Tea 
Plantation Agronomy, 2013). 
 
1.5.3 Light 
It has been hypothesised that flavonoids, as well as other components in leaves, protect 
the plant against excess UV light by mopping up free radicals produced by UV light and 
the excess production of nicotinamide adenine dinucleotide phosphate (NADPH) 
(Edreva, 2005). It is also thought that the aromatic rings of the flavonoids absorb some 
light of the UV spectra and help dissipate the energy throughout the leaf (Dixon and 
Paiva, 1995). In support of these theories, it has been reported that exposure of tea 
plants to low influence short burst UV-B radiation increases the accumulation of 
catechins in the leaf, particularly EGCG (Zheng et al., 2010). Conversely, exposing the 
leaves to prolonged high influence long burst UV-B radiation suppressed the levels of 
total catechins (Zheng et al., 2010).   
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Shading has also been reported to affect the levels of polyphenols in tea leaves (Ku et 
al., 2010) It as found that shading tea bushes for 7-21 days, a common practice in 
Japanese cultivars for the production of sencha, reduced the levels of total catechins but 
increased the levels of chlorophylls and amino acids (Ku et al., 2010).  
1.5.4 Soil Composition 
Studies looking specifically at the levels of tea polyphenols in relation to soil 
composition are sparse but one study has shown that soil composition can influence the 
presence of polyphenols in tea leaves (Ruan et al., 2009). Soil provides the plants with 
many key nutrients and is a vital source of carbon and nitrogen. In a recent study, tea 
plants were grown hydroponically in a selection of rich nutrient media, which varied in 
their nitrogen content (Ruan et al., 2009). It was found that high concentrations of 
nitrogen in the growth medium (4.5 mmol/L) reduced the amount of polyphenols in the 
younger shoots (where they are greatest), increased the production of amino acids and 
the growth rate of the tea plant (Ruan et al., 2009).  
1.5.5 Water 
Water is another key component vital for plant growth. It is essential for photosynthesis 
and the subsequent production of primary and secondary metabolites in plants (Bray, 
1997). A study conducted by Cheruiyot et al. (2007) reported that reducing the soil 
water content of potted tea plants reduced the growth of new shoots and total 
polyphenols. Interestingly, some clones in the study were found to be drought-tolerant 
variants and thus maintained their polyphenol levels with fluctuating soil water content 
(Cheruiyot et al., 2007).  
1.5.6 Cultivating Altitude 
In many parts of China and India, tea is grown at high altitude (> 500 m above sea 
level). This is believed to enhance the flavour of teas, in particular, oolong and black 
teas (The Art of Tea, 2013). An example of this is Huang Zhi Xiang oolong tea, which 
is grown at high altitude regions of northern China. A study conducted on this tea 
showed that the plants growing at higher altitude had significantly (p<0.05) higher 
levels of EGCG (26 % increase), catechin gallate (CG) (22 % increase) and total 
catechins (TC) (11 % increase) than those grown at lower levels (≤ 300 m above sea 
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level) (Chen et al., 2010b). However, levels of simple catechins such as GC and C 
increased (2 %) in tea leaves grown at the lower altitude (Chen et al., 2010b). It is 
thought that the combination of higher air temperature, reduced humidity and increased 
exposure to sunlight at low altitudes accelerated growth of the tea plant (Hilton and 
Palmer-Jones, 1973), which consequently reduced the amount of secondary metabolites 
(Chen et al., 2010b). This is because fast growing tea plants use higher levels of amino 
acids to sustain growth, which causes a reduction in the production of secondary 
metabolites such as polyphenols (Ruan et al., 2009). 
1.6 The Health Benefits of Tea 
Since its discovery, tea has been associated with many health benefits (Sato and Miyata, 
2000; Weisburger, 2000; Hara, 2001). The most studied health benefits of tea are its 
antibacterial (Ikigai et al., 1993), antiviral (Nakayama et al., 1993), anticancer 
(Suganuma et al., 2010) and cardiovascular effects (Peters et al., 2001). Other studies 
have shown that tea may possess anti-inflammatory (Sueoka et al., 2006) and neuro-
protective effects (Hong et al., 2000). All these health benefits are thought to be 
associated either directly or indirectly with the presence of polyphenols in tea infusions. 
1.6.1 Cardiovascular Disease 
There have been several observational studies and meta-analyses of the cardiovascular 
benefits of both green and black tea (Deka and Vita, 2011). However, confounding 
variables such as lifestyle and diet make the data difficult to interpret. An early study in 
1989 of the consumption of green tea in Japan followed a cohort of 5910 women over 4 
years. It was found that the risk of cerebral haemorrhage and stroke was two times 
higher in women who drank less than 5 cups of green tea a day (Sato et al., 1989).  
More recently, a study was carried out on a cohort of 40,530 Japanese adults over a 
period of 11 years. An inverse dose dependant relationship was observed between tea 
consumption and cardiovascular mortality. This relationship was strongest in women 
who consumed more than 5 cups per day (Kuriyama et al., 2006). Of the different types 
of cardiovascular disease, the inverse relationship was strongest between tea 
consumption and stroke mortality (Kuriyama et al., 2006). The most recent and largest 
study to date was conducted by Mineharu et al., (2011), which enrolled 76,979 
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participants to determine the relationship between the consumption of coffee, green tea, 
black tea, oolong tea and the risk of cardiovascular mortality. A strong inverse 
relationship was found between people who drank more than 6 cups of green tea a day 
and their risk of cardiovascular mortality. It was also found that drinking more than one 
cup of oolong tea a day reduced the risk of cardiovascular disease (Mineharu et al., 
2010).  
Other studies in Asia have also shown a relationship between the consumption of green 
tea and a risk reduction in cardiovascular disease (Liang et al., 2009). However in the 
US and Europe, the majority of people consume black tea, which is the most consumed 
tea worldwide (World Green Tea Organisation, 2010). In light of this, a study 
investigating the trend in black tea consumption and cardiovascular disease was 
conducted in the Netherlands by de Koning Gans et al. (2010). This study followed the 
black tea consumptions habits of 37,514 participants over 13 years. It was found that 
drinking more than 6 cups of black tea a day was inversely associated with coronary 
heart disease (de Koning Gans et al., 2010). However, black tea consumption, unlike 
previous studies with green tea, was not shown to have an inverse relationship with the 
incidence of stroke (de Koning Gans et al., 2010).  
Two major risk factors of cardiovascular disease are increased blood pressure and 
dyslipidaemia. Tea consumption has been shown to have beneficial effects on these risk 
factors (Liang et al., 2009), which is likely to explain the beneficial effects of tea 
consumption against cardiovascular disease.  
It is also worth emphasising that there are several studies that have not been able to 
show a beneficial relationship between black tea and cardiovascular disease (Brown et 
al., 1993; Hertog et al., 1997). In Wales, a study involving 1900 men, showed that men 
who drank 8 or more cups of tea a day were at higher risk of ischemic heart disease than 
men who drank less than 2 cups per day (Hertog et al., 1997). As previously discussed, 
the chemical constituents of black tea are very different to that of green tea and this may 
be a factor in the results found in these studies. However, it must be noted that the 
authors were aware that most people in the UK consumed black tea with milk and since 
it is thought that milk binds to tea polyphenols, it may have affected the results (Hertog 
et al., 1997).  
	  
 
	  
 
GENERAL INTRODUCTION 
	  
	   	  
27	  
1.6.2 Antiviral Properties 
Tea is known to have a broad range of antiviral activity. Table 1.4 shows a list of some 
viruses that have been reported to be sensitive to tea and its polyphenols.  
 
Table 1.4. A summary of studies investigating the anti-viral properties of tea and tea 
polyphenols. 
 
 
The reported mechanisms of the antiviral action of tea include the ability of phenolic 
agents to act as antioxidants (Tzellos et al., 2010), inhibit adsorption (Mukoyama et al., 
1991; Song et al., 2005), disrupt cell membranes (Ikigai et al., 1993), prevent viral 
binding and penetration into cells (Imanishi et al., 2002) and trigger host defence 
mechanisms (Friedman, 2007). 
EGCG, the most abundant green tea polyphenol, has been of particular interest in 
antiviral screening. In a study by Mukoyama et al. (1991) EGCG was found to have 
anti-viral activity against rotavirus and enterovirus when added directly to the virus 
suggesting interference to virus adsorption. This observation was also seen observed 
theaflavin indicating both green and black tea may be effective antiviral agents against 
enterovirus and rotavirus (Mukoyama et al., 1991).   
Virus Tea/tea compoud Literature cited 
Adenovirus Catechins EGCG and theaflavin Webber  and Piddock, 2003
Bacteriophages Green and black tea de Siqueira et al., 2006
Bovine coronavirus (BCV) EGCG Clark et al., 1998
Human Rotavirus EGCG and theaflavin Mukoyama et al.,  1991
Epstein-Barr EGCG Chang et al., 2003
Herpes Simplex Catechins Savi et al., 2006
HIV Catechins Liu et al., 2005
Influenza Catechins Nakayama et al., 1993
Enterovirus EGCG and theaflavin Mukoyama et al., 1991
Hepatitis B Pu-erh tea extract Pei et al.,  2011
Human papillomavirus (HPV) Green tea extract Tzellos et al., 2010
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Another example of the antiviral activity of tea polyphenols was demonstrated in a 
study by Ho et al. (2009). They found that the tea polyphenols EGCG and gallocatechin 
gallate (GCG) inhibited the activity of enterovirus 71, a virus that can clinically 
manifest itself in a variety of debilitating diseases such as hand, foot and mouth disease 
(Shih et al., 2004). In combination with reducing the infectivity of the virus, the 
polyphenols also increased cell viability of infected cells 5-fold and suppressed 
replication of viral genomic RNA (Ho et al., 2009).  
Interestingly, the antiviral activity of tea has been exploited as a potential replacement 
of pomegranate rind as a virucidal agent in the phage amplification assay (de Siqueira et 
al., 2006). In this study, it was found that that a range of commercial black and green 
teas had the ability to inactivate Felix 01 and P22 bacteriophages. Furthermore, they 
found that in comparison to pomegranate rind, prepared tea solutions were more stable 
and demonstrated less batch-to-batch variation in virucidal activity (de Siqueira et al., 
2006). Another key advantage of using tea in the phage amplification assay is its broad 
range of activity against several bacteriophages, allowing the potential for extending the 
assay to other host organisms (de Siqueira et al., 2006).  
In 2006 the FDA has approved a green tea polyphenol extract incorporated into an 
ointment (Polyphenon E) for use as an antiviral agent against external anogenital warts 
(FDA, 2006). A supporting meta-analysis concluded that this preparation was clinically 
effective in treating the condition, showed low recurrence rates and had a favourable 
safety and tolerability profile (Tzellos et al., 2010).  
1.6.3 Anticancer Properties 
The anticancer properties of tea have been widely studied and research has shown that 
tea and some of its polyphenols can induce apoptosis in cancer cell lines of the prostate, 
colon and breast (Suganuma et al., 1999). Furthermore, epidemiological studies have 
reported that green tea has inhibitory and protective effects against esophageal (Wang et 
al., 2002), stomach (Gao et al., 2002), colon (Schut and Yao, 2000) and bladder (Bu-
Abbas et al., 1994) cancer. Of note, one study conducted by Wang et al. (2002) 
observed that the highest incidence of esophageal cancer in China was in the northern 
regions of the country, an area where tea is not produced or regularly consumed.  These 
results are further supported by an earlier study by Gao et al., 1994, who reported that 
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daily consumption of tea reduced the incidence of esophageal cancer by up to 50% (Gao 
et al., 1994).  
Another anticancer mechanism that the tea polyphenols may exert is their free radical 
scavenging activity (antioxidant activity) of potential carcinogens such as oxygen 
radicals that may be involved in DNA damage and the promotion of tumours 
(Suganuma et al., 1999). In combination with this radical scavenging activity, it is 
thought that tea polyphenols may prevent the bio-activation of carcinogens by 
interacting with p450 enzymes, as these phase 1 metabolism enzymes make the 
carcinogen more reactive and consequently more likely to bind to DNA (Suganuma et 
al., 1999). This suggests that tea may have cancer preventative as well as inhibitory 
properties.  
The antioxidant property of tea has been well characterised in vitro (Yang et al., 2002), 
but in vivo, it was observed that this effect only takes place when the subject is under 
oxidative stress (Yang et al., 2011). For example, a decrease in lipid peroxidation and 
protein carbonylation was observed after the administration of EGCG in old rats 
(Kumaran et al., 2008). However, in young rats no significant change was found 
(Kumaran et al., 2008). In human studies, the antioxidant effect of tea was demonstrated 
when smokers treated with green tea over a four week period showed a 50% decrease in 
the amount of cellular 8-hydroxydeoxyguanosine, a major DNA oxidation product and 
marker of oxidative stress, compared to the pre-treatment level (Schwartz et al., 2005). 
1.6.4 Antibacterial Properties 
The antibacterial activities of tea have been evident for some time and research is 
continually revealing new bacterial species that are sensitive to its effects. A summary 
of a few important bacteria that are known to be sensitive to tea and its polyphenols is 
shown in table 1.5. 
Some tea extracts and compounds have also been shown to inactivate bacterial toxins 
such as anthrax toxin, botulinum neurotoxins and pertussis toxin (Satoh et al., 2002; 
Deli’Aica et al., 2004). Looking at the cumulative evidence, there would appear to be 
an inverse relationship between antibacterial activity and the degree of tea fermentation 
suggesting that the catechins rather than their multimeric counterparts are likely to be 
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pivotal in the antibacterial activity of tea. However, some bacteria like B. cereus and C. 
tetani were shown to be sensitive to black teas and the direct components of catechin 
fermentation (Satoh et al., 2002; Friedman et al., 2006).  
Table 1.5. A list of some common bacteria sensitive to the effects of tea and its components. 
 
The mechanism by which polyphenols exert their antibacterial activity is not well 
understood, but one group has demonstrated that catechins may damage the lipid bi-
layer of bacteria (Ikigai et al., 1993). They found that EGCG and EC (to a lesser extent) 
caused leakage of fluorescent markers from phosphatidylserine liposomes and 
aggregation of liposomes in solution. Furthermore, they observed that this activity was 
reduced when liposomes were negativity charged and remained the same when 
liposomes had positive or no charge (Ikigai et al., 1993). Another study revealed that 
the presence of EC increased the uptake of EGCG into the lipid bi-layer (Kajiya et al., 
2002). Interestingly, a separate group observed the same relationship in an anticancer 
assay. They found that combining EC with EGCG greatly enhanced the effect of 
apoptosis (7.2 fold) compared to EGCG alone (EC had no direct effect on apoptosis) 
suggesting synergy between the catechin polyphenols (Suganuma et al., 1999).  
It has been reported that bacterial DNA gyrase, an enzyme involved in DNA unwinding, 
may also be possible target for tea polyphenols (Gradisar et al., 2007). A study by 
Gradisar et al. (2007) observed that tea catechins inhibit bacterial DNA gyrase by 
interaction with its ATP binding site. They also found that EGCG had the largest 
Bacteria Tea/tea compoud Literature cited 
Bacillus cereus Green and black tea Friedman et al ., 2006
Campylobacter jejuni Green and black tea Hamilton-Miller and Shah, 1999
Escherichia coli Green tea extract Chou et al., 1999
Mycobacterium tuberculosis EGCG Yam et al., 1997
Staphylococcus aureus Green tea and EGCG Taguri et al., 2004
Bacillus anthracis Green and black tea Dell'Aica et al., 2004
Clostridum tetani Thearubigin Satoh et al ., 2002
Helicobacter pylori EGCG Mabe et al ., 1999
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inhibitory activity followed by ECG and EGC. EC was shown to have no inhibitory 
activity against bacterial DNA gyrase (Gradisar et al., 2007). They concluded that 
EGCG and ECG had the highest inhibitory activity due to the ability of the galloyl 
moiety to anchor the benzopyran ring into the active site of the enzyme (Gradisar et al., 
2007).  
In addition to affecting vegetative bacteria, one study observed a reduction in the heat 
resistance of B. stearothermophilus and C. thermoaceticum spores when treated with 
EGCG and a mixture of tea polyphenols (Sakanaka et al., 2000). C. thermoaceticum 
was the most vulnerable of the two bacteria. In the presence of 500 µg/mL of green tea 
and heating the spores at 120 °C for 50 min, a 6 log drop in CFU/mL was observed 
compared to the control (Sakanaka et al., 2000).  
Overall, it may be a combination of factors that contribute to antibacterial activity of tea 
and the studies conducted by Suganuma et al. (1999) and Kajiya et al. (2002) have 
demonstrated how important the synergistic effects of the tea ‘cocktail’ are. 
1.7 Clostridium difficile 
Clostridium difficile (C. difficile) is a Gram-positive spore forming bacteria that has 
been subjected to intense media interest of late (fig. 1.16 and 1.17). Hall and O’Toole 
first discovered the bacteria in 1935 when they were investigating the intestinal flora of 
newborn infants. It was identified as a strict anaerobic bacterium with sub terminal, 
elongate non-bulging spores. Due to these characteristics and the difficulty experienced 
in culturing the bacteria, it was named Bacillus difficilis (Hall and O’Toole, 1935). It 
was also found to be a highly pathogenic organism that produced soluble exotoxins 
causing convulsions in young infants (Hall and O’Toole, 1935). The group 
hypothesised that the symptoms of the infection occurred due to the disruption of 
commensal flora allowing the proliferation of Bacillus difficilis (Hall and O’Toole, 
1935).  
Bacillus difficilis was later identified as belonging to the Clostridia family of bacteria 
and was subsequently named Clostridium difficile (Voth and Ballard, 2005). Since its 
discovery, reports of C. difficile isolation were infrequent until 1978 when it was 
identified as the primary cause of pseudomembranous colitis (Voth and Ballard, 2005).  
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Figure 1.16. Gram stain of C. difficile under a light microscope. 
 
Figure 1.17. Scanning electron image of C. difficile. 
It was also the primary isolate from the faeces of patients undergoing treatment with the 
broad-spectrum antibiotic clindamycin (Voth and Ballard, 2005). Antibiotic treatment 
was later identified as one of the most influential factors for the increase in cases of C. 
difficile infection (CDI) (McFarland, 1998) as it disturbs the natural gut flora, which 
serves as a major barrier against C. difficile proliferation (Lyerly et al., 1988). 
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Transmission of the pathogen is by the faecal-oral route. Most ingested vegetative cells 
succumb to the acidity of the stomach whilst spores remain unaffected (fig 1.18; A).  
 
 
Figure 1.18. Diagram of C. difficile transmission. Key: A – ingestion of C. difficile spores and 
vegetative cells; B – proliferation of C. difficile in the colon; C – adherence of C. difficile to the 
epithelial cells of the colon; D – pathogenesis of C. difficile in the colon; 1 – release of toxins 
A/B; 2 – neutrophil and monocyte recruitment; 3 – Junction formation between epithelial cells; 
4 +5 – connective tissue degradation and pseudmomembrane formation due to local hydrolytic 
enzymes. Adapted from Poutanen and Simor, 2004). 
Spore 
Vegetative Cell 
A"
B"
C"
D	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The ingested spores start to germinate in the small bowel on exposure to bile acids (fig 
1.18; B). Vegetative cells start to multiply in the colon and then adhere to colonic 
epithelium aided by the gut mucosa (fig 1.18; C). The bacterial cells then release toxins 
(A and/or B), which cause epithelial apoptosis (fig 1.18; D, legend 4) and 
pseudomembrane formation (fig 1.18; D, legend 5) leading to the symptoms of CDI 
(Poutanen and Simor, 2004).  
It is estimated that 3 – 15 % of the population are asymptomatic carriers of the pathogen 
(van Nood et al., 2009), however antibiotic use and immune-suppression can lead to 
proliferation of C. difficile in the colon resulting in CDI (Kelly et al., 1994). The main 
symptoms of mild to moderate CDI include diarrhoea and abdominal pains (Kelly et al., 
1994). However, in more severe cases, diarrhoea is more profuse and may be 
accompanied by fever, abdominal distension (toxic megacolon) and colonic bleeding 
(Kelly et al., 1994). In 1 to 3 % of cases fulminant colitis can develop, which can cause 
perforation of the colon and death (Kelly and LaMont, 2008).  
C. difficile is particularly prevalent in hospital and care settings as it can form spores, 
which persist in the environment for many years (Fekety et al., 1981). The spores are 
very resistant to cleaning and hospital disinfectants and can be passed between patients 
through contact with hospital staff (Fekety et al., 1981).  
 
Figure 1.19. Reported cases of C. difficile in England, Wales and N. Ireland in 2012 by age 
group (HPAa, 2012). 
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A factor that makes C. difficile a particularly difficult infection to treat and thus a heavy 
burden in the health care environment is the high recurrence rate in patients after 
treatment (~20 %; Kelly et al., 2008). The recurrence risk rises dramatically after first 
(40 %) and second recurrence (60 %) (Kelly et al., 2008). It is thought that this increase 
might be explained by a reduced immune response, which is often seen in the elderly 
and immuno-compromised patients (Kyne et al., 2000). This sub-group of patients are 
also the most susceptible to the effects of CDI and are more likely to present with 
severe cases of the disease (Mylonakis et al., 2001). In figure 1.19 it can be observed 
that the majority of patients presenting with CDI in England, Wales and N. Ireland in 
2012 were 75 years and above. 
 
 
Figure 1.20. Reported cases of C. difficile in England, Wales and N. Ireland from 1990 to 2012 
(HPAa, 2012). 
 
The prevalence of C. difficile has increased dramatically since the emergence of the 
epidemic 027 ribotype in 2003 (O’Conner et al., 2009). This ribotype was the subject of 
many outbreaks of CDI in hospitals worldwide and was found to produce much higher 
quantities of toxin compared to other strains leading to increased mortality (Warney el 
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al., 2005).  This coincided with the phase of increased of CDI’s in the UK. Since 
reporting started in 1990, cases C. difficile in the UK reached an all time high in 2007 
(fig. 1.20). Although cases have been steadily falling, C. difficile continues to be a 
significant problem in hospitals in the UK. In 2012, there were 14,910 reports of CDI, 
comprising of 13,352 cases from England, 969 cases from Wales and 589 cases from N. 
Ireland (HPAa, 2012).  
1.7.1 C. difficile Toxins 
C. difficile produces two major enterotoxins, TcdA (toxin A) and TcdB (toxin B), which 
are responsible for exerting the clinical symptoms of C. difficile infection (Voth and 
Ballard, 2005). The toxins are glucosyltransferases, which inactivate GTP-binding 
proteins in cells such as Rho, Rac, and Cdc42 (Voth and Ballard, 2005). Toxins A and 
B show a high degree of both sequence and structural homology (Kelly and LaMont, 
2008).  
 
 
Figure 1.21.  An illustration of the different sites on the C. difficile enterotoxins. (taken from 
Kelly and LaMont, 2008). 
 
Each of the toxins have a C-terminal receptor-binding domain and a central 
hydrophobic domain, believed to mediate the insertion of the toxin into the membrane 
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of the endosome, which allows the N-terminal glucosyltransferase enzymatic domain to 
enter the cytosol (Kelly and LaMont, 2008; fig 1.21 and 1.22). 
A third toxin, a binary toxin (CDT), is also produced in some strains of C. difficile. This 
binary toxin is an actin-specific ADP-ribosyltransferase that has a high homology to the 
Clostridium perfringens toxin (Popoff et al., 1988). It is not considered as important as 
toxin A or B in the pathogenicity of C. difficile, as 2% of toxin A and B negative strains, 
which are thought not to cause CDI, produce CDT. 
 
 
Figure 1.22.  The uptake of C. difficile toxins into the cell. (taken from Kelly and LaMont, 2008). 
 
Identification of the toxins in a faecal specimen is key to diagnosing CDI due to the 
high frequency of asymptomatic carriers of C. difficile (Johnson et al., 1992) and the 
occurrence of non-toxigenic C. difficile (Djuretic et al., 1999). As a result, the current 
gold standard for the clinical diagnosis of CDI is identification of cytotoxin B alongside 
an isolated culture of C. difficile on selective medium (Mylonakis et al., 2001). 
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1.7.2 Treatment of C. difficile Infection (CDI) 
1.7.2.1 Antibiotics 
Metronidazole and vancomycin are the current antibiotics of choice for the treatment of 
C. difficile infections (Martin et al., 2013) and have similarly high success rates (93 – 
98 %; Olson et al., 1994). Vancomycin is a glycopeptide that inhibits cell wall synthesis 
by binding to peptidoglycan precursors (Barna et al., 1984). The FDA approved it for 
use against CDI in 1986 (FDA, 1986). Administered at the recommended dose of 125 
mg four times a day (Martin et al., 2013), the concentration of vancomycin in the colon 
exceeds the MIC concentration for C. difficile by 1000 fold due to the limited 
metabolism and absorption of the drug when orally administered (Tedesco et al., 1978). 
Unlike vancomycin, metronidazole has not been approved by the FDA for CDI but is 
regularly used for the condition as studies have shown it to be as equally effective 
(Gerding, 1997). Metronidazole has now overtaken vancomycin as the drug of choice 
due to the high cost of vancomycin and the emergence of vancomycin resistant 
enterococci (Dever et al., 1995). The British National Formulary (BNF) recommends a 
dose of 800 mg initially followed by 400mg every 8 hours for the treatment of CDI 
(Martin et al., 2013).  
Nevertheless, vancomycin is preferred treatment in pregnant and lactating women and 
in patients who are on medication that interacts with metronidazole (i.e. warfarin) 
(Gerding et al., 2008).  As mentioned, both antibiotics are very effective in treating CDI 
but relapse of CDI occurs in 15 – 20 % of cases. There has also been an emergence of 
vancomycin and metronidazole (Pelaez et al., 2002) resistant isolates of C. difficile, 
although it is yet to influence the clinical outcome.  
More recently, the FDA approved fidaxomicin, a macrocyclic antibiotic for the 
treatment of CDI (Crook et al., 2011). A clinical trial showed that fidaxomicin was non-
inferior to vancomycin for the treatment of CDI. Furthermore, patients receiving 
fidaxomicin had lower rates of recurrent infection (15.4% vs. 25.3%).  
1.7.2.2 Probiotics 
The term probiotics was first coined in 1974 as it was used to describe ‘organisms and 
substances which contribute to intestinal balance’ (Fuller, 1989). This definition has 
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now been revised to ‘a live microbial feed supplement, which beneficially affects the 
host animal by improving its microbial balance’ (Fuller, 1991). After administration, 
they are thought to enhance and replenish the natural gut flora and protect against 
diseases in the gut (Fuller, 1989). The use of probiotics is supported by the fact that CDI 
is predominately a consequence of disruption to the gut micro flora caused by antibiotic 
treatment (Bartlett et al., 1978).  Probiotics come in a range of different products and 
are also differentiated by the microorganisms they contain and the dosage. There have 
been many clinical trials looking at the effects of probiotics in CDI, but the results are 
conflicting. A few studies suggest that probiotics may be beneficial in primary 
prevention, secondary prevention and adjuvant therapy of CDI. A large (n=246) double 
blind randomised controlled trial comparing a probiotic containing S. boulardii and 
placebo in conjunction with vancomycin, was conducted in patients with CDI 
(McFarland et al., 1994). After treatment for four weeks, it was found that treatment 
with S. boulardii greatly reduced relapse of CDI. However, further analysis of the data 
revealed that this finding was limited to patients treated for recurrent CDI (McFarland et 
al., 1994). A further three trials followed the publishing of this result (Surawicz et al., 
2000; Wullt et al., 2003; Lawrence et al., 2005), but only one found a significant benefit 
of probiotics over placebo in combination with high dose vancomycin in patients with 
CDI (Surawicz et al., 2000). This study failed to demonstrate any benefit when 
probiotics were administered with metronidazole (1 g/day) or low dose vancomycin 
(500 mg/day) (Surawicz et al., 2000). It should also be noted that all three of these 
studies were statistically underpowered. 
The safety of probiotics has also been brought into question as a study reported that 
administration of probiotics to patients with severe inflammatory gut conditions might 
actually increase mortality (Besselink et al., 2008).  It is clear that further research is 
needed in this area to confirm the efficacy and safety of probiotic use in the prophylaxis 
and treatment of CDI. 
1.7.2.3 Faecal Infusion 
Faecal infusion may be seen as the ‘ultimate’ probiotic therapy for CDI, in the respect 
that it involves supplementing the patient’s gut flora with the faeces of a healthy donor 
via a colonoscopy, enema or nasogastric tube (Aas et al., 2003). This method was first 
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described in 1958 as a potential treatment for severe antibiotic associated diarrhoea 
(Eiseman et al., 1958). The reported success rate of this method is approximately 91 % 
(van Nood et al., 2009) and recently, a case series has reported a 100% success rate 
(n=7) in treating CDI using a low volume faecal transplantation (Silverman et al., 2010). 
Due to a lack of randomised controlled trials and the potential risk of secondary 
infection, faecal transplants are usually only offered as a treatment after two or more 
relapses and is still considered as a last line treatment for CDI (van Nood et al., 2009).  
1.7.3 Tea as a Possible Treatment for C. difficile Infection 
Tea is known to have antibacterial properties and anecdotal evidence has suggested that 
C. difficile may be inhibited by catechins and green tea extract (Ahn et al., 1990, 1991; 
Lee et al., 2006). The central problem with using tea polyphenols in a clinical setting is 
their extremely poor oral bioavailability. Several studies have shown that the proportion 
of ingested polyphenols absorbed in the systemic circulation after consumption varies 
from 0.2 % to 0.9 % for tea catechins to 20 % for quercetin and isoﬂavones (Hollman et 
al., 1995; Wang et al., 1995). Although this may be a problem for treating systemic 
infections, C. difficile resides in the gut, an area where polyphenols have been reported 
to concentrate after ingestion (Lee et al., 1995). One study observed that after 1 h of 
ingesting radiolabeled EGCG, 72 % was found in the digestive track and the majority 
was located specifically in the colon (Lee et al., 1995).  
Specific targeting of the Clostridia species in the gut provides another strong argument 
for using tea as a potential treatment for CDI. A study conducted by Ahn et al. (1990) 
reported that green tea extract selectively inhibited the Clostrida species in the gut 
without any detrimental effect on other commensal flora. In addition, green tea was 
found to promote the growth of the healthy gut bacteria lactobacillus suggesting that tea 
may be useful for maintaining a healthy gut flora and could possibly be used to prevent 
diseases of the gut (Axling et al., 2012). 
Tea is also a long established food product that is regarded as safe for consumption and 
has not been associated with any serious adverse effects. Furthermore, a recent phase 2 
clinical trial reported that high doses of EGCG (4000 mg daily) and a purified green tea 
extract (Polyphenon E®) was well tolerated by participants. (Shanafelt et al., 2010).  
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In summary, the body of evidence presented suggests that tea may have potential in the 
treatment or prevention of C. difficile infection.  The combination of its selectivity 
against the Clostridia species in the gut, its long established safety profile in man and 
the possibility of selecting tea plants with exceptional polyphenol content makes it an 
exciting candidate as a potential nutraceutical for treating one of the most prevalent 
hospital infections. 
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1.8 Aim and Objectives of this Study 
1.8.1 Thesis Aim 
The aim of this thesis was to determine if tea infusions have inhibitory activity against 
clinical isolates of C. difficile and how the polyphenol content and physiochemical 
properties of tea infusions affect their antibacterial activity. 
1.8.2 Thesis objectives 
The objectives of this thesis were to: 
• Determine the catechin content and the chemical properties of a comprehensive 
range of tea infusions. 
• Establish how the catechin content of tea infusions is affected by source, country 
of origin and degree of fermentation. 
• Develop assays to determine the antibacterial activity of tea infusions in line 
with current international standards for antimicrobial testing. 
• Quantify the antibacterial activity of tea infusions against a representative 
collection of clinical C. difficile isolates.  
• Compare the catechin content and chemical properties of tea infusions with their 
antibacterial activity to help determine the antimicrobial components and 
potential mechanism of action. 
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2. General Materials and Methods  
2.1 Aim and Objectives 
The aim of this chapter was to describe all the methods and materials used throughout 
this thesis. The objectives of this chapter were to: 
• Detail the source and preparation methods of all materials used in this study. 
• List the bacterial cultures used in this investigation.  
• Describe the methods used for identification and determination of pure bacterial 
cultures.  
• Describe the method used to prepare tea infusions. 
• Explain the statistical methods used in this study. 
 
2.2 Materials 
2.2.1 Chemicals and Reagents 
All chemicals and reagents were from Sigma Aldrich Ltd., UK unless otherwise stated 
in the text.  
All solvents were from Thermo Fisher Scientific Ltd., UK, unless otherwise stated in 
the text.  
2.2.2 Biological Culture Media 
2.2.2.1 Agars and Broths 
Tryptone Soya Agar (TSA), Tryptone Soya Broth (TSB), Brain Heart Infusion agar 
(BHI), Nutrient Broth (NB), Iso-Sensitest® agar and Mueller-Hinton agar (MH) were 
from Thermo Fisher Scientific Ltd., UK.  
Brucella agar was from Sigma Aldrich Ltd., UK and Lysogeny agar (LB) was 
purchased from Thermo Fisher Scientific Ltd., UK.  
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All agars and broths were made according to the manufacturer’s instructions and 
sterilised by autoclaving at 121 °C for 15 min.  
2.2.2.2 Diluents 
Deionised water (diH2O) was obtained from an ELGA Purelab Option BP15 dispenser 
(ELGA labwater, UK). The inorganic content of the water at 25 oC was between 1 – 15 
MΩ-cm with a  total organic carbon content of  <30 ppb. 
Phosphate buffered saline (PBS) tablets were from Sigma Aldrich Ltd., UK. Once 
prepared in diH2O they produced solution containing 0.01 M phosphate buffer at pH 7.4 
(composed of 0.0027 M potassium chloride and 0.137 M sodium chloride). Solutions 
were sterilised by autoclaving at 121 oC for 15 min. 
2.2.3 Bacterial Cultures 
2.2.3.1 Staphylococcus aureus 
A culture of methicillin sensitive Staphylococcus aureus (9518) from the National 
Collection of Industrial and Marine Bacteria (NCIMB, UK) was kindly provided by Dr 
Jean-Yves Maillard (School of Pharmacy and Pharmaceutical Sciences, Cardiff 
University). The culture was stored in 10% glycerol on MicrobankTM cyro-protective 
beads (Pro-Lab Diagnostics Ltd., UK) at -80 oC until further use. 
2.2.3.2 Clostridium difficile 
Freezer stocks of C. difficile strains (table 2.1a) obtained from the Anaerobic Reference 
Centre (University Hospital Wales, Cardiff, UK). All cultures were stored in 10% 
glycerol on MicrobankTM cyro-protective beads at -80 oC until further use. 
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Strain No. PCR ribotype Isolation year Location Isolated 
R13929 001 2000 Edinburgh
R14057 106 2000 Ealing, London
R14496 020 2000 Liverpool
R14933 002 2000 Liverpool
R14935 014 2000 Liverpool
R14936 070 2000 Paisley
R15213 072 2001 Manchester
R15627 078 2001 Preston
R15632 001 2001 Preston
R15691 023 2001 Dublin
R16631 005 2002 Dumbartonshire
R16632 137 2002 Dumbartonshire
R16633 138 2002 Dumbartonshire
R16762 027 2002 Birmingham
R17015 001 2002 Paisley
R17060 106 2004 Poole
R17083 027 2004 Ayelsbury
R17302 106 2002 Ashford
R17849 078 2003 Preston
R17857 106 2003 Sutton Coldfield
R18080 018 2003 Fife
R18083 001 2003 Sheffield
R18413 002 2003 Kent
R18603 106 2003 Wolverhampton
R18738 005 2003 Glasgow
R19157 001 2004 Preston
R19630 015 2004 Preston
R19885 002 2004 Poole
R20063 106 2004 Birmingham
R20700 045 2005 Whittington, London
R20702 001 2005 Whittington, London
R20703 106 2005 Whittington, London
R20831 001 2005 Birmingham
R20962 106 2005 Kingston
R20976 106 2005 Aberystwyth
R21028 014 2005 Stoke Mandeville
R22487 017 2006 Nottingham
R22753 001 2006 St Georges, London
Table 2.1a. Clinical isolates of C. difficile obtained from the Anaerobic Reference Library, UHW, Cardiff, UK 
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2.2.4 Tea Samples 
Tetley® (C Donnelly, Head of Analytical Services, Global Compliance, Tata Global 
Beverages) provided samples of dried tea leaves from individual plantations shown in 
Strain No. PCR ribotype Isolation year Location Isolated 
R22814 106 2006 Cheltenham
R22887 174 2006 Truro
R22888 015 2006 St Georges, London
R22897 106 2006 Gloucester
R23121 027 2006 Cardiff
R23800 106 2007 Rhyl
R24565 027 2007 Swansea
R26452 020 2008 Cardiff
R26720 106 2008 Wrexham
R26797 027 2008 Bridgend
R28972 014 2010 Newport
R29035 002 2010 Rhyl
R29039 078 2010 Rhyl
R29078 027 2010 Withybush
R29096 106 2010 Swansea
R31056 027 2011 Cardiff
R31234 106 2011 Bangor
R31312 056 2011 Cardiff
R31315 013 2011 Cardiff
R31350 220 2011 Rhyl
R31382 118 2011 Wrexham
DS1407 015 2007 Southport
DS1447 081 2007 St Marys, London
DS1507 106 2007 Worthing
DS1758 023 2007 Maidstone
DS1859 001 2007 Sunderland
DS2090 124 2008 Manchester
DS2098 023 2008 Cumberland
DS2107 081 2008 Warrington
DS2117 014 2008 Liverpool
DS2205 001 2009 Plymouth
DS2285 106 2009 Leeds
DS2305 174 2009 Truro
DS2315 011 2009 Maidstone
DS2325 027 2009 Tameside
DS2335 027 2009 Stafford
DS2345 027 2009 Hillingdon, London
Table 2.1b. Clinical isolates of C. difficile obtained from the Anaerobic Reference Library, UHW, Cardiff, UK 
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table 2.2. Commercial teas were obtained from markets in the UK, Japan and India as 
shown in table 2.3. 
Table 2.2. A list of single plantations teas used in this investigation. 
 
Tea Code Batch No. Cultivation Year Type Country of Origin
GP-1 20111753 2006 Green Kenya
GP-2 20114725 2007 Green Kenya
GP-3 20116921 2008 Green Vietnam
GP-4 20111996 2006 Green Indonesia
GP-5 20114392 2007 Green Kenya
GP-6 20111891 2006 Green Sri Lanka
GP-7 20114677 2007 Green China
GP-8 20113252 2008 Green Indonesia
GP-9 20109727 2005 Green Indonesia
GP-10 20114172 2007 Green China
GP-11 20111754 2006 Green China
GP-12 20111755 2006 Green China
GP-13 20114709 2007 Green India
GP-14 20112242 2006 Green China
GP-15 20113252 2007 Green Indonesia
BP-1 20114171 2007 Black Papa New Guinea
BP-2 20161612 2008 Black India
BP-3 20112177 2006 Black India
BP-4 20116985 2008 Black Tanzania
BP-5 20111193 2006 Black Rwanda
BP-6 20112729 2007 Black Malawi
BP-7 20116165 2008 Black India
BP-8 20112733 2007 Black Zimbabwe
BP-9 20117048 2008 Black India
BP-10 20116934 2008 Black Argentina
BP-11 20114294 2007 Black India
BP-12 20111180 2006 Black Kenya
BP-13 20113667 2007 Black India
BP-14 20117049 2008 Black Sri Lanka
BP-15 20116555 2008 Black Indonesia
BP-16 20111663 2006 Black Vietnam
BP-17 20111440 2006 Black China
BP-18 20111454 2006 Black China
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Table 2.3. A list of commercially sourced teas used in this investigation (‘-‘ = information 
unknown). 
 
Tea Code Batch No. Type Country of Origin Brand
GC-1 L225498 Green - Tesco Green Tea
GC-2 L213898 Green Vietnam Tesco Finest Green Tea
GC-3 A15553996 Green - Twinning’s Green Tea
GC-4 442235 Green China Asda Green Tea
GC-5 L2164 Green - Pukka Green Tea
GC-6 G7073 Green - Clipper Green Tea
GC-7 XJT 500 Green China Sea Dike Jasmine Tea
GC-8 - Green Japan Yamakaen Matcha Powder
GC-9 - Green Japan Hojo Japanese Sencha
GC-10 - Green China Dragon Well Tea
GC-11 - Green Japan Catagreen Matcha Tea
GC-12 442200 Green - Asda Jasmine Tea
GC-13 XGT 200 Green China Sea Dike Green Tea
GC-14 13216362 Green China Whittard Sencha
GC-15 - Green Japan Mt. Fuji Region Sencha
GC-16 - Green Japan Kyoto Region Sencha
GC-17 502186 Green China Whittard Jasmine Tea
GC-18 23403310118 Green China Camel Gunpowder
GC-19 14165651 Green China Whittard White Tea
GC-20 - Green China Chinese Jasmine Pearl Tea
GC-21 - Green Taiwan Pouchong Oolong Tea 
GC-22 - Green Taiwan Alishan Oolong Tea
GC-23 - Green Taiwan Lishan Oolong Tea
BC-1 2114NBO Black - Taylors Yorkshire Tea
BC-2 - Black Kenya Morgan's Welsh Brew
BC-3 A15525830 Black - Twinning’s Afternoon Tea
BC-4 - Black China Chinese Red Oolong Tea
BC-5 A15510750 Black - Twinning's Darjeeling
BC-6 L2261 Black - Tetley Best of Both
BC-7 A15510751 Black - Twinning's English Breakfast
BC-8 442214 Black - Asda Loose Leaf Black Tea
BC-9 - Black India San-Cha Blue Mountain
BC-10 502322 Black * Whittard English Breakfast
BC-11 - Black India San-Cha Rainforest Black Tea
BC-12 - Black India San-Cha Darjeeling Tea
BC-13 - Black China Tieguanyin Tea
BC-14 AT220 Black China Bai Maohuo Tea
BC-15 - Black China Whittard Puh Er Tea
BC-16 21853J132 Black - Pg Tips Strong Black Tea
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2.3 Methods  
2.3.1 Tea Infusion Preparation 
Tea infusions were prepared by grinding 2.5 g of dried tea leaf into a course powder (>1 
mm) using a pestle and mortar.  The tea powder was then added to 200 mL of boiling 
diH2O (100 °C) in a 250 mL glass beaker (Fisher Scientific Ltd., UK) and infused for 5 
min.  After the infusion period, the solution was filtered through Whatman® grade 1 
paper using vacuum filtration to remove any solids. The supernatant was used 
immediately for any subsequent experiments. Although green teas can be brewed at 
temperature ranging from 70 – 100 °C, this extraction temperature was chosen to ensure 
a fair extraction profile between all teas and thus make all the comparisons between teas 
possible, as its been reported that catechin extraction in water is temperature dependant 
(Labbé et al., 2006). 
2.3.2 Streak Plate Method for Determining Culture Purity 
The streak plate method was used to confirm the purity of bacterial stocks and as a 
prerequisite for the Gram stain analysis. The objective of the technique was to spread a 
concentrated bacterial colony across an agar plate in a series of steps in order to obtain 
isolated colony forming units (CFU’s) on the last streak. Between each step, a fresh 
inoculation loop (10 µL) was used to streak the colonies. After the procedure has been 
completed, the plate was incubated at 37 °C for 24 h and the colonies were inspected 
(fig 2.1). 
 
 
Figure 2.1. The streak plate method showing 4 steps of streaking to isolate single colonies. 
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2.3.3 Gram Staining of Bacterial Cells  
An individual CFU was selected from a streaked culture (section 2.3.2) on an agar plate 
using a sterile inoculation loop (10 µL). The loop was spread on a microscope slide with 
sterile diH20 to create a thin film. The slide was left to air dry and the bacteria were heat 
fixed to the slide by passing it rapidly through a Bunsen flame. Crystal violet reagent 
(Pro-Lab Diagnostics Ltd., UK) was used to stain the bacteria for 1 min, followed by 
application of Gram’s iodine (Pro-Lab Diagnostics, UK) for 1 min. The slide was then 
rinsed with 70 %(v/v) ethanol for 15 sec and then finally, the red counterstain safranin 
(Pro-Lab Diagnostics, UK) was applied for 1 min. In between each staining step the 
slide was rinsed with distilled water. Slides were viewed under a microscope under oil 
immersion at a total magnification of 1000× (Olympus BX-50, Olympus, Japan).  
2.4 Statistical Analysis 
The results presented in this study are the mean of three results, unless otherwise stated. 
All statistics were performed using IBM® SPSS® Statistics version 20.  
2.4.1 Independent Samples t-test 
To determine the statistical difference in the means between two groups, the parametric 
independent students t-test was used if the following assumptions were met (Cohen, 
1988): 
1) The observations of the data were independent from each other.  
2) The results follow normal distribution and pass normality tests. 
3) The data sets to be compared show homogeneity of variance. 
To assess normality, a histogram plot of the data was inspected to determine if a normal 
bell shaped curve was observed with minimal kurtosis and skewedness. The Q-Q plots 
and de-trended Q-Q plots were also reviewed in conjunction with the results of the 
Kolmogorov-Smirnov and Shapiro-Wilk tests for normality.  
Levine’s test of the equality of variances was conducted to determine if the data sets 
showed homogeneity of variance.  
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If any of the assumptions were violated, an appropriate transformation of the data will 
be attempted (Log10, square root, etc.) to normalise the data or the equivalent non-
parametric test will be used (e.g. Mann-Whitney U). 
To determine the effect size between the two groups, or the magnitude of difference, the 
eta-squared value (η2) was determined by the following equation: 
𝜂! = 𝑡!𝑡! + (𝑛1+ 𝑛2− 2) 
Where t = t value from t-test, n1 = sample size of group 1 and n2 = sample size of group 
2. To interpret the η2 value, the guidelines set out by Cohen (1988) shown in table 2.4 
were implemented. 
 
Table 2.4. Interpretation of effect size of η2 between two statistically different groups (Cohen, 
1988) 
 
 
2.4.2 Mann-Whitney U Test 
If the assumptions were not met to perform the independent samples t-test, then the 
non-parametric Mann-Whitney U test was used to compare the difference between the 
medians of two groups.  
If a significant difference was found (p =<0.05) then the effect size (r) will be 
calculated using the following equation: 
𝑟 =    𝑧𝑛 
Effect size η2
Small 0.10 - 0.29
Moderate 0.30 - 0.49
Large => 0.50
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Where r = effect size, z = z value generated from test and n = total sample size. Effect 
size was interpreted using Cohen’s (1988) criteria as shown in table 2.5. 
 
Table 2.5 Interpretation of effect size of r between two statistically different groups. 
 
 
 
2.4.3 One-way Analysis of Variance (ANOVA) 
The parametric one-way ANOVA test was used to determine if there was significant 
difference in the means between two or more groups of data if the assumptions 
described in section 2.4.1 were met.  
If a significant difference between groups was found, Tukey’s honestly significant 
difference test was used to determine which groups were significantly different from 
each other. 
2.4.4 Kruskal Wallis Test 
The Kruskal Wallis test is the non-parametric equivalent to the one-way ANOVA and 
was used if the assumptions described in section 2.4.1 were not met. It determined if the 
medians of each group were significantly different. 
If a significant difference was found, the Bonferroni-Dunn’s multiple comparisons test 
was used to determine which groups are significantly different. 
 
 
 
Effect size r
Small 0.10 - 0.29
Moderate 0.30 - 0.49
Large => 0.50
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2.4.5 Pearson’s Correlation 
Correlation analysis was used to determine the strength and direction of a linear 
relationship between two variables. Pearson’s correlation, or parametric correlation, was 
used if the following assumptions were met (Cohen, 1988): 
1) The relationship between two or more data sets is linear. 
2) Observations in the data sets were independent. 
3) Each data set in the analysis followed normal distribution. 
4) The data sets showed homoscedasticity. 
The strength of the relationship between variables was determined by the guidance set 
out by Cohen (1988) in table 2.5. 
The coefficient of determination (r2) was calculated by squaring the Pearson product-
moment correlation coefficient (r) obtained between two variables.  
2.4.6 Spearman’s Correlation 
If the data sets to be analysed did not follow normal distribution but do meet the other 
assumptions described in section 2.4.5, then Spearman’s correlation was used to 
determine the strength and direction of the linear relationship between variables. Results 
were expressed as Spearman’s rho. 
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3. Chemical Analysis of Tea Infusions 
3.1 Chapter Introduction 
Dried tea leaves contain a complex mixture of polar and non-polar compounds that can 
be extracted into solution using a variety of solvents. When investigating the polar 
contents of tea, mid to high polarity solvents such as acetone (Sasaki et al., 2004), 
methanol (Anesini et al., 2008), ethanol (Nishimura et al., 2007) and water (Lin et al., 
2003) are normally used. However, very few researchers choose to use an extraction 
method, which is representative of the daily tea drinking habits of the general 
population, primarily because they aim to extract high yields of flavonoids and other 
polyphenols. In this thesis, the primary focus is to investigate the presence of 
polyphenols, particularly catechins, in aqueous extracts, which are comparable to 
everyday tea infusions. This can be achieved by using two different types of 
investigation; quick screening colourimetric assays and thorough quantitative analysis. 
The advantage of using quick screening assays is that they can give an estimation of the 
chemical components in tea infusions relativity quickly and help to differentiate unique 
teas from a large sample size.  
3.1.1 Colourimetric Assays 
The most widely used quick screening assays that have been reported in multiple papers 
are microtitre plate assays for determining total polyphenol content (TPC) (Lin et al., 
2003b; Yao et al., 2005; Ku et al., 2010) and total flavonoid content (TFC) (Chang et 
al., 2002; Cheruiyot et al., 2007; Kim et al., 2010). They are high throughput screens 
that estimate the total concentration of phenolic compounds and more specifically, 
flavonoids. 
3.1.1.1 Total Polyphenol Content (TPC) Assay  
The TPC assay is a rapid method for estimating the total concentration of polyphenols 
in a solution based on a standard phenol derivative, most commonly gallic acid. The 
reagent employed is a mixture of tungsten and molybdenum oxides, which is reduced 
by polyphenols and phenolic acids in the tea solution to produce an intense blue colour 
(Singleton and Rossi, 1965). The intensity of the colour produced can be measured 
using a spectrophotometer at 750 nm and compared against a standard to estimate the 
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TPC. In this investigation, gallic acid was used as a standard as it is present in both 
green and black tea. 
3.1.1.2 Total Flavonoid Content (TFC) Assay  
Like the TPC assay, the TFC assay is another fast colourimetric method of estimating 
the concentration of compounds in solution, in this case flavonoids. In contrast to the 
TPC assay, this experiment specifically identifies the flavonoid polyphenols, which are 
claimed to be the most biologically active components in tea (Hamilton-Miller, 1995). 
In this assay, a combination of aluminium chloride, sodium nitrate and sodium 
hydroxide produces an intense red/orange colour when in contact with the flavonoids. 
This is due to acid stable complexes formed between aluminium chloride and the C-4 
ketone group in flavonols or the C-3 or C-5 hydroxyl group in flavanols or catechins. 
Complexes are also formed with the ortho and dihydroxyl groups on the A or B ring of 
flavonoids (Mabry et al., 1970). Catechin is used as a standard as it is common to both 
black and green teas and contains both C-3 and C-5 hydroxyl groups (Ch. 1, fig 1.5). 
3.1.1.3 Ferric Reducing Antioxidant Power (FRAP) Assay  
Another microtitre assay routinely used is the ferric reducing antioxidant power (FRAP) 
assay. Antioxidants are described as substances that help prevent oxidation of other 
molecules, such as oxidative damage to cells and DNA (Sies, 1991). Since the 
antioxidant power of tea components is associated with the many health benefits of tea 
(Borse et al., 2007), it is a useful assay to quickly determine if a tea is likely to possess 
above average biological activity and merit further investigation. Again, this method is 
routinely reported in the literature and is often coincided with TPC and TFC 
measurements (Chang et al., 2002; Lin et al., 2003b; Yao et al., 2005; Ku et al., 2010).  
The FRAP assay is one of a few assays that can be used to estimate the total antioxidant 
power of a solution. The standard of choice for this assay is the vitamin E derivative 
Trolox® (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid). In contact with the 
buffered FRAP solution, compounds that have antioxidant properties, turn the solution 
from straw yellow to a light blue colour due to the reduction of Fe(III)-2,4,6-Tri(2-
pyridyl)-s- triazine complex to Fe(II) (Benzie and Strain, 1996). This can be measured 
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using a spectrophotometer at 595 nm and compared to the intensity of standard 
solutions of Trolox®.  
3.1.1.4 Hydrogen peroxide production  
Although tea polyphenols can act as antioxidants, they have been shown to act as pro-
oxidants by generating H2O2 (Nakayama et al., 2002) in neutral (pH 7) and in weak 
alkaline solutions (pH 7.5-8.5), in the presence of heavy metals and oxygen (Dai et al., 
2010). This can be measured using the ferrous oxidation-xylenol orange (FOX) assay 
(Jiang et al., 1990). As a result, H2O2 has been implicated in contributing to the 
antimicrobial activity of tea (Arkawa et al., 2004). The proposed mechanism of 
polyphenol autoxidation is shown in figure 3.1.  
 
Figure 3.1.  Proposed mechanism of the autoxidation of flavonoids. Adapted from Akagawa et 
al. (2003). 
 
In contrast to the FRAP assay, Fe(II) is oxidised to Fe(III) by hydroperoxides in acidic 
conditions in the FOX assays. When using the aqueous assay (FOX-1), hydroperoxides 
produce a peroxide radical by reacting with sorbitol initiating oxidation of Fe(II). 
However, in the lipid compatible assay (FOX-2), hydroperoxides react directly with 
Fe(II) (Jiang et al., 1990). The subsequent Fe(III)-xylenol orange complex in both 
assays produces an intense purple colour that can be measured by spectrophotometry. 
(Propagation) 
Cu2+ Cu+ 
(Catalysis) 
O2- O2 
O2- O2 
O2- H2O2 
(Initiation) 
O2- O2 
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3.1.2 Quantitative Analysis - High Performance Liquid Chromatography (HPLC) 
Ultimately, to characterise and determine the concentration of specific compounds in 
tea, techniques such as high performance liquid chromatography (HPLC) need to be 
employed. Quantitative analysis of the polyphenols in tea samples has traditionally been 
performed using HPLC analysis. It has proven to be a very effective technique and due 
to the vast number of different compounds in crude tea samples, many different 
methods have been published, each one tailored to identify one or multiple components. 
However, due to the complex stereochemistry of the catechin polyphenols, the methods 
used in the current literature are very diverse, ranging from isocratic two-phase solvent 
systems to complex gradient elution systems with acidic modifiers (Lee et al., 1995; 
Yao et al., 2005; Kim et al., 2010). The most sophisticated liquid separation method to 
date was conducted by Nováková et al., (2010), using ultra high performance liquid 
chromatography. In this study, the simultaneous separation of twenty-nine common 
phenolic compounds in tea was achieved.  
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3.2 Chapter Aim and Objectives 
The main aim of this chapter was to determine if selected tea samples differ 
significantly in their polyphenol content and anti/pro-oxidant properties. The 
experimental objectives were to: 
1. Determine the polyphenol content of aqueous tea extracts. 
2. Assess the pro and anti-oxidant properties of aqueous tea extracts. 
3. Compare the polyphenol content and anti/pro-oxidant properties of green, black, 
single plantation and commercial tea infusions. 
4. Quantify the levels of EGCG, EC, EGC, ECG, C, GCG and caffeine found in 
selected tea infusions and determine if there are significant differences between 
different types of tea. 
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3.3 Methods 
3.3.1 Colourimetric Assays 
For each colourimetric assay, aqueous tea extracts of single plantation and 
commercially sourced teas (Ch. 2, table 2.2 and 2.3) were prepared using the method 
described in chapter 2 (section 2.3.1). Each measurement for individual teas was 
performed in triplicate (technical repeat; average value recorded) and the assays were 
repeated three times (experimental repeat; n = 3).  
3.3.1.1 Determining the Total Polyphenol Content (TPC) of Aqueous Tea Infusions 
A microtitre plate method for measuring TPC was adapted from Ku et al. (2010), as 
follows. Each infusion was diluted 10-fold in diH2O and then 10 µL was pipetted into 
separate wells of a 96 well microtitre plate followed by 100 µL of 0.2 M Folin-
Ciocalteu reagent. The solutions were mixed and left to develop for 5 min. After this 
time, 80 µL of saturated sodium carbonate solution was added to each well and the 
solutions were mixed on a shaking platform (Stuart Gyro-rocker, Bibby Scientific Ltd., 
UK) for 1 h at room temperature. The absorbance of each solution was then measured 
using a microtitre plate spectrophotometer (Anthos htII Plate-reader, Richmond 
Scientific Ltd.) at a wavelength of 750 nm. Using linear regression the TPC of each tea 
was calculated by a linear equation generated by constructing a standard curve with 
gallic acid. The standard solution concentrations of gallic acid ranged from 15 to 500 
µg/mL in diH2O. The base line absorbance was set using a negative control (diH2O) 
solution. Results were expressed in milligrams of gallic acid equivalent (GAE) per gram 
of tea. The difference in TPC between types of tea (green and black), source (single 
plantation and commercially sourced) and origin was conducted using the appropriate 
statistical test as described in chapter 2 (section 2.4). 
3.3.1.2 Determining the Total Flavonoid Content (TFC) of Aqueous Tea Infusions 
TFC was determined for each tea infusion and standard using the method described by 
Yoo et al. (2008). Of each tea infusion, 20 µL was pipetted into separate wells of a 96 
well microtitre plate followed by 40 µL of diH2O and 6 µL of 5 % (w/v) sodium nitrate 
solution. The solution was mixed on a shaking platform and after 5 min, 12 µL of 10 % 
(w/v) AlCl3 was added. After 6 min, 40 µL of 1 M NaOH was added followed by 42 µL 
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of diH2O. The absorbance of each solution was measured in using a microtitre plate 
spectrophotometer at a wavelength of 515 nm. The TFC of each tea was calculated by 
the linear equation generated by constructing a standard curve with (+)-catechin. The 
standard solution concentrations of (+)-catechin ranged from 15 to 500 µg/mL in diH2O. 
The base line absorbance was set using a negative control solution (diH2O). Results 
were expressed in milligrams of catechin equivalent (CE) per gram of tea. The 
difference in TFC between types of tea (green and black), source (single plantation and 
commercially sourced) and origin was conducted using the appropriate statistical test as 
described in chapter 2 (section 2.4). 
3.3.1.3 Determining the Ferric Reducing/Antioxidant Power (FRAP) of Aqueous 
Tea Infusions 
3.3.1.3.1 Preparation of FRAP Reagent 
The FRAP reagent was prepared by adding 2.5 mL of a 10 mmol/L 2,4,6-tris(2-
pyridyl)-1,3,5-triazine (TPTZ) solution to 40 mmol/L hydrochloric acid (HCl). 2.5 mL 
of 20 mmol/L FeCl36H2O and 25 mL of 0.3 mol/L acetate buffer at pH 3.6 (Ku et al., 
2010). The reagent was freshly prepared on the day and warmed to 37 °C in an 
incubator. 
3.3.1.3.2 Determining the Antioxidant Power of Aqueous Tea Infusions 
The antioxidant capacity of each tea infusion and standard was estimated according to 
the procedure described by Benzie and Strain, (1996), with alterations explained by Ku 
et al. (2010). Each tea infusion was diluted 10-fold in diH2O and 10 µL was pipetted 
into separate wells on a 96 well microtitre plate followed by 300 µL of FRAP reagent. 
The solutions were mixed on a shaking platform and left to develop for 6 min. The 
absorbance of the solutions was then measured at 595 nm using a microtitre plate 
spectrophotometer. The antioxidant power of each tea was calculated by the equation 
linear equation generated by constructing a standard curve with 6-hydroxy-2,5,7,8-
tetramethylchroman-2-carboxylic acid (Trolox®). The standard concentrations of 
Trolox® ranged from 0.2 mM to 2 mM in diH2O. The base line absorbance was set 
using a negative control solution (diH2O). Results were expressed in millimols of 
Trolox® equivalent concentration (TE) per gram of tea. The difference in antioxidant 
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power between types of tea (green and black), source (single plantation and 
commercially sourced) and origin was conducted using the appropriate statistical test as 
described in chapter 2 (section 2.4). 
3.3.1.4 Determining the H2O2 production of Aqueous Tea Infusions using the FOX 
assay 
3.3.1.4.1 Preparation of working reagent 
The working reagent (WR) was prepared from 1 volume of reagent A (2.5 mM 
ammonium ferrous (II) sulphate in 1 mL 2.5 M H2SO4) and 100 volumes of reagent B 
(100 mM sorbitol, 125 µM xylenol orange in 50 mL diH2O). The WR was prepared on 
the day of use.  
3.3.1.4.2 Determining the H2O2 production of Aqueous Tea Infusions 
The H2O2 production of tea infusions was determined using the method developed by 
Jiang et al. (1990), as described by the PierceTM quantitative peroxide assay kit 
instructions. Each tea infusion was diluted 10-fold in PBS to buffer the solution at pH 
7.4. Of this solution, 20 µL was pipetted into separate wells on a 96 well microtitre 
plate followed by 200 µL of WR. The solutions were mixed on a shaking platform and 
left to develop for 20 min. The absorbance of the solutions was then measured using a 
microtitre plate spectrophotometer at 600 nm. The H2O2 production of each tea was 
calculated by the linear equation generated by constructing a standard curve with H2O2 
standards. The standard concentrations of H2O2 ranged from 1 µM to 1 mM in diH2O. 
The base line absorbance was set using a negative control solution (diH2O). Results 
were expressed in micromoles of H2O2 produced per gram of tea. The difference in 
H2O2 production between green and black tea was conducted using the appropriate 
statistical test as described in chapter 2 (2.4). 
3.3.2 HPLC Analysis of Aqueous Tea Extracts 
3.3.2.1 Preparation of tea extracts and standards 
Tea infusions were prepared fresh on the day as described in chapter 2 (section 2.2.1) 
and were diluted 10-fold in diH2O. Standards of gallic acid (GA), gallocatechin gallate 
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(GCG), EC, EGCG, EGC, ECG, and caffeine (concentration ranges between 1.5 µg/mL 
and 0.15 µg/mL) were dissolved in 100% HPLC grade methanol. 
3.3.2.2 HPLC Analysis 
A Waters 2695 liquid chromatograph system comprising of a vacuum degasser, 
quaternary pump, auto- sampler, thermostatted column compartment and photodiode 
array detector was used. The column used was a C18 reversed phase Kingsorb 5 mm 
(150 x 4.6 mm) (Phenomenex Ltd., UK) with a Kingsorb 5 mm C18 (30 x 4.6 mm) 
guard column. Mobile phases consisted of 0.1% ortho-phosphoric acid in ultra-purified 
water (v/v) (mobile phase A) and 0.1 %(v/v) ortho-phosphoric acid in methanol (mobile 
phase B). The gradient elution was performed as shown in table 3.1.  
Table 3.1 Composition of the mobile phase in the gradient elution system between 0 and 30 min. 
Mobile phase A consists of 0.1% ortho-phosphoric acid in ultra-purified water and mobile 
phase B 0.1 %(v/v) ortho-phosphoric acid in methanol (eluent B). All gradients were linear. 
 
 
 
Post-run time was 5 min. Elution was performed at a solvent flow rate of 1 mL/min. 
Detection was accomplished with a diode array detector and chromatograms were 
recorded at 210 and 280 nm. The column was maintained at 30 °C. The sample 
injection volume was 15 µL. Peaks were identified by comparing their retention times 
Time (min) A B
0 - 5 80 20
5 - 7 76 24
7 - 10 76 24
10 - 20 60 40
20 - 25 50 50
25 - 25.5 80 20
25.5 - 30 80 20
Mobile phase (%)
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and UV spectra in the 200 to 400 nm range with authentic standards. A calibration 
curve for each standard was constructed and the corresponding peaks in the tea extracts 
were determined using linear regression. 
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3.4 Results and Discussion 
 
3.4.1 The Polyphenol and Flavonoid Content of Aqueous Green and Black Tea 
Infusions 
3.4.1.1 The TPC of Aqueous Tea Infusions 
The TPC of aqueous infusions was determined by constructing a concentration versus 
optical density curve using gallic acid as a control.  As shown in figure 3.2, the 
relationship between concentration and absorbance was linear and therefore the TPC of 
each tea infusion could be estimated using the derived equation. 
 
Figure 3.2. Calibration curve of absorbance at 750 nm versus gallic acid concentration (error 
bars = SE; n = 3). 
 
It was found that the mean TPC of the green teas examined in this study was 77.5 ± 4.7 
mg/g (± = SE; n = 38) whilst the mean for the black tea was lower at 54.4 ± 4.3 mg/g (± 
= SE; n = 34). The range of TPC within green teas (23.9 – 144.9 mg/g; fig 3.3) and 
black teas (6.0 – 100.7 mg/g; fig 3.4) was considerable. 
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Figure 3.3 The TPC (GAE) of 38 green tea samples (error bars = SE; n = 3). 
 
 
Figure 3.4 The TPC (GAE) of 34 black tea samples (error bars = SE; n = 3). 
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It was found that both data sets followed normal distribution, therefore it was 
appropriate to compare the TPC values of green and black teas using the student’s t-test. 
A significant difference between the TPC of green and black teas was found (t = 3.57; p 
<0.001, two-tailed; n = 72; fig. 3.5). The magnitude of the difference in means (mean 
difference = 20.6 mg/g, 95% CI: 10.2 and 36.0 mg/g) was large (η2 = 0.16).  
 
Figure 3.5 Comparison of TPC of green (n=38) and black (n=34) teas by an independent 
students t-test (***=p<0.01). 
As previously mentioned, very few studies have looked at the properties of aqueous tea 
infusions based on typical tea drinking practices. Thus, it is not surprising to find in the 
current literature studies that agree (Manzocco et al., 1998; Anesini et al., 2008) and 
disagree (Khokhar et al., 2002; Hoff and Singleton, 1977) with the results of this 
investigation. Upon review of the studies, the most likely factors leading to the 
disagreement in results is the different extraction methods used and the relatively small 
numbers of samples included in these earlier studies (n = up to 12).  
There may be multiple reasons why black tea infusions have been shown to contain less 
phenolic compounds than green teas. The most likely explanation is due to the nature of 
black tea polyphenols. An example of this would be the theaflavin polyphenols in black 
tea, which have three accessible phenol groups. However, theaflavin is the sum of two 
monomeric catechins, which have two accessible phenol groups each. The same would 
Green Tea Black Tea
0
20
40
60
80
100
***
TP
C
 (m
g/
g)
	  
 
	  
 
CHAPTER 3 
	  
	   	  
69	  
hold true for the black tea thearubigins, which are much larger in size. A study by 
Hagerman et al. (1998), found that condensed tannins had slightly lower reducing 
ability than monomeric polyphenols over pH 3 – 8. Another possibility is that the 
extraction profiles of black tea polyphenols may be different to that of green tea 
polyphenols in water. Furthermore, it is also worth considering the limitations of the 
assay such as the influence of non-phenolic reducing agents and the difference in 
reductive power of unconjugated and conjugated polyphenols. Therefore, it would be 
unsound to suggest on the basis of this assay alone that there is a significant difference 
between the polyphenol content of green and black teas. Nevertheless, it can be 
concluded that green teas have more reducing power than black teas.  
Evaluation of the TPC data for commercially sourced and single plantation teas found 
that both data sets did not follow normal distribution. Therefore, a non-parametric 
Mann-Whitney U test was used to determine if there was a significant difference 
between the groups. The outcome of the test revealed no significant difference (U = 
626; z = -0.198; p = 0.84; r = 0.02; fig. 3.6) in the TPC of single plantation teas (Md = 
62.44 mg/g, n = 33) and commercially sourced teas (Md = 69.8 mg/g, n = 39). 
When comparing the TPC of green and black teas by origin, a non-parametric Kruskal 
Wallis test was used as the samples sizes were uneven and the data did not follow 
normal distribution.  
A significant difference (p <0.05) in TPC was found between green teas from Africa 
and China, however no difference was found between any of the other green teas (fig 
3.7). This may be due to the vastly different climates in both countries or a difference in 
variety of tea bush. In general, teas originating from China and Japan are of the 
Camellia var. sinensis variety whilst those from India are usually Camellia var. 
assamica (Takeda et al., 2004; Yao et al., 2005; Chan et al., 2007). If this is true of the 
samples in this study, then the results are consistent with what was found in a previous 
study on green teas by Takeda et al. (2004), which found that green teas from China and 
Japan had significantly lower polyphenol content than green teas from other regions. 
Sabhapondit et al. (2012) also observed a reduced polyphenol content in green teas 
from China. Although, in this study there was no significant difference between 
Japanese teas and the other groups, it can be seen that the mean TPC is lower than that 
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of African and Indonesian teas. Arguably, with a larger sample size this may prove to be 
significant.  
 
Figure 3.6. Mean TPC of single plantation green (n=15), commercially sourced green (n=23), 
single plantation black (n=18), commercially sourced black (n=16) teas (error bars = SE).  
 
 
Figure 3.7 Comparison of TPC of green teas from China (n=15), Africa (n=3), Japan (n=5) 
and Indonesia (n=4) using the Kruskal-Wallis test, (error bars = SE; *=p<0.05) 
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Figure 3.8. Comparison of TPC of black teas from China (n=5), Africa (n=5) and India (n=10) 
using the Kruskal-Wallis test (error bars = SE;  *=p<0.05; **=p<0.01).  
A similar trend was found with black teas (fig 3.8). Both African and Indian black teas 
had significantly higher TPC than teas from China. This is comparable to a study by 
Astill et al., (2001), which showed a similar result. Again this may be due to climate or 
tea bush variety and appears to be consistent been green and black teas originating from 
the country (Takeda et al., 2004; Yao et al., 2005; Chan et al., 2007).  
3.4.1.2 The TFC of Aqueous Tea Infusions 
The TFC of aqueous tea infusions was determined using a calibration curve constructed 
with catechin (C) as a standard. It was found that the relationship was linear and the 
therefore the TFC was estimated for each tea using the derived equation (fig 3.9). 
The average TFC of the green teas included in this study was 16.3 mg/g ± 0.9 mg/g (± 
SE; n = 38) whilst the average for the black teas was lower at 12.9 mg/g ± 0.8 mg/g (± 
SE; n = 34). In contrast to the observations in TPC, the range of TFC within the green 
(4.6 – 28.0 mg/g; fig 3.10) and black teas (4.0 – 20.8 mg/g; fig 3.11) was similar.  It was 
expected that black teas would have considerably lower TFC, as during the production 
of black tea the flavonoids conjugate to produce theaflavins and thearubigins, which 
reduce the concentration of monomeric flavonoids. Therefore, it may be possible that 
there is non-specific binding of the black tea pigments to the assay reagent.  
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Figure 3.9. Calibration curve of absorbance (515 nm) versus catechin concentration (n = 3). 
 
 
Figure 3.10. The TFC (CE) of 38 green tea samples (error bars = SE; n = 3). 
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Figure 3.11. The TFC (CE) of 34 black tea samples (error bars = SE, n = 3). 
 
Since the data followed normal distribution, an independent-samples t-test was 
conducted to compare the TFC of green and black teas (fig 3.12). There was a 
significant difference between the TFC of green tea (mean = 16.3 mg/g) and black tea 
(mean = 12.9 mg/g); t = 2.74; p <0.01, two-tailed; n = 72). The magnitude of the 
differences in means (mean difference = 3.5, 95% CI: 0.9 and 6.0 mg/g) was moderate 
(η2= 0.10). Therefore, it can be seen that the difference of TPC between green and black 
tea is greater than their difference in TFC. 
An independent-samples t-test was conducted to compare the TFC of single plantation 
and commercially sourced teas as both data sets showed normal distribution. No 
significant difference was observed between the TFC of single plantation (mean = 15.67 
mg/g) and commercially sourced (mean = 13.86 mg/g); t = 1.38, p = 0.17, two-tailed; n 
= 72) teas (fig. 3.13). The magnitude of the differences in means (mean difference = 
1.82 mg/g, 95% CI: 0.80 and 4.44 mg/g) was small (η2= 0.02). These results were 
consistent with those seen for TPC, showing that the total phenolic and flavonoid 
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content between single plantation and commercially sourced teas is not significantly 
different (p>0.05). 
 
Figure 3.12. Comparison of TFC (CE) of green (n=38) and black (n=34) teas by independent 
student’s t-test (error bars = SE; ***=p<0.001).  
 
 
Figure 3.13. Mean TFC (CE) of single plantation green (n=15), commercially sourced green 
(n=23), single plantation black (n=18) and commercially sourced black (n=16) teas (error bars 
= SE).  
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Similar to what was found with TPC, the TFC of green and black teas when compared 
by country of origin did not follow normal distribution and contained unequal sample 
sizes, thus a non-parametric Kruskal-Wallis test was used to compare the groups. The 
test found a significant difference (p<0.05) in TFC was seen between green teas from 
Africa and China, however no difference was seen between any of the other green teas 
(fig. 3.14). Although this is a unique result to the assay, it is not surprising that this is 
similar to what was found when comparing TPC, as flavonoids would account for a 
large proportion of the total polyphenols in tea infusions (Balentine et al., 1997).  
 
 
Figure 3.14. Comparison of TFC (CE) of green teas from China (n=15), Africa (n=3), Japan 
(n=5) and Indonesia (n=4) using the Kruskal-Wallis test (error bars = SE;  *=p<0.05). 
 
When comparing the black teas by origin, it was found that Chinese black teas had 
lower levels of flavonoids than African (p<0.01) and Indian (p<0.05) sourced teas (fig. 
3.15). This is likely to be explained by the reasons mentioned previously for TPC such 
as variety of tea bush used and environmental conditions (Takeda et al., 2004; Yao et 
al., 2005; Chan et al., 2007). However, since the results of the assay may have been 
skewed by the presence of black tea polyphenols due to non-specific binding, the results 
may be better explained by HPLC analysis. 
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Figure 3.15. Comparison of TFC (CE) of black teas from China (n=5), Africa (n=5) and India 
(n=10) using the Kruskal-Wallis test (error bars = SE; *=p<0.05; **=p<0.01).  
 
3.4.2 The Antioxidant and Pro-oxidant activity of Tea Infusions 
3.4.2.1 The Antioxidant Power (FRAP) of Tea Infusions 
The antioxidant power of aqueous infusion was determined using a concentration curve 
constructed with Trolox®. As shown in figure 3.16, the relationship between 
concentration and absorbance was linear and therefore the antioxidant power of each tea 
was estimated using the derived equation.  
The mean antioxidant power of the green teas was 2.7 ± 0.1 mM/g (± = SE; n = 38). In 
comparison, the average antioxidant power for the black teas was approximately half 
that of green teas at 1.5 ± 0.1 mM/g (± = SE; n = 34). Again, there was a considerable 
difference in the range of antioxidant power within the green (0.9 - 5 mM/g; Fig 3.17) 
and black teas (0.4 – 2.5 mM/g; Fig 3.18).  
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Figure 3.16. Calibration curve of absorbance (595 nm) versus antioxidant power (error bars = 
SE; n = 3). 
 
 
Figure 3.17. The antioxidant power (TE) of 38 green tea samples (error bars = SE; n = 3). 
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Figure 3.18. The antioxidant power (TE) of 34 black tea samples (error bars = SE; n = 3). 
 
To compare the difference in antioxidant power, the student’s t-test was conducted. A 
significant difference was found between the antioxidant capacity of green (mean = 2.7 
mM/g) and black tea (mean= 1.5 mM/g; t = 7.09; p <0.001, two-tailed; n = 72; Fig. 
3.19). Furthermore, the magnitude of the differences in means (mean difference = 1.3 
mM/g, 95% CI: 0.9 and 1.6 mM/g) was very large (η2= 0.42).  
The catechins in green tea are known to have considerable antioxidant activity, which 
can explain the high values observed in the green tea samples tested. However, the 
condensation products of the catechins in black teas, theaflavins and thearubigins, are 
also reported to have antioxidant activity (Paquay et al., 2000). Therefore, the results of 
the assay suggest that the black tea infusions have less antioxidant power than green tea 
infusions. This may the result of different extraction kinetics or that the black teas 
samples may have had lower catechin content than the green tea samples post-
harvesting resulting in lower concentrations of condensed polyphenols.  
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These results are also consistent with the TPC of the teas, which was expected, as it is 
another measure of reductive power (Benzie and Szeto., 1999). Other studies such as 
Quan et al. (2007), and Almajano et al. (2008), have found similar trends, however 
there was no statistical significance applied to their findings.  
 
Figure 3.19. Comparison of FRAP (TE) of green (n=38) and black (n=34) teas (error bars = 
SE;  ***=p<0.001). 
 
Figure 3.20. Mean antioxidant power of single plantation green (n=15), commercially sourced 
green (n=23), single plantation black (n=18) and commercial sourced black (n=16) teas (error 
bars = SE).  
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Since both data sets followed normal distribution, an independent-samples student t-test 
was conducted to compare the antioxidant power of single plantation and commercially 
sourced teas. The results of the analysis showed that there was no significant difference 
found between the single plantation (mean = 2.2 mM/g) and commercially sourced 
(mean = 2.1 mM/g); t = 0.60; p = 0.55, two-tailed; n = 72) teas (fig. 3.20). This is 
consistent with the results observed for TPC and TFC.  
As a result of the uneven sample sizes and non-normal distribution of the groups, the 
Kruskal-Wallis test was used to compare the antioxidant power of teas based on origin. 
Consistent with TPC and TFC, a significant difference (p <0.05) in antioxidant power 
was seen between green teas from Africa and China. There was no statistical difference 
between any of the other green teas (fig. 3.12). Furthermore, African (p<0.01) and 
Indian (p<0.01) black teas had significantly higher antioxidant power than Chinese 
black teas (fig. 3.13). Again this was similar to the conclusions of the TPC and TFC 
assay. 
 
Figure 3.21. Comparison of the antioxidant power (TE) of green teas from China (n=15), 
Africa (n=3), Japan (n=5) and Indonesia (n=4) using the Kruskal-Wallis test (error bars = SE; 
*=p<0.05). 
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Figure 3.22. Comparison of the antioxidant power of black teas from China (n=5), Africa 
(n=5) and India (n=10) using the Kruskal-Wallis test (error bars = SE; **=p<0.01).  
3.4.2.2 The Hydrogen Peroxide Production of Tea Infusions 
The hydrogen peroxide (H2O2) production of aqueous infusions was determined using a 
concentration curve constructed with H2O2 as a standard (fig. 3.23) The relationship 
between concentration and absorbance was found to be linear, therefore the H2O2 
production of each tea infusion was estimated using the derived equation. For this assay 
a representative sample of green (n =12) and black teas (n =12) were chosen based on 
their TPC, TFC and antioxidant power. 
After 48 hours, the tea that produced the most H2O2 was GP-1 (1196 ±	 53 µM/g; ± = 
SE) whilst GP-21 produced the least (393 ± 45 µM/g). The range in H2O2 production of 
the green and black teas was 393 – 1196 µM/g and 518 – 933 µM/g, respectively. 
The initial production of H2O2 (after the 5 min brew, t = 0 h) by the green teas was 53 ± 
2.5 µM/g (n = 12; ± = SE) whilst for black teas it was 47.2 ± 2.2 µM/g (n = 12; ± = SE).  
Between the initial brew and 12 hours of incubation there was a rapid increase in H2O2 
production by both green and black teas (more than 10 times). The maximum 
production of H2O2 was achieved after 48 hours for green and black teas, 928.3 ± 74.5 
and 725.6 ± 38.5 µM/g, respectively (n = 24; ± = SE).  
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Figure 3.23. Calibration curve of absorbance (600 nm) versus the concentration of H2O2 (µM) 
using the FOX assay (n = 3). 
 
Figure 3.24. The H2O2 production of green and black tea samples at pH 7.4 after incubation at 
37 °C for 48 h (error bars = SE; n=3). 
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The data points at each time point for both green and black teas were normally 
distributed, therefore a t-test was used to determine any significant differences. No 
significant differences were found in H2O2 production between 0 and 12 hours (p>0.05), 
although significant differences were found at 24 ((t = 2.38; p>0.05, two-tailed; mean 
difference = 174.6 µM/g; 95% CI: 22.4 and 326.9 µM/g; η2= 0.20; n = 24; Fig 3.25) and 
48 hours (t = 2.42; p>0.05, two-tailed; mean difference = 202.7 µM/g, 95% CI: 28.9 and 
376.6 µM/g; η2= 0.20; n = 24; fig 3.25).  
The difference in H2O2 production between green and black teas is most likely due to 
higher catechin content in green teas (Nakayama et al., 2002; Akagawa et al., 2003). 
Catechins have been shown to produce significant amounts of H2O2 between pH 7 and 
pH 9 (Nakayama et al., 2002), whilst black tea polyphenols are thought to have little or 
no pro-oxidant activity (Hagerman et al., 1998).  
 
Figure 3.25. The H2O2 production of green (n=12) and black tea samples (n=12) over 48 hours 
at pH 7.4 after incubation at 37 °C (error bars = SE; *=p <0.05). 
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Although limited by a small sample size (n=1), a study by Akagawa et al. (2003) 
reported similar results with green tea producing more H2O2 than black teas with peak 
production occurring at 48 hours (Akagawa et al., 2003).   
In summary, green and black teas produce considerable amounts of H2O2 at 
physiological pH. Therefore in the context of this thesis, its potential involvement in the 
antimicrobial mechanism of tea must be considered. 
3.4.3 Correlation of TPC, TFC and Antioxidant Power and H2O2 Production 
The assays to measure TPC, TFC, hydrogen peroxide production and antioxidant power 
all measure specific parameters of tea infusions, but it is obvious from the results that 
there are clear trends and agreement between the observations. To determine the extent 
of the relationship between these assays, a correlation analysis was performed.  
After reviewing the data, it was found that all the assumptions were met to perform 
Pearson’s correlation.  
Table 3.2 Pearson correlation matrix of the TFC, TPC, H2O2 production and FRAP of green 
and black teas (**=p<0.01). Values are expressed as Pearson’s product-moment correlation 
(coefficient of determination ‘r2’).  
 
 
From the analysis it can be seen that there are strong positive correlations between all 
the assays, the strongest being between H2O2 and FRAP (0.86; table 3.2). This supports 
the dual physiochemical properties of tea polyphenols (Nakayama et al., 2002; 
Akagawa et al., 2003; Arakawa et al., 2004), as the correlation suggests that teas with 
TFC TPC FRAP H2O2
TFC - 0.84 (0.70)** 0.82 (0.67)** 0.78 (0.61)**
TPC - 0.84 (0.70)** 0.72 (0.52)**
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high antioxidant power can also produce higher concentrations of H2O2 depending on 
the pH of the solution.  
The analysis also shows that total measured polyphenols (TPC) and flavonoids (TFC) in 
tea infusions explain most of the variance of H2O2 production, 52% (r2= 0.52) and 61% 
(r2= 0.61), respectively (table 3.2). That is to say, the difference in the amount of H2O2 a 
tea can produce is explained in part by the abundance or lack of polyphenols and 
flavonoids.  
Furthermore, the flavonoids (TFC) present in tea infusions explain the majority of the 
variance in polyphenol content (TPC) supporting that they are the major phenolic 
compounds present in tea (83%, r2 = 0.82; table 3.2). A study by Ku et al. (2010) 
showed a similar finding between TPC, TFC and antioxidant activity in black pu-erh 
teas.  
 
 
Figure 3.26. Pearson correlation of the H2O2 production and antioxidant power (FRAP) of 
green and black teas (n =24). 
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Figure 3.27. Pearson correlation of the H2O2 production and TPC of green and black teas (n 
=24). 
 
Figure 3.28. Pearson correlation of the TFC, TPC and antioxidant power (FRAP)of green and 
black teas (n =72). 
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Figure 3.29. Pearson correlation of the TFC and TPC of green and black teas (n =72). 
In summary, these assays have shown the diversity of the phenolic content and 
antioxidant/pro-oxidant properties of tea infusions. Good correlations between these 
assays help to give confidence in the selection teas with which to test the hypothesis 
that tea infusions with higher phenolic content and antioxidant/pro-oxidant power will 
have greater antimicrobial activity.  
3.4.4 HPLC Analysis of Aqueous Tea Infusions 
In this investigation the HPLC method developed by Wang et al. (2003), was chosen, as 
it allowed simultaneous identification of six different catechins, gallic acid and caffeine 
(fig 3.30). Initially, the PDA detector was set between 200 – 400 nm and after analysing 
a mixture of authentic standards; it was found that the optimal detection wavelength for 
this study was 210 nm. From the profiles of each standard compound (fig. 3.31) it can 
be seen that they also absorb strongly at 280 nm. A potential advantage of using higher 
wavelengths for detection is the reduction in the signal to noise ratio arising from 
impurities in the mobile phase solvents. However, in this study, it was found that at 280 
nm the limit of detection was reduced considerably. 
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Figure 3.30. The UV spectra of catechins, gallic acid and caffeine between 200 – 400 nm. 
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The concentration curve for each standard was linear between 0.15 – 1.5 µg/mL (fig 
3.31). Therefore, the concentrations of standards in the tea infusions were determined 
by their peak area using linear regression. 
 
 
Figure 3.31. Calibration curve of the peak area of absorbance (210 nm) for each standard 
versus their concentration (n = 3; r2 = 0.99 for all standards). 
 
Apart from gallic acid, the resolution of the standard peaks in the tea samples was 
comparable to the study by Wang et al., (2003) (fig 3.31 and 3.32). In that study, slight 
co-elution of gallic acid with other peaks occurs, although it was more pronounced in 
this study. This is likely due to differences in sample preparation and efficiency of the 
HPLC apparatus.  
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Figure 3.32. HPLC profile of green tea GP-2 at 210 nm. 
 
 
 
Figure 3.33. HPLC profile of black tea BP-5 at 210 nm. 
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Figure 3.34. Concentration of catechins and gallic acid in 38 green tea samples (n = 3). 
 
It is clear that the two most abundant catechins in green tea are EGCG and EGC; they 
are also the catechins that showed the most variation between the different samples (fig. 
3.34). In contrast, the levels of GA, C and GCG were fairly consistent between all the 
green teas regardless of total catechin content (full results matrix in appendix I).  The 
relative levels of each catechin and order of abundance, 
EGCG>EGC>ECG>EC>C>GCG, was comparable to that reported in other studies 
(Wang et al., 2003; Yao et al., 2005; Saito et al., 2006).  
Individually, tea infusion GP-2 contained the highest catechin content with more than 
twice the average amount of EGCG (132.77 ± 0.86 mg/200mL) and EGC (92.12 ± 0.84 
mg/200mL) of all the samples tested. Teas GP-2 and GP-5 also had higher than average 
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catechin content. Similar to GP-2, they are also single plantation teas originating from 
Kenya. This suggests that either the environmental conditions, processing or the variety 
of tea bush used in this region may be optimal for catechin production. However, to 
prove this hypothesis, more samples from this area would need to be investigated.  
The teas with the lowest catechin content were found to be GC-21, GC-22 and GC-23. 
These teas are all green oolong teas, which have all undergone partial fermentation. 
While the fermentation of these specific samples is minimal, it is the most likely reason 
why these teas have considerably lower than average catechin contents. On the other 
hand, it cannot be ruled out that these teas had lower levels of polyphenols post-
processing.  
 
Table 3.3. Comparison of the mean catechin, gallic acid and caffeine content (mg/200mL) of 
green (n=38) and black teas (n=36) by the Mann-Whitney U test (***=p<0.001; ns = not 
significant). 
 
 
 
On average, black teas only had a third of the catechin content of green teas (table 3.3). 
This difference was shown to be significant (p<0.001) after performing a Mann-
Whitney U test (U = 56; z = -6.66; r = 0.78). This was expected, as catechins are the 
building blocks of black tea polyphenols (Roberts, 1958). However, like green teas, 
Significance
GA 7.27 ± 0.67 9.54 ± 0.62 ns
EGC 40.28 ± 4.02 2.11 ± 0.50 ***
C 12.78 ± 0.32 10.72 ± 0.33 ns
EGCG 62.21 ± 4.57 14.18 ± 3.45 ***
EC 16.35 ± 0.91 6.51 ± 0.58 ***
GCG 3.98 ± 0.15 1.11 ± 0.26 ns
ECG 14.87 ± 1.19 5.86 ± 0.89 ***
Caffeine 55.58 ± 3.00 61.75 ± 2.64 ns
Total Catechins 158.26 ± 10.30 50.01 ± 5.53 ***
Green Tea Black Tea
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EGCG was found to account for most of the variation between black teas. Again, C and 
GA remained fairly consistent between black teas and were not found in significantly 
different concentrations to the green teas (table 3.3). This appears to support the current 
theory that C is not involved in black tea pigment formation, as thus far, black tea 
pigments containing catechin subunits have not been found (Tanaka et al., 2009a). The 
caffeine content between green and black teas was also not significantly different (table 
3.3). 
 
Figure 3.35. Concentration of catechins and gallic acid in 34 black tea samples (n = 3). 
 
Collectively, the catechin profiles of black teas are relativity similar apart from a few 
examples. In particular, tea BC-6 was shown to contain more than three times the total 
catechin content of other black teas (182.8 mg/200mL). This is because BC-6 is a 
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commercial tea marketed for health purposes and is composed of green and black tea at 
a ratio of 1:2. In comparison with the other black tea samples and with reference to the 
average green tea catechin content, it is obvious that a large proportion of the catechins 
in this tea blend are accounted for by the addition of the green tea leaves. However, this 
tea did not stand out in the TPC and TFC assays highlighting the limitations of these 
assays. In addition to BC-6, black teas BP-2, BP-3, BC-5 and BC-12 also showed a 
substantially higher than average catechin content (fig 3.35). These four teas are of the 
Darjeeling variety, which means that they have been grown and processed in the 
Darjeeling district of West Bengal, India. As previously discussed, many factors may be 
involved in determining the catechin content of tea leaves; however of the tested 
samples, it is evident that Darjeeling teas have disproportionately higher catechin 
content than other black teas. Although no specific reference to the observation was 
made, studies by Astill et al. (2001), and Fernández et al. (2002), also show that 
Darjeeling teas have higher catechin content that other types of black tea. Again these 
samples did not stand out in the TPC and TFC assays. However, they did appear to have 
higher than average antioxidant power compared to the black tea samples in this study.  
Another noticeably different black tea was BC-15. With only small concentrations of 
EC, ECG and GA, it had the lowest total catechin content (8.67 mg/200mL) of all the 
black tea samples. This can be explained by the processing of this tea; it is a Pu-erh tea 
variety that undergoes microbial fermentation after enzymatic fermentation is exhausted 
(Xie et al., 2009). This takes place over many years and ultimately produces teas that 
have little or no catechin content as seen with tea BC-15.  
Although a significant difference was found between green and black teas (p<0.001), a 
Kruskal–Wallis one-way ANOVA showed that there was no difference between 
commercially sourced and single plantation teas (fig. 3.36), which was consistent with 
the findings of the colourimetric assays. 
Grouping the green teas by country of origin and performing a Kruskal–Wallis one-way 
ANOVA showed that African teas contained significantly more catechins than those 
from China (p<0.01). However, there was no difference observed between any of the 
other groups (fig. 3.37). 
	  
 
	  
 
CHAPTER 3 
	  
	   	  
95	  
 
Figure 3.36. Mean catechin content of single plantation green (n=15), commercially sourced 
green (n=23), single plantation black (n=18) and commercially sourced black (n=16) teas 
(error bars = SE).  
 
 
Figure 3.37. Comparison of the total catechin content of green teas from China (n=15), Africa 
(n=3), Japan (n=5) and Indonesia (n=4) using the Kruskal-Wallis test (error bars = SE; 
**=p<0.01).  
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African green teas had the highest concentration of gallic acid and all six catechins apart 
from GCG (fig. 3.38). The concentration of EGCG in African teas was particularly high 
(>120mg/mL); a characteristic which is seen of the assamica variety of plant (Yang et 
al., 2007). The opposite was true for Chinese green teas, which specifically showed a 
marked reduction in concentrations of EGC and EGCG (fig. 3.38). Japanese teas had 
higher levels of EGC in comparison to Indonesian teas (66.6 ± 6.3 vs. 35.9 ± 7.7 
mg/200mL; ± = SE), however they had both had similar levels of other catechins. The 
findings of this analysis reinforce the conclusions of the colourimetric assays.             
         
 
Figure 3.38. Comparison of the individual catechin content of green teas from China (n=15), 
Africa (n=3), Japan (n=5) and Indonesia (n=4; error bars = SE).  
 
In contrast to the previous findings, a Kruskal–Wallis one-way ANOVA revealed no 
significant difference (p>0.05) in the catechin content of black teas based on country of 
origin (fig 3.39). It was previously found that Chinese black teas had significantly lower 
TPC, TFC and antioxidant power (section 3.4.1, 3.4.2 and 3.4.3). Therefore, this result 
GA EGC C EGCG EC GCG ECG
0
50
100
150
China
Africa
Japan
Indonesia
Catechin
C
on
ce
nt
ra
tio
n 
m
g/
20
0m
l
	  
 
	  
 
CHAPTER 3 
	  
	   	  
97	  
would imply that other flavonoids or black tea pigments rather than catechins in black 
teas are responsible for these differences.  
 
Figure 3.39. Comparison of the total catechin content of black teas from China (n=5), Africa 
(n=5) and India (n=10) using the Kruskal-Wallis test (error bars = SE). 
 
 
Figure 3.40. Comparison of the individual catechin content of black teas from China (n=5), 
Africa (n=5) and India (n=10; error bars = SE). 
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Reviewing the breakdown of the individual levels of catechins in each country, it was 
found that Indian teas have higher levels of EGCG and ECG. This variation is likely 
due to the influence of the four Darjeeling samples, which were previously shown to be 
catechin rich. In addition, African black teas contained no GCG and relatively low 
levels of EGC. This might be attributed to the method and extent of tea leaf processing 
at these cultivars. 
3.4.5 Correlation of Colourimetric assays with total catechin levels measured by 
HPLC 
The results of the HPLC analysis appear to complement the findings of the 
colourimetric assays. A correlation analysis was performed to determine the relationship 
between these assays. Pearson’s bivariate correlation was used to determine the 
relationship between the assays for green teas, as all the data set met the assumptions 
detailed in chapter 2 (section 2.3.5).  Conversely, the catechin content of black teas did 
not follow normal distribution. Therefore, the data was transformed using a log 
transformation, which was subsequently found to follow normal distribution.  
 
Table 3.4. Correlation of total catechins measured by HPLC in teas with their TFC, TPC, 
FRAP (n=72) and H2O2 production (n=24). Data represented as Pearsons r (rr). 
 
1 Data transformed using a log transformation; **=p<0.01, *=p<0.05. 
For green teas, strong correlations were observed between total catechins (as measured 
by HPLC) and all four colourimetric assays (r >0.70; table 3.4). The strongest 
correlations were found between total catechins, antioxidant power, H2O2 production 
and TPC in green teas, which had a shared variance of 79 %, 74 % and 73 %, 
respectively. These strong correlations support the hypothesis that catechins are the 
Total Catechins TPC TFC FRAP H2O2
Green 0.86 (0.73)** 0.76 (0.58)** 0.89 (0.79)** 0.86 (0.74)**
Black1 0.41 (0.17)* 0.28 (0.08) 0.71 (0.50)** 0.27 (0.07)
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main anti/pro-oxidants and account for the majority of the polyphenols present in green 
tea infusions. This would be expected as catechins are the predominant polyphenols in 
green tea and make up 30 – 40% of the extracted solids in tea infusions, whilst other 
flavonoids only account for 5 – 10% (Graham, 1992). 
In comparison, the total catechin content of black teas was weakly correlated to TFC 
(r=0.28; table 3.4) and H2O2 production (r=0.27; table 3.4). This would infer that H2O2 
production in black teas is due to other components, possibly thearubigins and 
theaflavins. In addition, the weak correlation between TFC and catechins would suggest 
that other compounds are the predominant flavonoids in black tea. The flavonols 
quercetin and kaempferol are present in black teas at similar levels to that of green teas, 
as they are not affected by the fermentation process to produce black tea (Wang and 
Helliwell, 2001). Alternatively, it may be due to non-specific binding of black tea 
polyphenols to the assay reagent or differential extraction kinetics.  
A moderate correlation (r=0.41; table 3.4) was found between the TPC and catechin 
content of black teas. This can be explained by the lower levels of catechins found in 
black teas and therefore the black tea polyphenols would account for the majority of the 
TPC.  
Black teas were previously shown to have significantly less antioxidant power than 
green teas (fig. 3.19). Thus, the strong correlation between the catechin content of black 
teas and antioxidant power (r=0.71; fig 3.41) would imply that the black tea 
polyphenols are less powerful antioxidants. 
3.4.6 Comparison of the Colourimetric assays with the HPLC analysis 
The TPC assay would appear to be an accurate estimation of the total catechin content 
of green and black infusions. In table 3.5 it can been seen the catechin content of green 
teas measured by HPLC and the estimated TPC are in agreement, as catechins make up 
the majority of polyphenols in green tea (Graham, 1992).  
The catechin content of black tea infusions is reported to be approximately 18 % 
dependant on the type of black tea (Graham, 1992). In this study it was found on 
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average that catechins made up approximately 38 % of the total phenolic content of 
black tea infusions. This slight over estimation may be due to the limitations of TPC 
assay or differences in extraction kinetics.  
On the contrary, the TFC assay severely underestimated the catechin content in both 
green and black teas (table 3.5). Based on these results and the correlation analysis, it 
would appear that the TFC assay could be used to differentiate teas by catechin content. 
However, the value obtained from this assay may not reflect the true concentration in 
the tea infusion.  
 
Table 3.5. The mean TPC, TFC and total measured catechins (HPLC) of black and green teas 
(values expressed as mg/200ml). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tea TPC TFC Catechins
Green 193.75 40.75 158.26
Black 136.25 32.35 50.01
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3.5 Conclusions 
The analysis of a substantial collection of single plantation and commercially sourced 
teas (n=72) has allowed the ability to perform a comprehensive statistical analysis of the 
following factors, TPC, TFC, FRAP and H2O2 production. This has shown that green 
teas on average have higher antioxidant power, produce more H2O2 at physiological pH 
(pH 7.4) and contain more catechins than black teas. It was also found that there is 
considerable variation in these properties within examples of the same type of tea.  
From this data it would appear that the country of origin might play a key role in 
defining the chemical makeup of individual tea infusions. The factors responsible are 
likely to include the variety of the tea plant and the environmental conditions under 
which the plant is grown.  To confirm the validity of these findings more tea samples 
from each country would need to be investigated and each sample would need to be 
supported by details of the tea variety, environmental growth conditions and processing 
method.  
On an experimental note, this investigation has found that the colourimetric assays for 
measuring TPC, TFC, H2O2 production and antioxidant power are robust methods with 
which to determine relative differences in the properties of tea samples, as long as the 
limitations of their use are taken into consideration. The high throughput of these 
techniques also enables a rapid preliminary determination to be made of unique or 
representative examples prior to quantitative analysis using a method such as HPLC.  
Furthermore, this chapter has demonstrated the dual antioxidant/pro-oxidant activity of 
tea and has emphasised the need to account for the pH of the testing environment when 
determining the potential health benefits or antimicrobial properties of a tea infusion.   
Ultimately, this chapter has quantified the attributes thought to contribute to the 
antimicrobial actives of tea. Thus, these findings will prove fundamental in interpreting 
the biological results of the following chapters. 
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4. Evaluation of the Antibacterial Activity of Tea Infusions 
4.1 Chapter Introduction 
Tea infusions are known to contain compounds with antimicrobial properties, 
particularly against Gram-positive organisms (Ahn et al., 1990; Ikigai et al., 1993; 
Taguri et al., 2004). However, contrary to the abundance of research into specific tea 
compounds, particularly catechins, relatively few studies have compared and screened 
the antimicrobial activity of whole tea infusions. As a consequence there are currently 
no standard methods for testing the antibacterial activity of tea infusions or an 
understanding of how the catechins contribute to the antibacterial activity of tea. 
4.1.1 Staphylococcus aureus as a Model Organism for Method Development 
Before determining the sensitivity of C. difficile to tea infusions and individual 
polyphenols, an assay for accurately quantifying the antimicrobial activity needed to be 
developed. Unfortunately, C. difficile is a particularly difficult organism to culture (Hall 
and O’Tool, 1935) and for this reason, Staphylococcus aureus, a bacterium that is 
relatively simple to handle and manipulate, was employed to develop the various assays 
to be used in future studies. 
S. aureus is a Gram-positive cocci  that measures between 0.7 and 1.0 µm in size 
(Cowan and Shaw, 1954). They are non-motile bacteria that form grape like structures 
in culture and unlike C. difficile, do not form spores (Shaw et al., 1951). Described as 
facultative anaerobes, they can grow in both aerobic and anaerobic conditions on a 
variety of general culture media preparations (Murray et al., 2007). Clinically, they are 
a common cause of community-acquired sepsis and are one of the most prevalent 
nosocomial infections in the UK (Murray et al., 2007). In 2012 there were 8000 cases of 
S. aureus reported in England alone (HPAa. 2012).  
Of particular interest to this study is the fact that the bacterium and its antibiotic 
resistant variants, Methicillin Resistant Staphylococcus aureus (MRSA), have been 
previously used by researchers to assess the antimicrobial effect of tea extracts and 
polyphenols (Chou et al., 1999; Hamilton-Miller and Shah. 1999; Hu et al., 2002; 
Stapleton et al., 2004). This has helped to provide an understanding of the sensitivity of 
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S. aureus to tea compounds and undoubtedly has prompted further investigation into the 
sensitivity of other Gram-positive bacteria to tea.  
In addition to the direct antimicrobial action, pre-treatment with tea polyphenols have 
been reported to reduce the oxacillin resistance of MRSA by interfering with penicillin 
binding protein 2a (Bernal et al., 2009). In this study ECG was found to be the most 
effective tea polyphenol and had profound effects on the cell surface causing cell wall 
thickening and aggregation of cells (Bernal et al., 2009). At a concentration of 12 
mg/mL the MIC of oxacillin was reduced from 256 µg/mL to 4 and 16 µg/mL with 
ECG and EGCG respectively. However, the non-galloyl catechin EC had no effect on 
the MIC of oxacillin against MRSA (Stapleton, 2007), suggesting that the galloyl 
moiety is important for this function. It was also demonstrated in this study that ECG 
treated MRSA prevented biofilm formation; a key function that is required for the cells 
to adhere to surfaces. 
In summary, S. aureus is an ideal model organism as like C. difficile, it is a Gram-
positive bacteria, it is relatively easy to culture and has been shown to be sensitive to the 
antimicrobial properties of tea.  
4.1.2 Methods for Determining the Antibacterial Activity of Tea 
Tea infusions are known to contain antimicrobial compounds (Ahn et al., 1990; Ikigai 
et al., 1993). However, dependence on qualitative susceptibility tests, such as the agar 
diffusion assay and a lack of robust standard methods to quantify the degree of 
antimicrobial activity, has made it difficult to compare the results of different studies 
and determine the antimicrobial profile of individual tea infusions (Ahn et al., 1991; Yi 
et al., 2010; Tariq and Reyaz 2012). To the best of our knowledge, quantitative 
antimicrobial testing has only been performed on dried tea extracts, obtained using 
extensive extraction techniques (> 30 min) with solvents such as ethyl acetate, ethanol 
or methanol (Ahn et al., 1991; Yam et al., 1997; Neyestani et al., 2007; Tahir and 
Moeen, 2011). To date, no standard assay has been developed to determine the 
minimum inhibitory concentration of aqueous tea infusions. 
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A further point that warrants consideration when designing antimicrobial assays is to 
determine the possibility of negative interactions between the active compounds and the 
constituents of the assay. For example, the biological growth medium used for testing 
tea infusions or polyphenols may contain elements that inhibit activity.  
The addition of milk to tea is thought to have a detrimental effect on its health benefits 
due to the presence of casein proteins in milk, particularly β-casein (Lorenz et al., 2007), 
binding to the major tea catechins (EC, EGC, ECG and EGCG) by a combination of 
hydrophobic and hydrophilic interactions (Bourassa et al., 2013). The relevance of these 
observations to microbial culture media is that many preparations contain casein 
proteins to aid microbial growth. Hence, it is plausible that these compounds, 
particularly in solid based media, may affect the antimicrobial activity of polyphenols 
and tea infusions. Furthermore, other components such as heavy metals in the media 
may also interact with polyphenols, as they may instigate Fenton reactions resulting in 
polyphenol oxidation (Nakagawa et al., 2002).  Therefore, it is essential that these 
factors are considered when attempting to design an assay which accurately and 
reproducibly determines the antibacterial activity of a tea infusion.  
4.1.3 Ascertaining the Antimicrobial Compounds in Tea Infusions 
4.1.3.1 Combining HPLC Analysis with Antimicrobial Activity 
The chemical complexity of the tea infusion inherently makes it difficult to establish the 
contribution of individual compounds to the overall antimicrobial activity. To date the 
sole factors have not been determined. Further compounding this problem is the 
observation that tea polyphenols can act synergistically, potentiating the activity of 
other polyphenols (Sasaki et al., 2004).  
At present, it is thought that the catechin polyphenols are the primary contributors to 
tea’s antimicrobial activity, as they represent by weight, the major components in 
aqueous tea infusions and individually have been shown to possess antimicrobial 
activity (Ikigai et al., 1993; Chou et al., 1999; Sakanaka et al., 2000). However, other 
compounds in tea, such as the flavonols quercetin (Hamburger and Cordell, 1987), 
kaempferol (Koo et al., 2000) and myricetin (Bylka et al., 2004) have also been shown 
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to possess antimicrobial activity. Although present in smaller quantities than the 
catechins, these compounds represent 2 – 3 % of the aqueous tea infusion (Balentine et 
al., 1997). 
Combining HPLC analysis, standardised antimicrobial assays and statistical analysis 
such as correlation and multiple regression, may help to determine the most important 
factors in tea and their contribution to the overall activity of the infusion. A similar 
approach was attempted by Sasaki et al., (2004). This study compared the HPLC 
profiles of fractionated oolong tea extracts in relation to their antimicrobial activity 
(Sasaki et al., 2004). The study reported that synergism was present between the main 
catechins, but due to the design of study and limited number of catechin combinations, 
it was not able to rule out if other components in the tea infusion may have contributed 
to the activity (Sasaki et al., 2004).  
4.1.3.2 High Performance Counter Current Chromatography (HPCCC) 
In addition to HPLC, non-destructive fractionation techniques such as high performance 
counter current chromatography (HPCCC) may also prove useful in determining active 
components of tea. Described as an orthogonal approach to HPLC, it has become an 
increasingly popular technique in natural product drug discovery in the last 10 years 
(Sutherland and Fisher, 2009), largely due to its ability to isolate large quantities of pure 
compounds from crude extracts.  The application of this technique to tea extracts is 
relatively new, however a notable example of its use demonstrated the ability to 
separate gram quantities of pure EGCG and ECG (Baumann et al., 2001). The 
principals are the same as HPLC in that the crude mixture is carried in the mobile phase 
(MP) and then is separated in a stationary phase (SP) due to the different affinities of 
the individual compounds to the stationary phase (Sutherland and Fisher, 2009). Thus 
resulting in compounds eluting from the system at different times, and if a preparatory 
method is used, the individual peaks, detected by UV, can be collected as they elute. In 
HPLC, the SP is solid, usually a column of packed C-18 silica.  
In HPCCC the SP is liquid and separation of individual components does not arise due 
to physical interaction, but on basis of the different partition coefficients (Kd) of the 
individual compounds in the mixture to the SP and the MP (Martin and Synge, 1941). 
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This is advantageous, as there is no loss of compounds due to physical adsorption onto 
the column (Sutherland et al., 1987). To aid the separation of the compounds in CCC 
and increase the contact of the compounds to each phase, the column (which is filled 
with SP liquid) is spun at high speed in a planetary motion (Sutherland et al., 1987). 
This results in hundreds of individual mixing and separation waves throughout the 
column, which can be controlled by the flow rate of the solvent, the temperature of the 
oven and the speed of the column (Sutherland et al., 1987). The MP then flows through 
the column in an ‘Archimedes Screw’ like fashion through the SP and is collected at 
time points defined by the user (Sutherland et al., 1987). Ultimately, using this 
technique, crude mixtures can be separated for further analysis or desired peaks can be 
extracted in large volumes. An overview of this system is shown figure 4.1. 
 
 
 
Figure 4.1. A schematic diagram of HPCCC equipment and set up. 
 
Although HPCCC is a powerful tool for separating crude mixtures (Sutherland et al., 
2007), selecting a solvent system to use in the apparatus is the limiting step and the 
major drawback to progression of the technology (Ignatova et al., 2011). The solvent 
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selection is crucial for successful isolation of compounds, as their interaction with the 
two phases is key to their separation (Sutherland et al., 1987). If a compound or groups 
of compounds only have affinity for one phase, they will not mix during the run and 
will therefore co-elute with other compounds (Martin and Synge. 1941). Therefore, to 
determine the ideal solvent system, the crude mixture must be tested in a wide variety of 
solvent systems in the HPCCC, often with limited success (Ignatova et al., 2011). Not 
only is this a labour intensive process, it is impractical if a limited amount of starting 
material is available. 
In context, using this method to sub-fractionate tea extracts into its component parts in 
combination with HPLC and antimicrobial activity assays may be a powerful method to 
discover new compounds or attribute activity to known components. However, to 
achieve the potential of this technique, a method must be developed to ensure desired 
fractionation of compounds and selection of an appropriate solvent system. 
4.1.4 The Involvement of H2O2 in the Antimicrobial Mechanisms of Tea Infusions 
and Catechins 
The antimicrobial mode of action of catechins or tea infusions is not well understood, 
yet the body of evidence suggests that the likely targets are the outer structures of the 
bacterial cell such as the lipid membrane or cell wall, at least for Gram-positive bacteria 
(Stapleton et al., 2004; fig 4.2). It has been proposed that binding of catechins to 
peptidoglycan via hydrogen bonds, results in the degradation of peptidoglycan 
crosslinking (Yoda et al., 2004). It has also been observed that polyphenols with higher 
affinity for lipid membranes, such as catechin gallates, have more pronounced 
antimicrobial activity and therefore, exert their action by perturbing the membrane 
(Hashimoto et al., 1999). More recently, catechins have been shown to interact with 
bacterial DNA gyrase (Gradišar et al., 2007) suggesting that more than one mechanism 
of action may exist.  
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Figure 4.2. The structure of the cell envelope of Gram-positive and Gram-negative bacteria. 
Adapted from Denyer et al. (2004). 
 
In addition to the direct interaction of polyphenols with bacterial components, it has 
been proposed that antimicrobial activity could be a consequence of hydrogen peroxide 
production by tea polyphenols and it is this, which is key to their antimicrobial action 
(Arakawa et al., 2004). A study by Arakawa et al. (2004), found that the most 
biologically active polyphenols generated the most H2O2 by the mechanism proposed in 
chapter 3 (section 3.1.1.4). They also reported that the addition of catalase, an enzyme, 
which degrades H2O2, eliminated the antibacterial activity of EGCG in a dose-
dependent manner (Arakawa et al., 2004). This was supported by a previous study, 
which showed that H2O2 production was related to the presence of pyrogallol and 
galloyl moieties (Akagawa et al., 2003) of catechins, as it is known that these types of 
catechins have more potent antimicrobial activity (Sasaki et al., 2004). Furthermore, 
EGC, which is one of the most potent antimicrobial catechins, produces more H2O2 than 
other catechins (except EGCG) and yet has the lowest affinity for lipid bilayers 
(Nakayama et al., 2002). The galloyl and pyrogallol groups of the catechin EGCG is 
shown in figure 4.3. 
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Figure 4.3. The structure of EGCG. The galloyl moiety is highlighted in blue whilst the 
pyrogallol moiety is highlighted in red. Adapted from Bradfield and Bate-Smith, (1950). 
 
Contrary to these findings, a recent study has suggested that H2O2 is involved in the 
antimicrobial activity of catechins against Gram-negative bacteria but not Gram-
positive bacteria (Cui et al., 2012). The study observed, using Atomic Force 
Microscopy (AFM) that S. aureus treated with catechins caused cell aggregation and 
distortion of the outer cell structure, a phenomenon that was also observed with MRSA 
by Taylor et al. (2009) using Scanning Emission Microscopy (SEM). However, when 
the bacteria were treated with H2O2, these changes were not found (Cui et al., 2012).  
Although, in the same study, it was found that H2O2 was most likely to be implicated in 
the antimicrobial mechanism of catechins against Gram-negative bacteria, as AFM 
images showed similar types of damage to the outer membrane of E. coli treated with 
H2O2 (Cui et al., 2012).  
It is clear that there is uncertainty surrounding the involvement of H2O2 in the 
antimicrobial action of catechins. However, in the context of tea infusions, a complex 
mixture in which synergy is implicated (Sasaki et al., 2004), the role of H2O2 in their 
antibacterial action is unknown.  
To help determine the antimicrobial mechanism of tea infusions, this study will attempt 
to investigate how H2O2 production contributes to activity and if structural derivatives 
of the pyrogallol or galloyl moiety in catechins can further improve the understanding 
of these underlying mechanisms. 
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4.2 Aim and Objectives 
The aim of this chapter was to determine the antimicrobial activity of a comprehensive 
range of tea infusions and attempt to underpin their antimicrobial components. 
The objectives of this chapter were to: 
1) Develop a reproducible and accurate method for quantitatively determining the 
antimicrobial activity of tea infusions. 
 
2) Quantify the antimicrobial activity of tea infusions and determine the difference in 
activity between green, black, commercial and single plantation teas. 
 
3) Determine the relationship between the chemical properties, composition and the 
antimicrobial activity of different tea infusions. 
 
4) Evaluate the relationship between chemical structure, hydrogen peroxide production 
and the antibacterial activity of catechin polyphenols.  
 
5) Develop a novel method to fractionate tea using HPCCC to help the identification of 
the antimicrobial components in tea infusions.  
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4.3 Methods 
4.3.1 Culture Preparation and Enumeration 
4.3.1.1 Preparation of Fresh Bacterial Culture Slopes 
A 10 mL volume of molten sterile tryptone soya agar (TSA) was added to a sterile 20 
mL McCartney bottle and allowed to set at a gradient.  The agar slope was inoculated 
with a loop of S. aureus (NCIMB 9581) obtained from a freshly thawed freezer culture 
and then incubated at 37 °C (Memmert Ltd., UK) for 24 h. The resulting culture was 
then checked for purity using the streak plate method (Ch. 2; section 2.3.2) followed by 
Gram staining isolated colonies (Ch. 2; section 2.3.3). Cultures were then stored in a 
fridge  (2 oC - 8 oC) (Scandinova, Comet Ltd., UK) until further use.  Fresh culture 
slopes prepared from frozen stocks every two weeks.  
4.3.1.2 Determining the Concentration of Re-suspended Bacterial Cultures 
Centrifuge tubes (Thermo Fisher Scientific Ltd., UK) containing 30 mL of tryptone 
soya broth (TSB) were inoculated from a bacterial slope culture using a 10 µL 
inoculation loop (Microspec, Ld., UK).  The inoculated broths were incubated at 37 °C 
for 24 h in a shaking incubator set at 100 revolutions per minute (rpm) (Thermo Fisher 
Scientific Ltd., UK).  After 24 h the broths were centrifuged at 2600 xg for 15 min 
(Avanti J-20 XP, Beckman Coulter Inc. UK).  The supernatant was removed and the 
pellet was re-suspended in sterile PBS to produce a stock solution with an optical 
density of 0.8 as determined by a spectrophotometer (Ultrospec 3100 Pro, Amersham 
Biosciences Ltd., USA) set a wavelength of 600 nm (OD600).  The neat bacterial culture 
stock was diluted with PBS to produce a range of OD600 between 0.1 – 0.8. 
Simultaneously, a viable count of the colony forming units (CFU)/mL for each dilution 
was performed using the drop counting method by Miles et al., (1938).  The method by 
Miles et al., (1938) was performed as follows. A 10 µL aliquot of each culture dilution 
was pipetted onto a sector of a circular TSA plate in triplicate and incubated for 24 h.  
Following incubation, colonies were counted on each sector that contained between 3 - 
30 countable CFU’s per spot and the average of the three spots was calculated.  
 
	  
 
	  
 
CHAPTER 4 
	  
	   	  
113	  
The log CFU/mL was then calculated by the following equation: 
Log CFU/mL = !"#$  !"#!"#$%"&'  !"#$%&  
The results were then recorded into an Excel® spread sheet and an OD600 versus 
CFU/mL graph was constructed (fig 4.4). This produced the linear equation to predict 
the CFU/mL in a sample based on the optical density of the solution at 600 nm. This 
method was repeated five times. 
 
 
Figure 4.4.  An OD600 versus CFU/mL x 109 for S. aureus NCIMB 9518. 
 
4.3.1.3 Preparation of a Working Culture 
Bacteria were cultured as described in section 4.3.1.2 and diluted in PBS to an OD600 
indicative of a concentration 1 x 109 CFU/mL. This working culture was then further 
diluted in PBS using serial dilution to achieve the CFU/mL required for subsequent 
assays. 
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4.3.2 Developing a Method for Determining the MIC of Tea Infusions  
All experiments in this section were repeated in triplicate unless otherwise stated. The 
MIC of ampicillin was tested simultaneously in each experiment between the 
concentration ranges of 0.015 – 0.48 %(w/v) in sterile diH2O as a positive control. Tea 
infusions were prepared using the method previously described in chapter 2 (section 
2.3.1). 
4.3.2.1 Determining the MIC of Tea Infusions and Catechins Using the Broth 
Dilution Method 
To each well of a 96 well microtitre plate, 20 µL of 10 times concentrated LB broth was 
added. A 1 x 108 CFU/mL bacterial suspension of S. aureus NCIMB 9518 was prepared 
as described in section 4.3.1. The suspension was serially diluted and 10 µL of each 
dilution (1 x 103 to 1 x 108 CFU/mL) was added to each row of a 96 well plate. Next, 
170 µL of EGCG at solutions between 0.18 – 2.4 mg/mL (diluted in sterile diH2O) were 
added to each row in duplicate. The same procedure was performed for each tea 
infusion. Of each tea infusion, 170 µL of samples containing 100, 50 and 25 %(v/v) 
dilutions in sterile diH20 were added. The plates were then incubated for 18 h at 37 °C 
on a shaking platform at 80 rpm. After 24 h wells were checked for growth by 
comparing the OD600 of each well to the negative and positive control wells. Negative 
control wells contained 10 µL of sterile PBS while positive control wells contained 10 
µL of each bacterial inocula in 10 times concentrated LB broth.  
4.3.2.2 Determining MIC of Tea Infusions by a Modified Agar Dilution Method  
Neat tea infusions were serially diluted with sterile diH2O to produce a concentration 
range between 3.13 and 100 %(v/v). To the wells of a 6 well cell culture plate (Corning, 
UK), 2 mL of each tea dilution was added with 2 mL of autoclaved and cooled (60 oC) 
double concentrated LB agar and left to set, which produced agar wells containing 1.6 
to 50 %(v/v) of tea infusion agar (fig. 4.5). A standard inoculum of S. aureus was 
prepared as described in section 4.3.1 containing 104 CFU/10 µL. Three 10 µL inocula 
of S. aureus were pipetted onto separate areas of each tea agar well and the plate was 
incubated for 18 h at 37 oC. After incubation, wells were checked for the growth of 
colonies. The minimum concentration of tea incorporated agar that prevented growth of 
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bacteria after 18 h was recorded as the MIC of that tea infusion. The negative control 
was 2 mL double strength LB agar diluted with 2 mL of sterile diH2O. Tea infusion 
plates and control plates were produced in triplicate. This method was adapted from the 
BSAC agar dilution MIC protocol (BSAC., 2012).  
The appropriate statistical analysis as described in chapter 2 (section 2.4) was used to 
determine if there was a significant difference in the MIC of green, black, commercial 
and single plantation tea infusions.  
The experiment was also repeated at the end of the study period to validate the stability 
of the stored tea leaf material. 
      
Figure 4.5. Tea incorporated agar placed into 6 well culture plates at different concentrations. 
 
4.3.2.3 Determining MIC of Tea Components by a Modified Agar Dilution Method  
Stock solutions of each catechin or tea components were prepared to achieve a 
concentration of 2 mg/mL in sterile diH2O. Compounds with a solubility limit lower 
than 2 mg/mL were made up to the highest achievable concentration. The stock 
solutions were serially diluted in sterile diH2O to produce a concentration range 
between 31.25 µg/mL – 1 mg/mL. Dilutions were made up to a volume of 2 mL. The 
agar dilution plates were produced and the MIC was determined as described in section 
4.3.1.2. The negative control was 2 mL double strength LB agar diluted with sterile 
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diH2O. Compounds with an MIC of 31.25 µg/mL were retested at a dilution range 
between 0. 97 – 31.25 µg/mL.  
4.3.2.4 The Effect of Casein Hydrolysate on the MIC of Tea Infusions and 
Catechins 
Agar dilution plates of tea infusions and catechins were produced as described in 4.3.2.2 
with LB agar and with Muller-Hinton agar. To the LB agar plates, 0, 1, 1.75, 2 or 
3 %(w/v) casein hydrolysate was added. The MIC was then determined as described in 
section 4.3.2.2. The negative control was 2 mL double strength LB agar diluted with 
sterile diH2O at each casein concentration. 
4.3.2.5 The Effect of Different Agars on the MIC of Tea Infusions and Catechins 
Agar dilution plates of tea infusions were produced with LB, MH, Iso-sensitest®, 
Brucella, BHI and TSA agars and the MIC of tea infusions was determined using the 
method described in section 4.3.2.2. The negative control was 2 mL of each agar 
(double concentrated) diluted with sterile diH2O. 
4.3.3 Evaluation of the Relationship Between the Properties of Catechins and Tea 
Infusions with Antimicrobial activity 
4.3.3.1 Determining the MIC of Gallic Acid Derivatives  
The MIC’s of gallic acid derivatives: 3,4,5-trimethoxybenzyl alcohol, shikimic acid, 
3,4,5-trimethoxybenzoic acid, 3,4,5-trihydroxybenzamide, pyrogallol, gallacetophenone, 
2,3-dihydroxybenzoic acid and 2,5-dihydroxybenzoic acid were determined using the 
method previously described in section 4.3.2.2. All compounds were dissolved in sterile 
diH2O.  
4.3.3.2 Determining the Relationship Between Hydrogen Peroxide Production 
from Tea Infusions and Antimicrobial Activity 
The relationship between H2O2 production and antimicrobial activity was determined 
using the appropriate correlation analysis as described in chapter 2 (section 2.4).  
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4.3.3.3 The Effect of the Addition of Catalase to the MIC of Tea Infusions and 
Catechins  
Tea infusion or catechin agar plates were prepared as described in section 4.3.2.2 with 
the following modifications. To each tea or catechin dilution, 100 µL of catalase 
solution (1000 Units/mL in sterile diH2O) or diH2O (negative control) was added. The 
MIC was then determined as described in 4.3.2.2.  
4.3.3.4 Determining the Relationship Between Total Polyphenol Content, 
Antioxidant Power, Total Flavonoid Content, Hydrogen Peroxide Production, 
Total Catechins and the MIC of Tea Infusions 
The relationship between TPC, FRAP, TFC, H2O2, total catechins and the MIC of tea 
infusions was determined using the appropriate correlation analysis as described in 
chapter 2 (section 2.4). 
4.3.3.5 Determining the MIC of a Synthetic Copy of Tea Infusion GP-2 
A synthetic version of tea GP-2 was made using the same quantities of GA (17.3 
mg/mL), EGCG (132.8 mg/mL), ECG (28.6 mg/mL), EGC (92.1 mg/mL), EC (26.1 
mg/mL), C (19.3 mg/mL) and GCG (5.5 mg/mL) in diH2O found in GP-2 based on the 
HPLC analysis (appendix 1). The MIC of the synthetic tea was determined as described 
in section 4.3.2.2. 
4.3.3.6 Determining the Relationship Between The Concentration of Individual 
Catechins and the MIC of Tea Infusions 
The relationship between the concentration of individual catechins and the MIC of tea 
infusions was determined using the appropriate correlation analysis as described in 
chapter 2 (section 2.4). The relationship was also determined between galloyl and 
pyrogallol containing catechins and MIC.  
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4.3.4 Bioactivity Guided Solvent Selection for HPCCC 
4.3.4.1 Preparation of Green Tea Extract 
A methanol extract of green tea GP-2 was prepared as follows. To 500 mL of methanol, 
25 g of tea was added and left to stir at room temperature for 24 h using a magnetic 
stirrer to create a vortex. The supernatant was then collected by vacuum filtration using 
Whatman® grade 1 filtration paper. The solvent was then removed using a Büchi 
Rotavapor R-124 (Büchi Ltd., UK) at room temperature and the remaining solid was 
stored between 2 – 8 °C. 
4.3.4.2 Solvent Selection 
Two-phase solvent systems were made using an automated Multiprobe II Plus liquid 
handling system (PerkinElmer Ltd., UK). Each system was made up to a total volume 
of 5 mL in test tubes (table 4.1). Next, the tea extract was prepared. To 5 mL of 
analytical grade methanol, 300 mg of a dried methanol extract of green tea GP-2 was 
dissolved. To each solvent system, 50 µL of the green tea solution was added and the 
test tube was manually shaken to aid distribution of the compounds between the two 
solvent phases. The solvent systems were then left to settle at room temperature for 10 
min. After settlement, a 500 µL sample was taken from the upper phase and lower 
phase of each system and transferred to labelled HPLC vials in duplicate. The solvent in 
each vial was then evaporated using a solvent concentrator (Eppendorf® Concentrator 
5301, UK). After evaporation, the vials were then stored between 2 – 8  °C until needed 
for HPLC analysis or biological activity screening.  
4.3.4.3 HPLC Analysis of Solvent System Partitions 
Samples of the lower and upper phase of each solvent system were analysed by HPLC 
using the method described in Chapter 3 (section 3.3.2.2). Standards of EGCG, EC, 
ECG, EGC, GA and caffeine were used to identify reference peaks in the chromatogram. 
The area under each peak was recorded for compounds in the lower and upper phase of 
each solvent system.  
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4.3.4.4 Bioactivity Screen of Solvent Systems Against S. aureus 
4.3.4.4.1 Preparation of Bacterial Susceptibility Plates 
Plates were prepared by adding 30 mL of sterile molten LB agar to sterile square petri 
dishes (100 mm x 100 mm; Sterilin Ltd., UK), which were left to set at room 
temperature.  The agar plate was inoculated with 500 µL of S. aureus  (1×105  CFU/mL) 
and evenly spread across the surface of the agar using a cotton swab under aseptic 
conditions. A cork borer with a diameter of 1 cm was sterilised with ethanol and a 
Bunsen flame. It was then used to bore 12 individual wells into the agar plate. 
4.3.4.4.2 Bacterial Susceptibility Assay 
The upper and lower phase samples of each solvent system were suspended in 100 µL 
of 2 %(v/v) dimethyl sulfoxide (DMSO) in diH2O. Of each sample, 50 µL was pipetted 
into a well of a bacterial susceptibility plate in triplicate and labelled. A volume of 50 
µL (2 %(v/v)) dimethyl sulfoxide was also pipetted into triplicate wells as a negative 
control. The plates were then incubated at 37oC for 24 h. Following incubation plates 
were inspected for growth and zones of inhibition were determined using the following 
equation:  Zone of Inhibition = Total Diameter of Inhibition - Diameter of Well 
4.3.4.5 Preliminary HPCCC method 
Based on the bioactivity assay, solvent system 5 was selected for a preliminary HPCCC 
run.  The solvent system of heptane, methanol and water was made up to 1 L using the 
ratios shown in table 4.1 and mixed in a separating funnel. After vigorous shaking, 
solvents were left to settle until both phases become transparent and, therefore, 
equilibrated. Then the two phases were separated shortly before HPCCC separation. 
The upper aqueous phase (more polar) was used as the stationary phase and the lower 
organic phase (less polar) as the mobile phase, which corresponds to normal phase 
mode. 
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To 3 mL of stationary phase (upper phase), 300 mg of methanolic tea extract GP-2 was 
dissolved and added to the 3.66 mL sample loop. In each HPCCC preparative separation 
run, the column was filled with the stationary (upper) phase in the head to tail mode into 
a Midi HPCCC system (Dynamic Extractions Ltd., UK). Then the mobile (lower) phase 
was pumped into the coil at a flow rate of 2 mL/min with a centrifuge rotational speed 
of 1600 rpm at 30 °C to equilibrate. When hydrodynamic equilibrium was established, 
the sample solution was injected into the coil and the flow rate was increased to 4 
mL/min. The eluent was continuously monitored by connecting the tail outlet of the 
coiled column to an Algilent PDA detector set at wavelengths 250, 275, 310 nm. 
Fractions were collected every minute from the eluting solvent (4 mL per fraction). 
After the separation was completed, pressurised nitrogen gas was used to force out the 
stationary phase from the column. Stationary phase fractions were collected every 
minute (4 mL per fraction).  
4.3.4.6 Bioactivity Screen of HPCCC fractions against S. aureus 
Fractions of the eluting mobile phase were collected at time points corresponding to 
peaks on the UV spectra for antimicrobial testing. Of each fraction, 500 µL was pipetted 
into a vial and the solvent was evaporated using a solvent concentrator. The dried 
samples were then re-suspended in 100 µL of 2 %(v/v) DMSO. The antimicrobial 
activity was then determined using the method described in section 4.3.4.4. 
4.3.5 Determining the Antibacterial Components of Green Tea using HPCCC 
4.3.5.1 HPCCC Method (Normal Phase) 
The HPCCC method described in 4.3.4.5 was repeated for the same methanol extract of 
green tea.  
4.3.5.2 HPCCC Method (Reverse Phase) 
The HPCCC method described in 4.3.4.5 was repeated for the same methanol extract of 
green tea, however, the mobile phase in the first run (lower phase) was used as the 
stationary phase and vice versa. This means that the eluting fractions in the first run 
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(section 4.3.5.1) now remained in the column whilst the compounds previously retained 
in the column were fractionated.  
4.3.5.3 Bioactivity Screen of Normal and Reverse Phase Fractions 
Fractions from the normal phase run (every minute from 20 – 64 min) and reverse phase 
run (every minute from 18 – 64 min) were selected for antimicrobial testing. Of each 
fraction, 500 µL was pipetted into a vial and the solvent was evaporated in a solvent 
concentrator. The dried samples were then re-suspended in 100 µL of 2 %(v/v) DMSO. 
The antimicrobial activity was then tested using the method described in section 4.3.4.4. 
4.3.5.4 HPLC Analysis of HPCCC Fractions 
The same HPLC method in Chapter 3 (section 3.3.2.2) was used to analyse the fractions 
collected in the normal and reverse phase HPCCC experiments. The chromatograph for 
every fraction was reviewed and the area of each peak was calculated. Fractions were 
collected every min, therefore, when looking at the HPLC chromatograms, from 
fraction 18 (time = 18 min) to fraction 64 (time = 64 min) the elution of each peak could 
be observed over time. This data was used to produce a fractogram. A fractogram 
quantifies the elution of compounds or a compound over time. 
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4.4 Results and Discussion 
4.4.1 Development of a Quantitative Antimicrobial Assay for Tea Infusions  
4.4.1.1 Evaluation of the Broth Dilution Method  
Testing antimicrobial compounds using an MIC broth dilution assay is an alternative 
method to using agar dilution. The advantage of performing a broth dilution test is that 
it can be done on a 96 well microtitre plate and many concentrations of a potential 
antibacterial agent can be tested simultaneously. The compounds are added to the wells 
along with broth and a known inoculum of bacteria. The optical density (OD) of each 
well is read in a spectrometer at 600 nm before and after the plate is incubated overnight. 
The OD readings of each well pre-incubation are compared to the readings post-
incubation. If the concentration of the antibacterial compound is less than the amount 
needed to inhibit the growth of the bacteria, an increase in OD would be seen post-
incubation. Bacterial inhibition was determined as no change in OD and no visible 
bacterial growth.   
Initially, using the broth dilution method, different concentrations of EGCG were tested 
against S. aureus and it was found following incubation that optical density in all wells 
had increased considerably (> 1 absorbance unit), even at the maximum concentration 
of EGCG tested (2.4 mg/mL). This was unexpected and closer examination of the wells 
revealed that there was a significant amount of precipitate in the solutions. At first, it 
was thought that the large volume of broth compared to the volume of EGCG solution 
might have caused the EGCG to precipitate out of the solution. Therefore, the 
experiment was repeated using a more concentrated (10 ×), but lower volume of broth 
(20 µL vs. 200 µL). By reducing the volume of broth, the final solutions in the wells 
were clear and no precipitate was evident. However, after incubation, the OD of each 
well had increased again, suggesting that EGCG had no inhibitory effect. However, 
media control wells (no EGCG or bacteria) had remained clear , and although the OD of 
the positive growth control wells  (bacteria but no EGCG) had increased, the colour of 
the well had not changed, indicating that the wells containing EGCG were changing 
colour over time regardless of bacterial growth (fig 4.6). 
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Figure 4.6. A 96 well plate containing different concentrations of EGCG inoculated with S. 
aureus after 18 h incubation at 37 °C. 
 
A similar effect was observed when testing both green and black tea samples. A 
possible explanation of this observation was the oxidation of polyphenols over time.   
Since a change in optical density could not be used as a reliable indication of bacterial 
growth, an agar dilution based method was adopted instead. 
4.4.1.2 Evaluation and Modification of the Agar Dilution Method  
The agar dilution method is commonly used to determine the activity of antimicrobial 
agents. This method involves incorporating the antimicrobial agent in different 
concentrations into the agar, allowing it to set, then inoculating the surface of the agar 
with a known quantity of bacteria. With antibiotics or any other pure compounds, they 
can simply be added into cooled agar to create a stock solution of a desired 
concentration, which is then diluted with further agar to achieve different concentrations 
in the testing range (BSAC, 2012). The starting stock solution can be as high as dictated 
by the solubility of the compound. Therefore small, concentrated volumes of the 
antibiotic can be added to the agar without having any detrimental effect to its 
consistency. With aqueous tea infusions however, this is not achievable. When using a 
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standard aqueous tea infusion, the concentration of the infusion is determined by the 
initial brewing, therefore it cannot be further concentrated to achieve a higher stock 
solution at a lower volume. This is a problem, as when making a dilution series using 
the agar dilution method, only small amounts of the tea infusion could be added to the 
agar without disturbing its consistency. Consequently, the stock solution is so dilute that 
any antibacterial activity is likely to be quenched.  To overcome this problem, double 
strength agar was used and the tea infusions were diluted with diH2O to achieve a 
doubling dilution series. As a result, once 2 mL of tea dilution was added to 2 mL of 
double strength agar, the resulting agar mix retained the correct consistency and set 
after cooling. 
This method proved to work well with good reproducibility when testing tea infusions 
and tea polyphenols (section 4.4.2). Therefore, throughout this investigation this 
modified agar dilution method was used to determine the MIC of any tea samples, 
polyphenols or related compounds. 
4.4.1.3 The Interaction of Casein Hydrolysate with Tea Infusions and Polyphenols  
It is important to determine which microbial media are suitable for assessing the 
antimicrobial activity of tea infusions. Many broths and solid media preparations for 
antibacterial testing and culturing contain casein or components of casein, such as 
casein hydrolysate, casein peptones and other digests of casein proteins. In agar, these 
casein components are usually found at concentrations between 1 and 1.75 %(w/v). As 
previously discussed, casein may interact with tea components and if these components 
are responsible for the antibacterial activity of tea, then any testing performed on media 
containing casein could potentially affect the results of the test. 
To determine if the presence of casein hydrolysate in media affected the antibacterial 
activity of tea, different concentrations of the protein were added to LB agar and its 
effect on the antibacterial activity of selected green and black teas was determined 
(table 4.2). The following teas GP-1, GP-2, GP-3, BP-1, BP-2 and BP-3 were selected 
for this experiment as their catechin content was representative of the complete sample 
set (Ch. 3, section 3.4.6). LB agar was chosen as the base agar since it supports the 
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growth of S. aureus, is casein hydrolysate free and contains only the basic ingredients to 
support microbial growth.  
Table 4.2. The effect of the addition of different concentrations of casein hydrolysate %(w/v) to 
LB agar on the antimicrobial activity of tea infusions and ampicillin against S. aureus.  
 
Values represent the MIC of tea infusions (% v/v) and ampicillin (µg/mL) (n=3). 
 
It was found that the MIC of green teas increased when the amount of casein 
hydrolysate present in the agar was 2 %(w/v) or greater. For black teas, which were less 
active than green teas, the antibacterial activity was inhibited after more than 
1.75 %(w/v) of casein hydrolysate was added to the agar. Contrary to this, the 
antimicrobial activity of ampicillin was unaffected by the addition of casein. Therefore, 
this study highlights that casein hydrolysate, a common additive to microbial media, 
specifically interacts with antimicrobial compounds in tea infusions and should be 
considered when selecting an appropriate medium to test tea or related compounds. 
To determine if this effect was due to the binding of casein to a specific polyphenol, 
3 %(w/v) casein hydrolysate was added to LB agar containing either EGCG or GA 
(table 4.3). The assay revealed that the MIC of EGCG increased by 2-fold compared to 
the un-supplemented media whilst the antibacterial activity of gallic acid was 
completely eliminated. This would suggest that there is a stronger interaction between 
GA and the casein proteins than EGCG, or that its structure plays a key role in the 
Tea 0.00 0.50 1.00 1.75 2.00 3.00
GP-1 6.3 6.3 6.3 6.3 12.5 50
GP-2 3.1 3.1 3.1 3.1 6.3 12.5
GP-3 12.50 12.50 12.50 12.50 50 >50
BP-1 50 50 50 >50 >50 >50
BP-2 25 25 25 >50 >50 >50
BP-3 25 25 25 >50 >50 >50
Control
Ampicillin 0.03 0.03 0.03 0.03 0.03 0.03
Added casein hydrolysate %(w/v)
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interaction. It may also suggest that the gallic acid group or the galloyl moiety of 
catechins is important for antimicrobial activity but not essential.  
Table 4.3. The effect of adding different concentrations of casein hydrolysate %(w/v) to LB agar 
on the antimicrobial activity of EGCG, GA and ampicillin against S. aureus. Values represent 
the MIC of tea compounds (% v/v) and ampicillin (µg/mL) (n=3). 
 
 
Given the effect of casein on the antibacterial activity of tea, it was important to 
determine if casein containing microbiological growth media had similar inhibitory 
effects. Therefore, the inhibitory activity of different green and black tea samples 
against S. aureus was determined using a variety of common aerobic and anaerobic 
media (table 4.4), as shown in table 4.5. 
Table 4.4. The casein components and concentrations (% w/v) in common commercially 
available bacterial growth media. 
 
LB = Lysogeny broth agar; TSA = Trytone soya agar; BHI = Brain heart infusion agar. 
Compound 0 3
GA 62.5         >1000
EGCG 125 250
Control
Ampicillin 0.03 0.03
Added casein hydrolysate %(w/v)
Agar Casein Component Concentration %(w/v)
LB Tryptone 1.00
TSA Tryptone 1.50
Brucella Peptone 1.00
BHI Proteose petones 1.00
Mueller-Hinton Hydrolysate 1.75
Iso-SensitestTM Hydrolysate 1.10
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Table 4.5.. The effect of different media on the MIC of tea infusions (% v/v) and ampicillin 
(µg/mL) against S. aureus (n=3). 
 
 
Muller-Hinton is the agar of choice for the susceptibility testing of antibiotics in the 
United States of America. This recommendation comes from the Clinical and 
Laboratory Standards Institute (CLSI), as they concluded that this agar is compatible 
with most antibiotics and supports the growth of a large number of microorganisms 
(CLSI., 2007). It contains approximately 1.75 %(w/v) of casein hydrolysate, therefore, 
based on the previous results, it was expected that an MIC value similar to LB agar 
supplemented with 1.75 %(w/v) casein hydrolysate would be attained for green and 
black teas. Although, this was true for green tea, it was not the observation for black tea, 
since the MIC values of black tea incorporated into this media did not change compared 
to the control of un-supplemented LB agar. This may be due to other components in the 
media that prevented the binding of casein to the antimicrobial compounds, as Muller-
Hinton is a more complex mixture than LB agar. Similarly, in other media containing 
casein such as TSA, Brucella and BHI, the MIC of both black and green teas did not 
change in comparison to LB agar, suggesting that they could be potentially used for 
MIC testing.   
Although, the MIC values of the teas were reproducible in most media, using Iso-
SensitestTM, the most complex media, had a detrimental effect. In this media the MIC of 
green tea increased 4-fold whilst the activity of black tea was completely abolished. 
This is most likely due to the presence of trace metals in the media, which may cause 
Tea Mueller-Hinton TSB Brucella BHI LB Iso-SensitestTM
GP-1 6.3 6.3 6.3 6.3 6.3 25
GP-2 3.1 3.1 3.1 3.1 3.1 12.5
GP-3 12.5 12.5 12.5 12.5 12.5 50
BP-1 50 50 50 50 50 >50
BP-2 25 25 25 25 25 >50
BP-3 25 25 25 25 25 >50
Control
Ampicillin 0.03 0.03 0.03 0.03 0.03 0.03
Agar
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oxidation of polyphenols through Fenton reactions (Dai and Mumper, 2010). There was 
no change in the MIC of the antibiotic control, suggesting that this effect is limited to 
tea compounds. Iso-SensitestTM is currently the media of choice for antimicrobial 
susceptibility tests in the UK, as recommend by the British Society for Antimicrobial 
Chemotherapy (BSAC, 2012). However, based on this study, it is unsuitable for testing 
the inhibitory concentration of tea infusions and related compounds.  
It is evident that the antimicrobial factors in tea infusions can be affected by 
components in different biological media, however, the extent of this effect may be 
influenced by other unrelated components. In light of this, LB agar was used for all 
subsequent MIC testing of activity against S. aureus, as it does not contain any 
components known to interfere with tea or polyphenols. Furthermore, based on the MIC 
of ampicillin in each agar, it would appear that using LB agar, does not give the bacteria 
either an advantage or disadvantage when testing antimicrobial compounds. This is 
important, as it could be potentially argued that using a less rich media such as LB 
would put the bacteria at a disadvantage and therefore yield MIC values for compounds 
that are overestimated. 
4.4.2 The Antimicrobial Activity of Tea Infusions  
4.4.2.1 The MIC of Tea Infusions  
A wide range of antibacterial activity was observed between the different tea infusions 
(table 4.6). Green teas had an mean MIC of 13.7 %(v/v) whilst the mean MIC of black 
teas was much higher at 40.8 %(v/v) (geometric means).  The variation of MIC between 
the green tea samples was larger than the black tea samples, as the MIC ranged from 
3.13 – 50 %(v/v) for green teas and 12.5 – >50 %(v/v) for black teas. The most active 
tea was a Kenyan green tea GP-2, which was also found to have the highest catechin 
content (322.2 mg/200mL; ± = SE). The other Kenyan green teas GP-1 and GP-5 also 
had very low MIC values (6.25 %(v/v)) and had above average catechin content (297.3 
mg/200mL and 265.8 mg/200mL, respectively; ± = SE).  
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Table 4.6 The MIC %(v/v) of green and black tea infusions against S. aureus on LB 
agar (n=3). 
 
Code MIC %(v/v) Code MIC %(v/v)
GP-1 6.3 BP-1 50
GP-2 3.1 BP-2 25
GP-3 12.5 BP-3 25
GP-4 12.5 BP-4 50
GP-5 6.3 BP-5 25
GP-6 12.5 BP-6 50
GP-7 12.5 BP-7 25
GP-8 12.5 BP-8 50
GP-9 12.5 BP-9 25
GP-10 25 BP-10 50
GP-11 25 BP-11 25
GP-12 12.5 BP-12 25
GP-13 12.5 BP-13 50
GP-14 12.5 BP-14 50
GP-15 12.5 BP-15 50
GC-1 6.3 BP-16 >50
GC-2 12.5 BP-17 >50
GC-3 12.5 BP-18 >50
GC-4 12.5 BC-1 25
GC-5 12.5 BC-2 25
GC-6 12.5 BC-3 25
GC-7 12.5 BC-4 >50
GC-8 6.3 BC-5 50
GC-9 12.5 BC-6 25
GC-10 12.5 BC-7 25
GC-11 12.5 BC-8 50
GC-12 12.5 BC-9 50
GC-13 12.5 BC-10 50
GC-14 25 BC-11 50
GC-15 12.5 BC-12 12.5
GC-16 12.5 BC-13 50
GC-17 25 BC-14 50
GC-18 12.5 BC-15 >50
GC-19 25 BC-16 25
GC-20 50
GC-21 25
GC-22 50
GC-23 25
         Green tea        Black tea
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Conversely, oolong teas GC-21, GP-22 and GC-23 were the least active green tea 
samples with MIC values of 50, 25 and 50 %(v/v), respectively. This is most likely due 
to the reduced catechin content, which on average was 58.2 ± 2.8 mg/200mL (± = SE), 
as the result of partial fermentation. 
In contrast, the majority of black teas showed no activity at the highest concentration 
achievable (50 %(v/v)) or had an MIC of 25 or 50 %(v/v). Only one black tea had an 
MIC lower than 25 %(v/v), which was the Darjeeling tea BC-12 (12.5 %(v/v)). 
Surprisingly, this Darjeeling tea was not the most catechin rich black tea, which would 
suggest factors other than catechin content in this tea are responsible for its 
antimicrobial activity.  
Furthermore, after repeated study during the investigation period (2010 – 2013), MIC’s 
for all tea infusions remained consistent suggesting that no degradation of active 
components of the stored tea leaf material had taken place. 
4.4.2.2 Comparison of the MIC of Tea Infusions by Type, Source and Origin 
To compare the difference between the antimicrobial activity of green and black teas 
using statistical analysis, the MIC values were transformed using a log transformation. 
This is because the MIC values were obtained by a doubling dilution series and 
therefore will inherently follow a logarithmic scale, which is incompatible with the 
statistical tests.  
Following a log transformation and after assessing the normality of the data sets, it was 
found that the data did not follow normal distribution, therefore the teas were compared 
using a Mann-Whitney U test. Teas that had MIC values of >50 %(v/v) were excluded 
from the analysis.  
The test revealed that there was a significant difference in the MIC values between 
green and black teas (U= 107.5; z = -5.899; p <0.001; r = 0.73; fig 4.7). The results in 
the preceding chapter support the theory that this may be due to a significantly higher 
catechin content in green teas (section 3.4.4).  
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In support of these results, several other studies have shown that extracts of green teas 
contained more potent antibacterial activity than black teas, however the samples sizes 
in these studies were considerably lower than the numbers examined in this work 
(Neyestani et al., 2007, n= 2; Almajano et al., 2008, n = 10).  
 
Figure 4.7. Comparison of the antimicrobial activity of green (n=38) and black tea (n=29) 
infusions against S. aureus by the Mann-Whitney U test (***=p<0.001; error bars = 95 %CI). 
Comparison of the MIC values obtained with commercial and single plantation teas was 
conducted using a Kruskal-Wallis test, as the samples sizes were uneven and the data 
did not follow normal distribution. The analysis concluded that there was no significant 
difference in MIC between commercial and single plantation green teas (p>0.05; fig 
4.8). There was also no significant difference in MIC between commercial and single 
plantation black teas (p>0.05; fig 4.8). These results were supported by the analysis of 
the catechin content of the two groups in chapter 3 (section 3.4.4).   
To determine if there was any significant difference between the teas based on country 
of origin, the Kruskal-Wallis test was used due to the unequal sample sizes.  
Green teas from China showed significantly less antimicrobial activity than green teas 
from other regions (p <0.01; fig 4.9). This is most likely due to their lower catechin 
content (Ch. 3; section 3.4.4). However, no significant differences in MIC were found 
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between black teas based on origin (p>0.05; fig 4.10). Though, it is important to note 
that 4 of the 6 Chinese black tea samples had no activity at all, which were not 
accounted for in this analysis. These teas also had lower TPC and catechin content than 
black teas from Africa and India (Ch. 3; section 3.4.4), suggesting that these compounds 
play the most important role in antimicrobial activity. 
 
 
 
Figure 4.8. The antimicrobial activity of commercially sourced green (n=23), single plantation 
green (n=15), commercially sourced black (n=12) and single plantation black (n=15) tea 
infusions against S. aureus using the Kruskal-Wallis test (error bars = 95 %CI). 
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Figure 4.9. Comparison of the antibacterial activity of green teas from China (n=15), Africa 
(n=3), Japan (n=5) and Indonesia (n=4) against S. aureus using the Kruskal-Wallis test 
(**=p<0.01; error bars = 95% CI).  
 
 
Figure 4.10. Comparison of the antibacterial activity of black teas from China (n=2), Africa 
(n=5) and India (n=10) against S. aureus using the Kruskal-Wallis test (**=p<0.01; error bars 
= 95 %CI). 
It is evident that green teas possess significantly more potent antimicrobial activity than 
black teas, most likely due to their higher catechin content (Ch. 3; section 3.4.4). This 
would explain why green teas from Africa have particularly high antimicrobial activity, 
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as they were shown to have the highest catechin content of all the green tea samples (Ch. 
3; section 3.4.4). It would also explain why there was no regional difference in 
antimicrobial activity seen in black teas, as the HPLC analysis revealed that their 
catechin profiles were not significantly different (Ch. 3; section 3.4.4). Therefore, since 
catechin levels appear to be good indicators of antimicrobial activity in tea infusions, it 
is important to determine their individual activity and to rule out other contributing 
factors. 
4.4.3 The Antimicrobial Activity of Catechins and Tea Components  
Tea infusions are a complex mixture of polyphenols, methylxanthines, amino acids and 
other molecules. As demonstrated, tea infusions have quite varied antibacterial activity, 
hence, it is important to understand which individual components may be responsible 
for this activity. The MIC values of the major catechins and other non-catechin 
components of tea infusions can be seen in table 4.7. Of the selected compounds, only 
the catechin polyphenols showed antibacterial activity. The most active components by 
weight were GA and the pyrogallol containing catechins (EGCG and EGC), followed 
by the EGCG epimer GCG and the catechin gallate ECG. Based on molar mass, the 
activity of the catechins and gallic acid follows the order 
EGCG>GA>EGC>GCG>ECG>EC=C. This is consistent with the findings of other 
studies (Hara, 2001; Stapleton et al., 2004). Furthermore, the MIC values obtained are 
also similar, supporting the transferability of the modified agar MIC assay (Stapleton et 
al., 2004; Hara., 2001). 
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Table 4.7. The antibacterial activity of catechins and other tea components against S. aureus 
(n=3). 
 
 
 
 
Although the methylxanthines are utilised for their potent respiratory and stimulant 
effects, they are generally not considered to be antibacterial agents. However, there is 
some evidence to suggest that at high doses (> 1 g/100 mL), they can inhibit the growth 
of Gram-negative bacteria such as E. coli (Ramanavièienë et al., 2003). As shown in 
table 4.7, none of the methylxanthines had antimicrobial activity below 2 mg/mL, 
which is a considerably higher concentration than would be found in tea infusions (e.g. 
average caffeine content = ~ 0.3 mg/mL; Ch. 3, 3.4.4).   
Compounds MIC (µg/mL)
Catechins
Gallic acid (GA) 63
Epigallocatechin gallate (EGCG) 125
Epigallocatechin (EGC) 125
Epicatechin gallate (ECG) 250
Gallocatechin gallate (GCG) 250
Epicatechin (EC) 2000
Catechin (C) 2000
Methylxanthines
Theobromine >1000
Theophylline >1000
Caffeine >2000
Other components
Coumarin >500
Rutin >500
L-Theanine >2000
Caffeic acid >2000
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4.4.4 The Relationship of Catechin Structure to Antimicrobial Activity and H2O2 
Production 
4.4.4.1 The Antibacterial Activity of Gallic Acid Derivatives 
From the MIC study, it would appear that the structure of the catechins is key to their 
inhibitory activity. It has been previously suggested that the pyrogallol and to a lesser 
extent, the galloyl group is responsible for the antimicrobial activity of the catechins 
(Ikigai et al., 1993). To try and understand more about this relationship, the antibacterial 
activity of various gallic acid derivatives (fig 4.11) was determined (table 4.8). 
 
 
 
Figure 4.11. The structure of gallic acid and similar compounds. 
 
Gallic acid Shikimic acid Quinic acid 3,4,5 Trihydroxybenzyl amide 
3,4,5 Trimethoxybenzyl alcohol 3,4,5 Trimethoxybenzyl acid Gallacetophenone 
2,5 Dihydroxybenzoic acid 2,3 Dihydroxybenzoic acid Pyrogallol 
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Table 4.8. The antibacterial activity (MIC) of gallic acid and similar compounds against S. 
aureus (n=3). 
 
 
 
Of all the tested compounds, pyrogallol was the most active followed by gallic acid, 
3,4,5 trihydroxybenzyl amide and gallacetophenone. It is clear that the conjugated 
system of overlapping electrons in the benzene is important for activity, as quinic acid 
(a tea phenolic acid) and shikimic acid did not show any activity. Due to the bonds of 
these two compounds within the carbon ring, they lack the planar structure required for 
sharing pi electrons in order to create a conjugated system and will prevent the 
withdrawal of electrons from the hydroxyl groups and subsequent benzoquinone 
formation.  
The tri-hydroxyl group is also an important feature for activity as when the tri-hydroxyl 
group is replaced with methoxy groups, or one hydroxyl group is missing, the activity is 
completely abolished. Furthermore, adding electron-withdrawing groups to the benzene 
such as –COOH (e.g. gallic acid), -CONH2 (e.g. 3,4,5 trihydroxybenzyl amide) and -
COCH3 (gallacetophenone) reduces activity. This would suggest, as previously thought 
by Nakayama et al., (2002), that reducing the electron density in the benzene ring 
reduces the electron-donating ability of the compound resulting in attenuation of the 
Compound MIC (µg/mL)
Pyrogallol 31
Gallic acid 63
3,4,5 Trihydroxybenzyl amide 63
Galloacetophenone 125
Quinic acid >2000
Shikimic acid >2000
2,3-Dihydroxybenzoic acid >2000
2,5-Dihydroxybenzoic acid >2000
3,4,5 Trimethoxybenzoic acid > 2000
3,4,5 Trimethoxybenzyl alcohol > 2000
	  
 
	  
 
CHAPTER 4 
	  
	   	  
139	  
autoxidation cycle.  In the case of gallacetophenone, the reduction in activity in 
comparison to other tri-methoxy compounds is likely due to the proximity of the ortho- 
position hydroxyl group in relation to the ketone group.  
These results support the MIC of the tea catechins as C and EC, which only have 2 
hydroxyl groups on the B-ring (Ch. 1, fig 1.5), have no antimicrobial activity, whilst 
EGCG and EGC, which have tri-hydroxyl groups are the most active. Furthermore, the 
catechin ECG, which only has a galloyl group, has less activity than EGC that only has 
the pyrogallol group. In addition, EGCG, which contains both groups, is the most active 
catechin.  
This structure activity investigation agrees with a study showing that compounds such 
as pyrogallol with more reactive hydroxyl groups are more readily converted to 
quinones forming H2O2 as a byproduct in the autoxidation cycle (Akagawa et al., 2003). 
This would therefore support the theory that H2O2 is involved in the antimicrobial 
action of polyphenols (Akagawa et al., 2003). Furthermore, they showed that the 
pyrogallol moiety produced more H2O2 than the dihydroxyl pyrocatechol group and that 
the order of H2O2 production of the catechins was EGCG>ECG>GA>EGC>EC>C 
(Akagawa et al., 2003). This is similar to the order of activity of catechins by molar 
mass in this thesis and in other studies (Stapleton et al., 2004; Hara, 2001).  
4.4.4.2 The Effect of Catalase on the Antimicrobial Activity of Tea and Catechins 
To confirm the role of hydrogen peroxide in antibacterial activity the enzyme catalase 
which specifically converts H2O2 to O2 and H2O was added to green and black tea 
infusions. As shown in table 4.9, the addition of catalase completely abolished the 
antibacterial activity of the tea infusions. The addition of catalase also inhibited the 
antibacterial activity of EGCG and GA (table 4.9). A previous study by Arakawa et al. 
(2004) demonstrated the same effect with the catechin EGCG.   
This provides evidence that the production of H2O2 is involved in the antibacterial 
mechanism of tea infusions. Therefore, based on these results, it would be rational to 
hypothesise that teas that produce more H2O2 would have greater antibacterial activity. 
To test the validity of this hypothesis, the relationship between antibacterial activity and 
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H2O2 production of tea infusions was compared using Pearson correlation (fig 4.12). It 
was found that there was a strong inverse correlation between MIC and H2O2 production 
(r=- 0.66; p=<0.01). In other words, tea infusions that produce more H2O2 have more 
potent antimicrobial activity. Although, correlation alone does not prove causation, the 
latter experiments with catalase support the interaction of these two variables. 
Table 4.9. The effect of catalase on the antibacterial activity of tea infusions, GA, EGCG and 
ampicillin against S. aureus (n=3). The MIC values for tea infusions are expressed in %(v/v) 
while the values for EGCG, GA and ampicillin are expressed in µg/mL. 
 
 
A correlation analysis was also performed between antimicrobial activity and H2O2 
production for green and black teas separately. Due to the normality of the data sets, 
Person correlation was performed for green teas whilst Spearman correlation was 
performed for black teas. A strong inverse correlation was found between antimicrobial 
activity (Log MIC) and H2O2 production for green teas (r = -0.733; p<0.01) whilst there 
was poor correlation in black teas (r = -0.171; p = 0.59). This would suggest that H2O2 
production is more important to the inhibitory activity of green teas than black teas. 
However, this would contradict the observation that the addition of catalase removes the 
inhibitory activity of both green and black teas. In light of this, it is possible the small 
Tea 0 1000
GP-1 6.25 > 50
GP-2 3.13 > 50
GP-3 12.50 > 50
BP-1 50 > 50
BP-2 25 > 50
BP-3 25 > 50
EGCG 63 > 1000
GA 125 > 1000
Control
Ampicillin 0.03 0.03
Catalase (Units/mL)
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sample size (n=14) and poor distribution (highly skewed) of antibacterial activity of 
black tea may be responsible for this ambiguity.  
 
Figure 4.12. Pearson correlation of antimicrobial activity (Log MIC) and H2O2 production (µM 
at 24 h) of green and black tea infusions (p<0.01; r2=0.44; n=24). 
It was found in chapter 3 (section 3.4.2.2) that green tea infusions generated higher 
concentrations H2O2 than black teas, however this was only significant after 24 h. 
Furthermore, the rate of production between 0 – 12 h was similar for both types of tea. 
Since the inhibitory effect of teas is likely to occur before 12 h, it would suggest that 
amount of H2O2 produced does not fully explain the difference in activity between 
green and black teas.  
It has been shown that catechins may insert themselves into the membranes of bacteria 
and can protrude into the cell cytoplasm (Sirk et al., 2008). Therefore, it is a possibility 
that local H2O2 production at these sites give rise to the antibacterial activity of tea. This 
would explain why black teas, which produce similar amounts of H2O2 over 12 h, are 
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less potent, as black tea polyphenols have lower affinities for bacterial membranes 
compared to catechins due to their high molecular weight (Sirk et al., 2011).  
Overall, these studies would suggest while H2O2 production is essential for antibacterial 
activity of tea, the manner by which it contributes to this effect is yet to be determined.  
Therefore, understanding the contribution of catechins in the tea infusion to the overall 
antimicrobial activity of the infusion may help to provide an insight into the basis of the 
antimicrobial mechanism of tea infusions.  
4.4.5 The Antimicrobial Components in Tea Infusions 
4.4.5.1 Correlation of Log MIC with Total Catechins, TPC, TFC and Antioxidant 
Power 
When comparing the antimicrobial activity to the chemical properties of tea infusions, it 
is clear from this study that trends exist and that polyphenols, most likely catechins, 
may account for the majority of antimicrobial activity seen. To test this hypothesis, a 
correlation analysis between the antimicrobial activity of green and black teas and the 
chemical properties of the teas (TPC, TFC, antioxidant power and total catechins) were 
performed to identify any significant relationships. Since black and green teas differ 
significantly in their chemical composition and in antimicrobial potency, separate 
correlation analyses of each groups was performed. Pearson correlation was used for 
green teas as the data met all the assumptions described in chapter 2 (2.3.5). Spearman’s 
correlation was used for analysing black teas, as the data was not normally distributed. 
Teas with MIC values >50 %(v/v) were excluded from the analysis as their 
antimicrobial activity was outside the tested range (i.e. did not represent a valid integer). 
Table 4.10. Correlation of Log MIC, TPC, TFC, FRAP and total catechin content of green 
(n=38) and black (n=34) teas (**=p<0.01; *=p<0.05). 1 Pearson correlation; 2 Spearman 
correlation. 
 
Log MIC TPC TFC FRAP Total Catechins
Green1 -0.747** -0.661** -0.761** -0.849**
Black2 -0.377* -0.439* -0.544** -0.408*
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The analysis showed a strong inverse correlation between Log MIC and TPC, TFC, 
FRAP and total catechins (table 4.10). Therefore, an increase in antimicrobial activity 
was seen when tea infusions have higher polyphenol content, flavonoid content, 
antioxidant power and more catechin polyphenols. In green teas the correlation between 
catechins and Log MIC would appear stronger than in black teas (-0.849 vs. -0.408). 
This would support the suggestion that other compounds in black tea, apart from the 
green tea catechins, such as theaflavins, contribute to antimicrobial activity (Betts et al., 
2011). This correlation also supports the hypothesis that catechins are the predominant 
antimicrobial compounds in green tea, as the difference in concentration of catechins 
between the tea samples explains 72 % of the variance in MIC (r2=0.72), which is very 
high. Furthermore, antioxidant power appears to be a good predictor of antibacterial 
activity for both green and black teas (table 4.10). This is in agreement with the 
observed H2O2 production and antibacterial activity of green teas, but not with black 
teas (section 4.4.4.2).  
Overall, it would appear that there are stronger correlations with TFC, antioxidant 
power and TPC with regards to the inhibitory activity of green teas. However, to 
determine if these differences are significant, more black teas with a wider range 
inhibitory activity would need to be tested. The black teas in this study have a poor 
distribution of antimicrobial activity in comparison to green teas, which currently limits 
the interpretation of these correlations.   
4.4.5.2 Synthetic Tea as a Model to Determine the Contribution of Catechins to 
Antimicrobial Activity in Green Tea Infusions. 
To understand the contribution of catechins on the antimicrobial activity of green and 
black teas, the average concentration of each catechin present at the minimum inhibitory 
concentration of the tea infusions was determined (table 4.11).  
Comparing these values to the inhibitory concentrations of the catechins in isolation 
(table 4.7), it is clear that they are present at sub-MIC concentrations in tea infusions. 
That is to say, when the tea infusions are diluted to the lowest possible active 
concentration, the levels of catechins are considerably below their individual 
antimicrobial concentration. This would suggest that the antimicrobial activity of tea 
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infusions is the sum of additive or synergistic interactions between catechins rather than 
the action of a single antimicrobial compound. However, although unlikely, it cannot be 
ruled out that the activity may be due to completely different compounds not accounted 
for in this study or that the catechins are interacting with other non-catechin compounds. 
Table 4.11. The mean concentration of catechins present in green (n=38) and black (n=34) tea 
infusions (µg/mL± SE) at their minimum inhibitory concentrations.  
 
To strengthen the hypothesis of this thesis, that the catechins are the predominant 
antimicrobial factors in tea infusions, the catechin content of the most active green tea 
GP-2 was replicated using pure standards in water according to the results from the 
HPLC analysis (appendix I). 
As predicted, a synthetic version of GP-2 consisting of EGCG, EC, C, EGC, ECG, 
GCG and GA at the same concentrations found in the original tea demonstrated the 
same level of antibacterial activity with an MIC of 3.13 %(v/v). This provided 
compelling evidence to suggest that these compounds are the sole factors responsible 
for the antimicrobial activity of green tea infusions. It also demonstrated that in this 
green tea, and most probably other green tea infusions, that antimicrobial activity is the 
sum of synergistic or additive interactions between these particular catechins.  
Compound Green Black 
GA 4.9 ± 0.5 20.9 ± 1.9
EGC 23.7 ± 1.6 3.3 ± 0.9
C 10.8 ± 1.3 24.2 ± 2.4
EGCG 39.5 ± 2.1 21.1 ± 3.7
EC 11.5 ± 0.7 13.4 ± 1.1
GCG 3.1 ± 0.3 2.4 ± 0.8
ECG 10.4 ± 1.0 10.3 ± 1.4
Mean Concentration of Catechin in 
Tea at the MIC of the Infusion
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Although synergy has been shown previously to exist with combinations of individual 
catechins (Sasaki et al., 2004), this is the first time to our knowledge that it has been 
shown to be responsible for the antimicrobial activity of green tea infusions. 
4.4.5.3 Determining the Individual Contribution of Catechins to the Antimicrobial 
Activity of Tea Infusions  
Multiple regression is a powerful statistical analysis that can be used to help determine 
the contribution of individual factors to a particular outcome (Tabachnick and Fidell, 
2007). Since it has been demonstrated that the 6 catechins and gallic acid are likely to 
be the sole antimicrobial factors, it would seem an appropriate technique to determine 
the individual contribution of each catechin in the tea infusion to the antimicrobial 
activity.  
Prior to building a multiple regression model, correlation analysis of each factor must 
be undertaken to determine if any factors, in this case catechins, show co-correlation. 
This is an essential first step, as strongly co-correlating factors cannot be used to build a 
robust multiple regression model (Tabachnick and Fidell, 2007).   
The results of the correlation show a significant inverse correlation with the 
concentration of all the catechins and Log MIC, apart from C (table 4.12). In other 
words, an increase in catechin concentration, apart from C, in the green tea infusion 
would indicate a tea with more potent antimicrobial activity. Overall, this was expected, 
as the majority of catechins have individual activity. However, the strong inverse 
correlation of Log MIC with EC  (-0.749; table 4.12) was unusual, as like C, it has 
negligible antimicrobial activity when tested alone (table 4.7). Therefore, this 
correlation may suggest that EC plays a synergistic role in the antibacterial activity of 
the tea infusion. Although, without further analysis such as multiple regression, this 
observation may be the result of other confounding factors. In support of this hypothesis 
is a study by Kajiya et al. (2002) observed that the presence of EC increased the 
incorporation of EGCG and ECG into lipid bilayers, suggesting that it potentiated the 
antimicrobial activity of these polyphenols. Furthermore, EC has also been reported to 
increase apoptosis in cancer cell lines in combination with EGCG, yet it had no activity 
alone (Suganuma et al., 1999) 
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Table 4.12. Spearman correlation of catechin concentration and the antimicrobial activity (Log 
MIC) of green teas (n=38; **=p<0.01; *=p<0.05). Highlighted values in red show co-
correlation (i.e =>0.7). 
 
The correlation analysis revealed that there are several co-correlating factors in the 
matrix. Since some of the factors in the model are so closely correlated, a technique 
such as multiple regression would not be able to adequately differentiate between the 
factors, meaning that this approach it is not suitable for determining how much 
contribution each catechin in the infusion makes to the antimicrobial activity. Generally, 
to overcome co-correlation, similar factors would be combined to form new factors and 
an analysis such as principle components would be implemented.  However, in relation 
to this study, it would not make sense to combine factors, as it would not help answer 
the initial question of the study.  
Although multiple regression cannot be used to determine the contribution of individual 
catechins in the tea infusion to the antimicrobial activity, correlation can be used to 
determine the relationship between antimicrobial activity and the ratio of pyrogallol or 
galloyl catechins in the green tea infusions.  
Using spearman correlation, it was found that a high ratio of pyrogallol containing 
catechins (EGCG, GCG and EGC) in relation to the other catechins in green tea 
infusions is strongly correlated with more potent antimicrobial activity (rho= -0.739, 
p<0.01; n=38). Conversely, a high ratio of galloyl catechins (EGCG, GCG and ECG) 
did not show any correlation with antimicrobial activity (rho= 0.056, p=>0.05; n=38). 
This would suggest, as hypothesised in the MIC study, that the pyrogallol containing 
catechins are more active and are also more important for antimicrobial activity in tea 
infusions. 
GA EGC C EGCG EC GCG ECG Log MIC
GA 0.483** 0.535** 0.658** 0.537** 0.153 0.688**  -0.502**
EGC 0.122 0.835** 0.846** 0.492** 0.350*  -0.816**
C 0.347* 0.429** 0.371* 0.729**  -0.253
EGCG 0.735** 0.558** 0.624**  -0.764**
EC 0.457** 0.598**  -0.749**
GCG 0.244  -0.460**
ECG  -0.442**
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In summary, the body of evidence in this chapter supports the hypothesis that the 
catechins are likely to be the sole contributors to antimicrobial activity in green tea 
infusions. However, to help reinforce this hypothesis, HPCCC was used to confirm the 
identity of the active components and to rule out the presence of other contributory 
factors. 
4.4.6 High Performance Counter Current Chromatography (HPCCC) 
4.4.6.1 Bioactivity Guided Solvent Selection for HPCCC 
High performance counter current chromatography is a powerful technique to 
fractionate samples into their component parts or to remove specific compounds from a 
crude mixture (Sutherland and Fisher, 2009).  In this study, HPCCC was used to 
fractionate an extract of green tea, GP-2, to help determine which compounds in the 
extract are responsible for antimicrobial activity. 
Before HPCCC was used to fractionate the green tea sample, a suitable solvent system 
had to be selected (Ignatova et al., 2011). To overcome the trial and error nature of this 
selection process (Ignatova et al., 2011), a biological based assay was designed to select 
the ideal solvent system to separate the tea extract in the HPCCC. For an ideal run, the 
active components need to have affinity for both solvent systems. Therefore, by adding 
the tea extract directly to a 2 phase solvent system and then testing the upper and lower 
phase for antibacterial activity the presence of active components in both phases could 
be determined. Complementary to this process, HPLC was used to determine the 
distribution ratios of each identified peak in the crude mixture within the two phases. In 
table 4.13 (a-c) the distribution ratios of each identified peak in each solvent system are 
shown with the presence (green) or absence (red) of antimicrobial activity in each phase, 
as determined by bacterial susceptibility well assays.  
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Table 4.13a. The solvent systems screened in this study to determine a system suitable for 
analysing tea by HPCCC. Green columns indicate antibacterial activity against S. aureus in 
that layer whilst red indicates no activity. For each compound, the area under the peak is listed 
for each phase. UP = upper phase, LP = lower phase 
 
	  
 
	  
 
CHAPTER 4 
	  
	   	  
149	  
Table 4.13b. The solvent systems screened to determine a suitable system for analysing tea by 
HPCCC. Green columns indicate antibacterial activity against S. aureus in that layer whilst red 
indicates no activity. For each compound, the area under the peak is listed for each phase. UP 
= upper phase, LP = lower phase 
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Table 4.13c. The solvent systems screened to determine a suitable system for analysing tea by 
HPCCC. Green columns indicate antibacterial activity against S. aureus in that layer whilst red 
indicates no activity. For each compound, the area under the peak is listed for each phase. UP 
= upper phase, LP = lower phase 
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Figure 4.13. HPCCC chromatogram of a methanol extract of green tea GP-2 at wavelengths 
210 (blue), 280 (red) and 310 (green) nm.  
 
There were several solvent systems that demonstrated antibacterial activity in both 
phases.  However, solvent system 5 consisting of heptane (0.36 mL), ethyl acetate (2.14 
mL), methanol (2.14 mL) and water (0.36 mL) was selected for the first HPCCC run as 
it had good distribution of all the compounds between the two phases and consisted of 
four solvents.  The advantage of the latter point is that there is more scope for solvent 
adjustment when seeking to further optimise the system (Ignatova et al., 2011).  
Table 4.14. The mean zone of inhibition (mm) against S. aureus for mobile phase fractions 
(min) collected from the HPCCC run of green tea extract GP-2 using the bacterial susceptibility 
well assay (n=3). Activity after 18 h incubation at 37 °C 
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As predicted, solvent system 5 appeared to give good separation of the green tea extract 
as two distinct peaks were observed on the HPCCC chromatogram (fig. 4.13). To 
determine if these peaks contained compounds that had antibacterial activity, samples 
collected at time points 24, 28, 34, 42 and 48 min were tested for activity using the 
bacterial susceptibility well assay. Of these time points, only the fractions that fell 
within the area of the two peaks had activity (table 4.14). The stationary phase was 
extruded from the column over 30 min, which produced several coloured fractions and 
fractions with precipitate. Of these fractions, time points 8 min, 15 min and 22 min 
produced the most intense colours and precipitate. These fractions were tested for 
antimicrobial activity and as shown in table 4.15, fractions at time points 8 and 15 min 
had activity. Demonstrating that compounds left in the stationary phase after separation 
had antimicrobial activity.   
Table 4.15. The mean zone of inhibition (mm) against S. aureus for stationary phase fractions 
(min) collected from the HPCCC run of green tea extract GP-2 using the bacterial susceptibility 
well assay (n=3). Activity after 18 h incubation at 37 °C 
 
 
 
4.4.6.2 Determining the Antibacterial Compounds of Green Tea using HPCCC 
The preliminary HPCCC run revealed that solvent system 5 was an appropriate solvent 
for separating compounds in the green tea fraction. It also showed that antibacterial 
activity resided in the fractions at time points coinciding with the two major peaks and 
also in the residual stationary phase. Therefore, the experiment was repeated and each 
time point from 20 – 64 min was screened for antibacterial activity (fig. 4.14a). In 
figure 4.14b it was found that activity was exclusively within the two major peaks as 
seen in the preliminary run.  
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Figure 4.14a. Normal phase HPCCC chromatogram of a methanol extract of green tea GP-2 at 
wavelengths 210 (blue), 280 (red) and 310 (green) nm. 
 
 
 
 
 
Figure 4.14b. Normal phase HPCCC chromatogram of a methanol extract of green tea GP-2 
with an indicator of antibacterial activity against S. aureus overlaid. At each time point, the 
mean zone of inhibition against S. aureus: 0 - 2 mm = red, 3 - 4  mm = yellow and >4 mm = 
green (n=3). 
Peak 2 
 
Peak 2 
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Figure 4.15a. A fractogram showing of the peak area of each compound in GP-2 identified by 
HPLC at each time point on the normal phase HPCCC run.  
 
 
 
Figure. 4.15b. A fractogram showing of the peak area of each compound in GP-2 identified by 
HPLC at each time point on the normal phase HPCCC run with an indicator of antibacterial 
activity overlaid. At each time point, the mean zone of inhibition against S. aureus: 0 - 2 mm = 
red, 3 - 4  mm = yellow and >4 mm = green (n=3). 
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To identify which compounds were responsible for the antibacterial activity, HPLC was 
performed on each fraction from time points 20 - 64 min. This information was then 
plotted on a fractogram (fig. 4.15a) and the fractions were tested for antimicrobial 
activity (fig. 4.15b). It was found that peak 1 in the HPCCC spectra  (32 - 34 min) was 
EGC, whilst peak 2 contained EGCG and caffeine. Caffeine has been shown not to have 
any antimicrobial activity against S. aureus (table 4.7), therefore the antibacterial 
activity in these fractions must be attributed to EGC and EGCG.  
In the preliminary HPCCC run, it was found that there was residual antibacterial 
activity left in the stationary phase. Therefore, the green tea sample GP-2 was run again, 
but this time the mobile phase was used as the stationary phase and vice versa (reverse 
phase). This would result in the fractions collected in the first HPCCC run being 
retained in the column whilst the compounds left in the stationary phase were 
fractionated.  
Three major peaks were observed when the green tea sample was run in reverse phase 
HPCCC (fig. 4.16a). An antimicrobial assay of the time points showed that the activity 
was due to peaks 2 and 3 in the chromatogram (fig. 4.16b). When cross-referenced with 
the fractogram of the fractions (fig. 4.17a) collected from this run, the activity in peak 2 
was attributed to EGCG, C and EC whilst the activity in peak three was due to ECG (fig. 
4.17b). In light of the results from the MIC study, it is likely that the activity of peak 2 
is due to EGCG rather than of C or EC.  
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Figure 4.16a. Reverse phase HPCCC chromatogram of a methanol extract of green tea GP-2 at 
wavelengths 210 (blue), 280 (red) and 310 (green) nm. 
 
 
 
 
 
Figure 4.16b. A reverse phase HPCCC chromatogram of a methanol extract of green tea GP-2 
with an indicator of antibacterial activity against S. aureus overlaid. At each time point, the 
mean area of inhibition against S. aureus: 0 - 2 mm = red, 3 - 4  mm = yellow and >4 mm = 
green (n=3). 
Peak 1 
 
Peak 2 
 
Peak 2 
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Figure 4.17a. A fractogram showing the peak area of each compound in GP-2 identified by 
HPLC at each time point on the reverse phase HPCCC run. 
 
 
Figure 4.17b. A fractogram showing of the peak area of each compound in GP-2 identified by 
HPLC at each time point on the reverse phase HPCCC run with an indicator of antibacterial 
activity overlain. At each time point, the mean area of inhibition against S. aureus: 0 - 2 mm = 
red, 3 - 4  mm = yellow and >4 mm = green (n=3). 
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In both the normal phase and reverse phase runs, there were no other major peaks in the 
HPLC spectra in the fractions with antimicrobial activity. This would suggest that in 
this tea, there were no other major antimicrobial compounds. Furthermore, since the 
extract is more concentrated than a typical tea infusion, it also helps to rule out the 
presence of antimicrobial compounds present in only trace amounts in tea infusions. 
Overall this supports the results from the MIC study of the individual catechins and the 
hypothesis that the catechins are the key antimicrobial compounds in tea.  
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4.5 Conclusions 
In this chapter, a method for testing tea infusions has been successfully developed and 
enabled the screening of a large sample of single plantation and commercial teas for 
antimicrobial activity. In comparison to other studies, the MIC values for catechins 
determined in this study are similar to published MIC’s, thus supporting the validity of 
this agar based method (Stapleton et al., 2004; Hara, 2001). 
For the first time, using this modified agar method, the antimicrobial activity of 
standard tea infusions has been quantified to a standard similar to that used for 
antibiotics and other antibacterial agents, and as a result, has allowed for robust 
screening and selection of teas with exceptional antimicrobial activity.  
A large variation in the antimicrobial activity of teas was observed even if they were of 
the same type (i.e. green or black) suggesting that the growth environment or variety of 
tea plant may play a key role in its antimicrobial activity. A large part, if not all, of this 
variation in green teas can be attributed to the levels of catechin polyphenols. In black 
teas, this trend was not so clear, and although residual catechins appear to still play an 
important role, other factors are contributing to the antimicrobial activity. However, as 
can be seen from generally low activity of black teas, these other compounds are either 
not as active as the green tea catechins or are present in very small amounts in black tea 
infusions.  
The ability of the synthetic tea to recreate the exact antimicrobial activity of the tea on 
which it was based, strengthened the hypothesis that the six catechins and gallic acid 
identified in this study are the sole factors contributing to the antimicrobial activity of 
green teas. This was further supported by the HPCCC analysis, which helped to rule out 
the presence of other antimicrobial compounds.  Furthermore, for the first time, the 
synthetic tea also provided a clear demonstration of the synergistic and/or additive 
effects of the antimicrobial action of tea infusions. Unfortunately, statistical analysis 
and review of the data was inadequate to determine the nature of these synergies, but 
did provide some insight into the importance of the galloyl containing catechins to 
activity. 
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Comparing the antimicrobial activity of individual tea infusions, catechins, gallic acid 
and galloyl like compounds has shown that chemical structure is very important for 
antimicrobial activity. Overall, it would appear that catechins with galloyl or pyrogallol 
groups, which favour benzoquinone formation and subsequent hydrogen peroxide 
production, are the most potent antimicrobials. Furthermore, it was observed that teas 
that produced more H2O2 had more potent inhibitory activity. Clearly, hydrogen 
peroxide production plays an important role in antimicrobial activity of teas. However, 
whether it has a direct antimicrobial effect or is a component required for further 
reactions is still unknown. 
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5. Antimicrobial Activity of Tea Infusions Against Clostridium difficile 
5.1 Chapter Introduction 
The antibacterial effects of tea against C. difficile are relatively unknown, however 
some anecdotal evidence has shown that the Clostridia species are susceptible to the 
inhibitory effects of green tea (Ahn et al., 1990) and catechins (Ahn et al., 1991; Lee et 
al., 2006). It was also been observed that tea catechins had relatively poor inhibitory 
activity against other bacteria that form the commensal gut flora (Ahn et al., 1991; Lee 
et al., 2006) and may help to promote the growth of the lactobacillus species (Axling et 
al., 2012). This would suggest that teas inhibitory effects in the gut may have a degree 
of selectivity, promoting growth of the healthy intestinal microbiota whilst inhibiting 
the growth of potential pathogenic strains.  
Based on this evidence it is important to establish if tea or its constituents could be 
employed as a potential treatment for C. difficile and it is essential that any such 
therapeutics is active against as wide a range of strains and ribotypes as possible. 
Evaluation of whether  tea interacts with the antibiotics used to treat the infection is also 
warranted to access the possibility of combination treatment. Furthermore, with the 
availability of advanced microscopy technology such as scanning electron microscopy 
(SEM), visualising the effect of tea treatment against C. difficile may provide an insight 
into the antimicrobial  mechanism of action. 
5.1.1 Distribution and Relevance of C. difficile ribotypes  
Ribotyping is a tool that can be used for differentiating between different strains of 
bacteria according to their DNA, or more specifically the 16S and 23S regions of their 
genome (Grimont and Grimont, 1986). The 16S and 23S regions of the C. difficile 
genome are extremely heterogeneous and thus has proved to be the best method for 
determining Polymerase Chain Reaction (PCR) ribotypes (Aktories and Wilkins, 2000).  
To date a large number of C. difficile ribotypes have been identified (>116; Aktories 
and Wilkins, 2000) and the most commonly occurring ribotypes in England and 
Northern Ireland are 027, 002, 106, 015 and 001 (HPAb, 2012; table 5.1).  In Europe 
the most common Ribotypes are 027 and 001  (HPAb, 2012). In 2008, the majority of C. 
difficile cases were from ribotypes 027, 106 and 001. However, over the last three years 
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their incidence has become less prevalent and the distribution of ribotypes has become 
more uniform (table 5.1).  
The 027 ribotype has been linked with several global C. difficile epidemics (Carlson et 
al., 2013) and is also the most prevalent C. difficile pathogen worldwide (O’Connor et 
al., 2008). Clinically, it has been shown to have a higher rate of spore production and 
produce higher levels of toxin, which is thought to be responsible for more severe cases 
of CDI (Carlson et al., 2013). Furthermore, clinical isolates of ribotype 027, 106 and 
001 have been shown to more resistant to the first line antibiotics vancomycin and 
metronidazole (HPAb, 2012; Moura et al., 2013), highlighting the need to screen the 
activity of novel  antimicrobials against  multiple ribotypes. 
Table 5.1. The percentage of C. difficile ribotypes accounting for CDI’s reported from hospitals 
in England and Northern Ireland between 2008 and 2011 (HPAb., 2012). 
 
5.1.2 Combinational Effects of Tea and Antibiotics  
Combinational synergy or additive interactions of antimicrobial compounds are much 
sought after due to their potential to improve clinical outcomes (Lambert et al.,2003). 
Synergy is present when the combined activity of the antimicrobials exceeds the sum of 
their individual activities, whereas additive interactions are defined as a linear 
combination of the two individual effects (Lambert et al., 2003). Bacteriostatic and 
bactericidal synergistic interactions have been shown to take place between compounds 
with different mechanisms of action. A good example of bactericidal synergy is the 
Ribotype 2008 2009 2010 2011
027 55.3 36.1 22.1 12.4
106 13.0 12.7 7.3 7.3
001 8.7 7.3 7.4 6.8
002 2.7 5.7 6.0 7.5
014 2.8 5.4 2.6 1.2
015 2.4 5.3 6.6 7.7
078 1.8 3.5 5.7 6.2
005 1.4 2.9 4.3 5.4
023 1.0 2.7 3.0 2.5
026 0.2 2.1 0.8 0.8
Reporting year
	  
 
	  
 
CHAPTER 5 
	  
	   	  
164	  
facilitation of streptomycin penetration into bacterial cell wall by the presence of 
penicillin (Lopardo et al., 2005).  In addition, combinations of the preservatives 
chlorocresol and 2-phenylethanol produce bacteriostatic synergy by acting in a 
complementary manner against the cell membrane, ultimately resulting in disruption of 
proton gradient-supported transport processes (Denyer et al., 1986).  
There have been multiple reports of synergistic effects of tea or catechins with 
antibiotics against bacteria in vitro (Zhao et al., 2001; Hu et al., 2002; Stapleton et al., 
2004). One such study observed that EGCG interacted synergistically with β-lactam 
antibiotics against S. aureus and its resistant type MRSA (Zhao et al., 2001). It was 
hypothesised that this synergy was due to both agents attacking the cell wall and was 
supported by observations of synergy between EGCG and another cell wall inhibitor 
DL-cycloserine (Zhao et al., 2001). Further supporting this theory was observation of 
indifferent interactions of EGCG and ofloxacin (nucleic acid synthesis inhibitor) and 
additive interactions with minocycline (protein synthesis inhibitor) (Zhao et al., 2001).  
Another notable study observed largely additive or indifferent interactions between 
EGCG and protein or nucleic acid inhibitors such as tetracycline, chloramphenicol and 
erythromycin against S. aureus (Hu et al., 2002). However they also found that 
combinations of EGCG and glycopeptide antibiotics such as vancomycin and 
polymyxin B showed antagonistic tendencies (Hu et al., 2002). This was thought to be 
due to physical binding of the polyphenol to the glycopeptide antibiotics (Hu et al., 
2002).  
Synergistic interactions have also been reported with green tea extracts and antibiotics 
against Gram-negative bacteria (Tiwari et al., 2004). These included the protein 
synthesis inhibitors chloramphenicol and gentamycin, and also the DNA gyrase 
inhibitor nalidixic acid (Tiwari et al., 2004). However, the mechanism of their 
interaction is currently unknown. 
Clearly there is a body of evidence to suggest that tea or its catechins can interact with 
antibiotics both synergistically and antagonistically against bacterial pathogens, which 
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emphasises the importance of determining the interactions of tea with the antibiotics 
used in the treatment of CDI. 
5.1.3 Microscopic Evaluation of the Antibacterial Effects of Tea  
The effect of tea infusions against bacteria at the microscopic level has yet to be 
determined. Nevertheless, a limited number of studies have shown that individual tea 
catechins can cause gross changes to the outer cell structures of both Gram-positive and 
Gram-negative bacteria (Taylor et al., 2009; Cui et al., 2012).  These effects are evident 
when S. aureus is treated with ECG as seen in figure 5.1. It is thought that these surface 
changes are the result of cell membrane perturbation and thickening of the cell wall due 
to the retention of autolysins (Taylor et al., 2009).  
Using Atomic Force Microscopy (AFM), similar irregularities have been observed on 
the outer structures of E. coli and S. aureus following treatment with EGCG (Cui et al., 
2012; fig 5.1). This would suggest that tea, which is a combination of catechin 
polyphenols, may produce similar result against C. difficile and therefore warrants 
investigation.  
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Figure 5.1.  1. The effects of ECG against S. aureus viewed by SEM; (A) Untreated cells, (B) 
Cells treated with ECG 12 mg/L (taken from Taylor et al., 2009). 2. The effects of EGCG 
against S. aureus viewed by AFM; (C) Untreated cells, (D) Cells treated with EGCG 12.5 mg/L 
for 1 h, (E) Cells treated with EGCG 12.5 mg/L for 2 h (taken from Cui et al., 2012). 
C"
D"
E"
1" 2"
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5.2 Aim and Objectives 
The aim of this chapter was to determine the antimicrobial effects of tea infusions 
against C. difficile. The objectives of this chapter were to: 
1. Determine the antimicrobial activity of tea and catechins against C. difficile.  
2. Determine if the antimicrobial activity of tea infusions against C. difficile is 
affected by strain, ribotype or year of isolation. 
3. Determine the interactions (antagonism, synergy or indifference) between tea 
infusions and the antibiotics vancomycin and metronidazole against C. difficile. 
4. Investigate the effects of tea and EGCG on the structure of C. difficile cells 
using scanning electron microscopy. 
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5.3 Methods 
5.3.1 Determination of  the MIC of Tea Infusions and Catechins against C. difficile 
using the Clinical and Laboratory Standards Institute Method for Testing 
Anaerobic Bacteria 
5.3.1.1 Preparation of Agar plates 
Agar plates containing tea or catechin were prepared as described in chapter 4 (section 
4.3.2.2) with the following modifications. To accommodate multiple isolates of C. 
difficile, square petri dishes (100mm x 100mm) were used for each tea dilution rather 
than a well of a 6 well culture plate. Double strength Brucella agar supplemented with 
5 %(v/v) laked sheep’s blood, 0.0001 %(w/v) vitamin K1 and 0.0005 %(w/v) hemin was 
used instead of double strength LB agar as recommend by the CLSI (2003).  
Vitamin K1 was added to the agar as described by CLSI, (2003). Briefly, a 
0.098 %(w/v) solution vitamin K1 was prepared by diluting 200 µL of neat vitamin K1 
(density 0.984 g/mL) into 19.8 mL 95% ethanol and then diluting this solution 1 in 10 
with sterile diH2O. Of this solution, 500 µL was added to 500 mL of double 
concentrated Brucella agar (CLSI, 2003). The final concentration of vitamin K1 in the 
agar was 984 ng/mL.   
Hemin was prepared as described by CLSI, (2003). To 2 mL of 1M NaOH, 100 mg of 
hemin was added. Once the hemin dissolved in solution, the mixture was made up to 20 
mL with sterile diH2O. Of this solution, 500 µL was added to 500 mL of double 
concentrated Brucella agar. The final concentration of hemin in the agar was 5 µg/mL. 
Agar plates were produced by adding 15 mL of tea/polyphenol dilution with 15 mL of 
cooled (60 °C) supplemented double strength Brucella agar. Serial dilutions of tea were 
prepared as described in chapter 4 (4.3.2.2). An agar plate composed of 15 mL sterile 
diH2O and 15 mL of cooled (60 °C) supplemented double strength Brucella agar was 
used a positive growth control.  
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5.3.1.2 Preparation of Cultures from Freezer Stocks and Standard Inoculum 
Preparation 
Frozen stocks of C. difficile strains (table 5.2) obtained from the Anaerobic Reference 
Centre (University Hospital Wales, Cardiff, UK) were thawed, streaked for purity  
(Ch.2; section 2.2.3 and 2.2.5) on pre-prepared fastidious anaerobe agar plates and 
incubated at 37 °C for 18 h in an anaerobic cabinet (A95 Workstation, Don Whitley 
Ltd., UK). The gas mixture of the cabinet was composed of 10 % CO2, 10 % H2 and 
80 % N2 as recommend by the CLSI, (2003). Post incubation, plates were inspected for 
purity and visible CFUs were added to 3 mL of sterile Brucella broth using a 10 µL 
inoculation loop to give the broth turbidity equal to a McFarland standard of 1 (~108 
CFU/mL).   
5.3.1.3 Quality Control of McFarland Standard  
To ensure that suspensions of cultures with turbidity equal to a McFarland standard of 1 
approximately contained 1 x 108 CFU/mL, viable counts were performed on strains 
DS2315 (PCR ribotype 001), DS1507 (PCR ribotype 106) and DS2335 (PCR ribotype 
027) using the Miles and Misra method (Miles et al., 1938) as described in chapter 4 
(section 4.3.1.2) with the following modifications. Briefly, Brucella agar was used to 
perform viable counts in place of TSA and all cultures were incubated anaerobically at 
37 °C for 48 h. These strains were chosen as they covered the major ribotypes in the 
samples set (Ch. 2; table 2.1). 
5.3.1.4 Measuring MIC values 
Of the standardised cultures (~108 CFU/mL) and negative control solution (sterile 
Brucella broth), 100 µL was added to a 96 well grid (fig. 5.2) suitable for use in a 
Denley® multipoint inoculator (Denley Ltd, UK). Each tea infusion agar plate and 
control plate (50% double strength agar and 50% sterile dH2O) were inoculated with the 
isolates of C. difficile and the control solutions using a Denley® Multipoint Inoculator. 
The pins of the inoculator delivered 1 µL of each solution to the surface of the agar 
plate (approximately 105 bacteria per spot). Control plates were inoculated at the start 
and finish of each tea plate series to check growth and potential contamination during 
the inoculation process. After the plates were inoculated, they were allowed to dry 
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briefly for up to 10 min and placed in an anaerobic cabinet at 37 °C. After 48 h, plates 
were checked to determine the MIC value of each tea sample using the MIC endpoint 
criteria described by CLSI (2003). The data was evaluated by various statistical analysis 
described in (Ch.2; 2.4). 
 
Figure 5.2. A diagram of the 96 well Denley® multipoint inoculator grid. Numbers 1 – 75 
represent cultures of C. difficile while ‘C’ represents the negative growth control (sterile 
Brucella agar), ‘BF’ represents B. fragilis NCTC 9343 and ‘SA’ represents S. aureus NCTC 
6571. 
5.3.2 Determination of  the MIC of Tea Infusions against C. difficile using a 
modified version the CLSI Method for Testing Anaerobic Bacteria. 
This method was performed exactly as described in section 5.3.1 except the double 
strength Brucella agar was not supplemented with laked sheep’s blood, vitamin K1 or 
hemin. 
5.3.3 Comparison of  the CLSI method with the modified CLSI Method  
The MIC of the antibiotics vancomycin (Flynn Pharma Ltd., UK) and metronidazole 
were determined for C. difficile strains DS2315 (PCR ribotype 001), DS1507 (PCR 
ribotype 106) and DS2335 (PCR ribotype 027) using the method described in 5.3.1 and 
1 2 3 4 5 6 7 8 9 10
11 12 13 14 15 16 17 18 19 20
21 22 23 24 25 26 27 28 29 30
31 32 33 34 35 36 37 38 39 40
41 42 43 44 45 46 47 48 49 50
51 52 53 54 55 56 57 58 59 60
61 62 63 64 65 66 67 68 69 70
71 72 73 74 75 BF SA C
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5.3.2.  Antibiotics were tested between the range of 0.03 – 8 µg/mL using serial 
dilutions with sterile diH2O. 
5.3.4 Determination of  the effect of Tea Infusions in Combination with Antibiotics 
against C. difficile 
The MIC of tea infusions and the antibiotics vancomycin and metronidazole were 
determined using the method described in 5.3.2. 
Tea infusions and antibiotics were combined using the checkerboard method described 
by Moody (1992).  The concentration ranges and combinations are described in tables 
5.2 and 5.3. Solutions of metronidazole and vancomycin were diluted in sterile diH2O 
and added to tea dilutions to obtain the desired concentration in each respective agar 
plate.  
Bacteroides fragilis NCTC 9343 was used as a quality control strain for metronidazole 
sensitivity, whilst S. aureus NCTC 6571 was used for vancomycin as recommended by 
the CLSI (2003).  
Table 5.2. Combinations of different concentrations of vancomycin (µg/mL) and green tea 
infusion GP-2 (%v/v) tested for antimicrobial activity against C. difficile according to the 
checkerboard method (Moody, 1992). 
 
To determine the interaction of each combination, the Fractional Inhibitory Index (FIC) 
was calculated for each compound using the following equations (Moody, 1992): 
 GP-2 %(v/v)
Concentration 1.6 3.1 6.3 12.5 25 50
31 1A 2A 3A 4A 5A 6A
63 1B 2B 3B 4B 5B 6B
125 1C 2C 3C 4C 5C 6C
Vancomycin 250 1D 2D 3D 4D 5D 6D
(µg/mL) 500 1E 2E 3E 4E 5E 6E
1000 1F 2F 3F 4F 5F 6F
2000 1G 2G 3G 4G 5G 6G
4000 1H 2H 3H 4H 5H 6H
8000 1I 2I 3I 4I 5I 7I
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𝑭𝑰𝑪  𝒐𝒇  𝒂𝒏𝒕𝒊𝒃𝒊𝒐𝒕𝒊𝒄 =   𝑴𝑰𝑪  𝒐𝒇  𝒂𝒏𝒕𝒊𝒃𝒊𝒐𝒕𝒊𝒄  𝒊𝒏  𝒄𝒐𝒎𝒃𝒊𝒏𝒂𝒕𝒊𝒐𝒏  𝒘𝒊𝒕𝒉  𝒕𝒆𝒂𝑴𝑰𝑪  𝒐𝒇  𝒂𝒏𝒕𝒊𝒃𝒊𝒐𝒕𝒊𝒄  𝒂𝒍𝒐𝒏𝒆  
𝑭𝑰𝑪  𝒐𝒇  𝒕𝒆𝒂 =   𝑴𝑰𝑪  𝒐𝒇  𝒕𝒆𝒂  𝒊𝒏  𝒄𝒐𝒎𝒃𝒊𝒏𝒂𝒕𝒊𝒐𝒏  𝒘𝒊𝒕𝒉  𝒂𝒏𝒕𝒊𝒃𝒊𝒐𝒕𝒊𝒄𝑴𝑰𝑪  𝒐𝒇  𝒂𝒈𝒆𝒏𝒕  𝒕𝒆𝒂  𝒂𝒍𝒐𝒏𝒆  
Table 5.3. Combinations of different concentrations of metronidazole (µg/mL) and green tea 
infusion GP-2 (%v/v) tested for antimicrobial activity against C. difficile according to the 
checkerboard method (Moody, 1992). 
 
The summation of FIC index (ΣFIC) was determined for each combination using the 
following equation (Moody, 1992): 
ΣFIC of combination = FIC of tea + FIC of antibiotic 
The ΣFIC was interpreted for each combination using the criteria in table 5.4. The 
geometric mean of the ΣFIC and range (ΣFICmin - ΣFICmax) for each combination was 
reported. The experiment was repeated three times.  
Table 5.4. The interpretation ΣFIC values for determining synergy, antagonism and 
indifference (Moody, 1992). 
 
 GP-2 %(v/v)
Concentration 1.6 3.1 6.3 12.5 25 50
31 1AA 2AA 3AA 4AA 5AA 6AA
63 1BB 2BB 3BB 4BB 5BB 6BB
125 1CC 2CC 3CC 4CC 5CC 6CC
Metronidazole 250 1DD 2DD 3DD 4DD 5DD 6DD
(µg/mL) 500 1EE 2EE 3EE 4EE 5EE 6EE
1000 1FF 2FF 3FF 4FF 5FF 6FF
2000 1GG 2GG 3GG 4GG 5GG 6GG
4000 1HH 2HH 3HH 4HH 5HH 6HH
8000 1II 2II 3II 4II 5II 7II
Interpretation ΣFIC
Synergism x < 0.5
Indifference 0.5 < x ≤ 4
Antagonism x ≥ 4
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5.3.5 Scanning Electron Microscopy of C. difficile treated with Tea (GP-2) and 
EGCG 
5.3.5.1 Treatment of C. difficile with Tea GP-2 and EGCG 
A freezer culture of C. difficile DS2335 was prepared as described in section 5.3.1.2. To 
1 mL of neat tea GP-2, EGCG (0.5 mg/mL) or sterile diH2O, CFU’s of C. difficile 
DS2335 were added to give a turbidity equalling that of a 1 McFarland standard (~108 
CFU/mL).  The samples were then incubated in triplicate anaerobically at 37 °C for 1, 5 
and 10 h as shown in table 5.5.  This was repeated three times to obtain three separate 
samples of each time point and treatment. 
Table 5.5. Samples prepared for scanning electron microscopy. 
 
 
5.3.5.2 Sample Preparation and Imaging 
Bacterial cultures suspended in treatment or control were pelleted by centrifuging at 
2600 xg for 10 min and the supernatant was removed. The cultures were fixed at room 
temperature for 1 h by suspending in 500 µL of 2 % glutaraldehyde in 0.1 M sodium 
cacodylate buffer (pH 7.4). The samples were then centrifuged at 2600 xg for 10 min 
and the supernatant was removed. To each sample, 500 µL of a solution containing a 
ratio of 2:2:1 of 2 % osmium tetroxide: 0.1 M sodium cacodylate (pH 7.4): 25 % 
glutaraldehyde was added and incubated for 1 h at room temperature.  
Sample No. Treatment Incubation Time (h)
1 Water (control) 1
2 " 5
3 " 10
4 EGCG (0.5 mg/mL) 5
5 " 10
6 Tea GP-2 (neat) 1
7 " 5
8 " 10
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After the fixing stage, samples were centrifuged again and the supernatant was removed. 
The samples were re-suspended in 50 % ethanol in diH2O and centrifuged at 5000 xg. 
After removing the supernatant this process as repeated with 70, 80 and 95 % ethanol 
followed by three washes with absolute ethanol.  The samples were stored in 1 mL of 
absolute ethanol at room temperature before dehydration under vacuum on carbon grids, 
sputter coating with platinum and imagining on a scanning electron microscope. 
For each sample, 10 different fields of view were examined at 25,000 x and 100,000 x 
magnification using a Zeiss SIGMA FEG-SEM scanning electron microscope.  
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5.4 Results and Discussion 
5.4.1 Antibacterial activity of Tea against C. difficile 
5.4.1.1 Comparison of Supplemented and Un-supplemented Brucella Agar 
Initially the agar specified  by the CLSI was used to determine the antimicrobial activity 
of tea infusions against C. difficile. Unfortunately it was found that Brucella agar 
supplemented with laked sheep’s blood, hemin and vitamin K1 inhibited the 
antibacterial activity of both green and black teas against C. difficile. In contrast, un-
supplemented Brucella agar containing tea inhibited the growth of C. difficile. This 
would suggest that one of the agar supplements inhibited the antibacterial activity of tea. 
Based on previous findings (Ch. 4; 4.4.1.3) and other observations of trace metals (Dai 
et al., 2010), it is most likely due to either the hemin or laked sheep’s blood, however 
further tests would be required to confirm this hypothesis.  
Due to the incompatibility of the standard CLSI media with tea, the antibiotic 
susceptibility of C. difficile was determined on un-supplemented and supplemented 
Brucella agar (table 5.6). This was performed to determine if antimicrobial testing using 
un-supplemented agar affected the susceptibility of the bacteria to antimicrobials.  
Table 5.6. The effect of supplementing Brucella agar with vitamin K1, laked sheep’s blood and 
hemin on the antimicrobial activity of vancomycin and metronidazole (µg/mL) against C. 
difficile (n=3). 1Results expressed as MIC range (geometric mean) of three repeats.  
  
From the observed results, it would appear that using either agar did not have an affect 
on antimicrobial susceptibility to these antibiotics.  Therefore, throughout this chapter 
Strain Supplemented Unsupplemented Supplemented Unsupplemented
DS2335 0.13 - 0.25 (0.15) 0.13 (0.13) 1 (1) 0.5 - 1 (0.63)
DS1507 0.25 (0.25) 0.25 (0.25) 1 (1) 1 (1)
DS2315 0.13 (0.13) 0.13 - 0.25 (0.16) 0.5 - 1 (0.63) 1 (1)
Metronidazole Vancomycin
 MIC Range (Mean1)
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the MIC of antibiotics and tea infusions against C. difficile isolates was determined 
using un-supplemented Brucella agar. 
5.4.1.2 The MIC of Tea, EGCG and GA against 75 Clinical C. difficile Isolates 
To determine the range of antimicrobial activity of tea infusions against C. difficile, a 
sample of the most prevalent ribotypes from 2000 – 2011 were selected for testing.  
A range of antimicrobial activity was seen against C. difficile for green and black teas 
(table 5.7a-d). The trend in antibacterial activity was similar to that of S. aureus NCTC 
9518 although the mean MIC of the tea infusions was slightly lower against C. difficile, 
particularly for black teas (e.g. MIC of BP-5 = 9.5C.difficle vs. 25.0S.aureus %(v/v) (Ch. 4; 
table 4.6). However, to determine the significance of this observation, a broader 
collection of S. aureus strains would need to be tested. 
The MIC of EGCG and GA against C. difficile was also similar compared to S. aureus 
(table 5.8). The mean MIC of EGCG was 53 µg/mL  (95 %CI = 44 and 64 µg/mL) 
while for GA the mean MIC was 70 µg/mL (95 %CI = 58 and 85 µg/mL). The most 
active green tea was GP-2 with a mean MIC of 3.4 %(v/v) (95% CI = 3.1 and 
3.8 %(v/v)) while the least active green tea was GP-8 with a mean MIC of 6.5 %(v/v) 
(95% CI = 5.7 and 7.5 %(v/v)). Within the black teas, BP-5 had the most potent 
antimicrobial activity with a mean MIC of 9.5 %(v/v) (95% Cl = 8.8 – 10.3 %(v/v)) 
while BP-17 was the least active black tea with a mean MIC of 25.3 %(v/v) (95% Cl = 
22.3 – 28.8 %(v/v)).  
To compare the difference between the antimicrobial activity within the green and black 
teas against C. difficile using statistical analysis, the MIC values were transformed using 
a log transformation. Following a log transformation and after assessing the normality 
of the data sets, it was found that the data did not follow normal distribution, therefore 
the teas were analysed using a Kruskal Wallis test. Groups were compared using the 
Bonferroni-Dunn’s multiple comparisons test. 
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A significant difference in antimicrobial activity was found within the green teas as 
shown in figure 5.3. 
 
Figure 5.3. Comparison of the mean (geometric) antimicrobial activity of green tea infusions 
against C. difficile (n=75). Groups were compared by the Kruskal-Wallis test (***=p<0.001; 
**= p<0.01; error bars = 95% CI). 
The antimicrobial activity of the Kenyan green teas GP-2 and GP-5 were significantly 
higher (p<0.001) than that of the other three green teas examined in this study, but were 
not significantly different from each other. These teas were also shown to be the most 
catechin rich (Ch.3; fig 3.34) and have the highest antimicrobial activity against S. 
aureus (Ch.4; table 4.6).  
In comparison to the green teas, there was greater variation in the antimicrobial 
activities of the black teas (fig 5.4).  Furthermore, it was observed that tea BP-17 had 
inhibitory activity across all strains of C. difficile in the study (table 5.7c-d). Previously, 
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it was shown to have no inhibitory activity against S. aureus (>50 %v/v) implying that 
C. difficile may be more susceptible to the antimicrobial effects of tea. However, more 
strains of S. aureus would need to be tested to confirm this theory.  
 
 
Figure 5.4. Comparison of the mean (geometric) antimicrobial activity of black tea infusions 
against C. difficile (n=75). Groups were compared by the Kruskal-Wallis test (***=p<0.001, 
**= p<0.01; Error bars = 95% CI). 
 
In the preceding chapter (Ch.4; table 4.10) a strong correlation was found between the 
catechin content of tea and its antimicrobial activity against S. aureus. It would appear 
that this trend is also true for C. difficile (fig 5.5).  
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Figure 5.5. Comparison of the catechin content of green (n=5) and black tea (n=5) ranked in 
order of descending antimicrobial activity against C. difficile (n=75).  
5.4.1.3 Comparison of the Antimicrobial Activity of Green and Black Tea 
Infusions against C. difficile 
The mean MIC of green and black teas against all strains of C. difficile (n=75) was 5.9 
and 17.4 %(v/v) respectively (fig 5.6). To determine if this difference was significant, 
the log MIC values were compared using a Mann-Whitney U test.  
The test revealed that there was a significant difference in the MIC values between 
green and black teas (U= 12237; z = -19.35; p = <0.001; r = 0.71). This is similar to 
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what was found with S. aureus (Ch. 4; fig 4.7) and would support that green tea, which 
has higher catechin content than black tea, are more potent antimicrobials.  
 
 
Figure 5.6. Comparison of the mean (geometric) antimicrobial activity of green (n=5) and 
black tea (n=5) infusions against C. difficile (n=75). Groups were compared by the Mann-
Whitney U test (***=p<0.001; error bars = 95% CI). 
5.4.1.4 Antimicrobial Activity of Tea against different C. difficile ribotypes 
To determine if green and black teas were equally effective against the different 
ribotypes of C. difficile, the log MIC of tea against the three most common ribotypes, 
namely 027, 001 and 106, were compared using the Kruskal Wallis and the Bonferroni-
Dunn’s multiple comparisons test (fig 5.7). 
It was found that there was no significant difference (p>0.05) in inhibitory activity of 
green and black teas between different ribotypes of C. difficile. As previously discussed, 
different ribotypes are related to different pathological attributes of the bacteria. 
However it would appear that this does not influence the susceptibility of the bacteria to 
the inhibitory activity of tea. This is advantageous, as it highlights the potential 
application of tea for treating patients presenting with both mild and severe cases of 
CDI.  
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Figure 5.7. Comparison of the mean (geometric) antimicrobial activity of green (n=5) and 
black tea (n=5) infusions against different C. difficile ribotypes. Ribotypes (n): 001 (10), 027 
(11), 106 (16), other (37). Groups were compared by the Kruskal-Wallis test (error bars = 95% 
CI). 
 
Figure 5.8. Comparison of the mean (geometric) antimicrobial activity of EGCG and GA 
against different C. difficile ribotypes. Ribotypes (n): 001 (10), 027 (11), 106 (16), other (37). 
Groups were compared by the Kruskal-Wallis test (error bars = 95% CI). 
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The Kruskal Wallis and the Bonferroni-Dunn’s multiple comparisons test was also used 
to determine if different ribotypes has different susceptibility to EGCG and GA. 
Comparable to what was observed with tea infusions, no significant difference (p>0.05) 
was found (fig 5.8). 
5.4.1.5 Susceptibility of C. difficile to Tea According to Year of Isolation 
It is well known that bacteria can acquire resistance to antimicrobials over time due to a 
variety of different factors (Levy and Marshall, 2004). Therefore, it is useful to compare 
the susceptibility of bacteria to an antimicrobial over a period of time to determine if 
any strains have acquired any resistant mechanisms that counteract its efficacy. 
Although tea is not currently used as a treatment for CDI, exposure of C. difficile to 
different antibiotics over time may affect the sensitivity of the bacteria to tea indirectly, 
as seen with other antibiotics. (Webber and Piddock, 2003). Furthermore, since tea is 
one of the world’s most popular drinks (Fernández-Cáceres et al., 2001) and at least 1 – 
3 % of the population are asymptomatic carriers of C. difficile (Carlson et al., 2013), 
exposure of C. difficile to tea in the environment is very likely.  
In figure 5.9, with the exception of 2002 and 2009, isolates of C. difficile appear to have 
become more sensitive to the effects of tea each year from 2000 to 2011. To determine 
if the inhibitory activity of tea was significantly different in 2000 compared to 2011 the 
Log MIC of green and black teas was compared using a t-test. A significant difference 
in the inhibitory activity of green tea against isolates from 2000 and 2011 was found (t 
= 5.18; p <0.001, two-tailed; n = 60; 95% CI: 0.15 – 0.33; fig 5.9.). The magnitude of 
the difference in means was large (η2= 0.32).  
Similarly, a significant difference in the inhibitory activity of black tea against isolates 
from 2000 and 2011 was found also (t = 4.35, p = <0.001, two-tailed; n = 60; 95% CI: 
0.14 – 0.37; fig 5.9). Again, the magnitude of the difference in means was large (η2= 
0.35).  
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Figure 5.9. Comparison of the mean (geometric) antimicrobial activity of green (n=5) and 
black tea (n=5) infusions against different C. difficile strains according to year of isolation. 
Strains per year (n): 2000 (6), 2001 (4), 2002 (6), 2003 (7), 2004 (6), 2005 (7), 2007 (7), 2008 
(7), 2009 (8), 2010 (5), 2011 (6). The antimicrobial activity of tea against isolates from the year 
2000 were compared to isolates arising in 2011 by the t-test (***=p<0.001; error bars = 95% 
CI). 
Even though a stable metronidazole resistant C. difficile has been isolated recently 
(Lynch et al., 2013), there is currently no evidence to suggest that globally, C. difficile 
is becoming more or less susceptible to the current antibiotics (Spigalia et al., 2011). 
Therefore, it is possible that other environmental factors may have given rise to the 
increased susceptibility of C. difficile to tea observed in this study, although further 
work on more isolates would be required to verify this observation. 
5.4.1.6 Identification of Strains with Increased or Decreased Susceptibility to Tea 
Collectively, the inhibitory concentration of tea infusions against C. difficile was 
comparable across different strains and ribotypes (table 5.7a-d). Furthermore, each tea 
within the tested dilution range inhibited all strains of C. difficile. However, it is 
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apparent that a few strains appeared to be more susceptible or more resistant to the 
inhibitory effects of tea. By reviewing the distribution of MIC values across strains for 
each tea, it was found that the extreme cases were present in the 15th and 85th percentile. 
The strains that had MIC’s in these percentiles for black and green teas most often are 
shown in table 5.9.  
Table 5.9. The occurrence of C. difficile strains identified as being resistant (MICs in 85th 
percentile) or susceptible (MICs in the 15th percentile) to the inhibitory effects tea infusions and 
their sensitivity to EGCG, GA, vancomycin and metronidazole. ‘-‘ = data not available. 1 Mean 
(geometric) MIC across all tested isolates; EGCG (n= 75), GA (n =75), vancomycin (n = 44), 
metronidazole (n = 44). 
 
As shown in table 5.9, strains R14057, R15627 and R17849 had MICs in the upper 85th 
percentile in every green and black tea tested in this study. Furthermore, the MIC’s of 
EGCG and GA against these three strains are also considerably higher than the mean 
MIC for these compounds across all the strains. This trend is also seen for the other 
Strain Green Black EGCG GA Vancomycin Metronidazole 
Resistant =
R15627 100 (5) 100 (5) 250 500 1 0.5
R14057 100 (5) 100 (5) 125 354 - -
R17849 100 (5) 100 (5) 198 198 0.5 0.5
R22888 80 (4) 100 (5) 250 250 1 0.12
R18603 100 (5) 80 (4) 64 500 - -
R20700 100 (5) 80 (4) 198 157 1 0.12
R21028 80 (4) 80 (4) 125 250 1 0.12
R19885 40 (2) 100 (5) 125 89 1 0.12
R14933 0 (0) 80 (4) 99 79 - -
Susceptible =
R22487 100 (5)  80 (4) 11 11 - -
R29039 100 (5)  80 (4) 64 64 0.06 0.06
R20703  80 (4) 100 (5) 25 8 - -
R31382  80 (4) 100 (5) 64 16 - -
R23800  60 (3) 100 (5) 64 64 - -
R16762  80 (4)  80 (4) 16 63 - -
R22753  80 (4)  80 (4) 64 64 - -
R31056  80 (4)  80 (4) 16 32 - -
DS2090  60 (3)  80 (4) 16 22 1 0.12
R26720  60 (3)  60 (3) 20 25 1 0.12
Mean1 53 70 1 0.12
% Occurrence (n) in teas
85th percentile of MIC values
15th percentile of MIC values
Antibiotic/Catechin MIC (µg/mL)
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strains as identified being less susceptible to the effects of tea (table 5.9). However, it 
did not appear that these stains are less susceptible to metronidazole or vancomycin, 
suggesting that that this affect is unique to tea (MIC range for metronidazole and 
vancomycin are 0.5 – 2 µg/mL and 0.06 – 2 µg/mL respectively; HPAb 2012). 
No strains of C. difficile had MIC’s in the lower percentile for every green and black tea. 
However, the distribution of susceptibility was even between green and black teas. 
Unlike with the resistant strains, the strains identified as susceptible to tea were not 
necessarily more susceptible to EGCG and GA, although strains R22487 and R20703 
had noticeably lower than average MIC for EGCG and GA. Due to the lack of available 
data it is unclear if these strains are more or less susceptible to vancomycin and 
metronidazole.  
5.4.2 The Interactions of Green Tea GP-2 with Vancomycin and Metronidazole 
Against C. difficile 
Combinations of green tea GP-2, vancomycin and metronidazole were tested against C. 
difficile to determine the presence of any synergistic or antagonistic relationships. In 
table 5.10 it can be seen that collectively (mean ΣFIC), combinations of vancomycin 
and GP-2 are predominately indifferent (98 %). In 16 (37 %) strains, antagonism was 
observed in at least one combination of vancomycin and GP-2, whilst in 2 strains (5 %) 
synergy was observed.  
In one strain of C. difficile, namely R22888, antagonism was the predominant 
interaction. Antagonism was seen with vancomycin at 0.25 and 0.06 µg/mL in 
combination with tea GP-2 at 12.5 %(v/v), and with vancomycin at 0.125 µg/mL and 
GP-2 at 6.1 %(v/v).  
A previous study found that combinations of EGCG and vancomycin resulted in 
antagonism against MRSA (Hu et al., 2002). However, it would seem that with green 
tea, which is a mixture of compounds, antagonism is not the predominant interaction 
with vancomycin.   
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Table 5.10. The interaction of combinations of different concentrations of green tea GP-2 and the antibiotics  
vancomycin and metronidazole against clinical isolates of  C. difficile (n=44).     
Strain Ribotype  ΣFIC Range (Mean1) Interpretation2 ΣFIC Range (Mean1) Interpretation2
R13929 001 1.00 - 2.50  (1.72) I 1.24 - 2.48  (1.71) I
R14496 020 1.00 - 2.25  (1.50) I 1.25 - 2.50  (1.77) I
R14935 014 1.06 - 2.50  (1.69) I 1.00 - 2.48  (1.60) I
R14936 070 1.00 - 2.50  (1.86) I 1.25 - 2.96  (1.84) I
R15691 023 1.00 - 1.25  (1.10) I 1.50  (1.50) I
R16631 005 0.75 - 1.50  (1.08) I 1.00 - 2.25  (1.50) I
R16632 137 1.50 - 4.13  (2.52) I 1.25 - 4.34  (2.04) I
R16633 138 1.06 - 5.01  (2.03) I 1.00 - 2.16  (1.48) I
R17015 001 0.31 - 1.25  (0.81) I 1.00 - 1.25  (1.12) I
R17060 160 1.06 - 3.00  (1.76) I 1.12 - 6.01  (2.55) I
R17083 027 1.24 - 4.51  (2.30) I 1.00 - 4.17  (2.34) I
R17857 106 0.56 - 1.50  (0.89) I 0.67 - 2.00  (1.08) I
R18080 018 1.06 - 2.06  (1.47) I 1.50 - 4.24  (1.99) I
R18413 002 0.56 - 2.00  (0.95) I 1.50 - 2.33  (1.85) I
R19630 015 0.56 - 2.50  (1.08) I 0.75 - 2.08  (1.30) I
R19885 002 0.56 - 2.50  (1.08) I 0.75 - 2.08  (1.17) I
R20063 106 1.06 - 4.51  (2.16) I 1.00 - 2.24  (1.00) I
R20700 045 1.06 - 2.16  (1.50) I 0.98 - 2.25  (1.35) I
R20962 106 0.75 - 1.50  (1.09) I 1.00 - 2.48  (1.28) I
R20976 106 0.56 - 6.17  (1.92) I 1.00 - 4.17  (1.92) I
R21028 014 0.56 - 3.00  (1.54) I 1.25 - 8.17  (2.68) I
R22814 106 1.06 - 1.50  (1.25) I 0.98 - 1.96  (1.22) I
R22887 174 0.75 - 2.12  (1.24) I 0.98 - 2.50  (1.56) I
R22888 015 4.13 - 8.26   (12.78) A 4.49 - 16.48  (8.60) A
R23121 027 0.50 - 1.12  (0.70) I 0.75 - 1.50  (1.06) I
R26452 020 0.56 - 1.50  (1.03) I 0.54 -1.48  (0.97) I
R26720 106 0.56 - 2.50  (1.55) I 0.50 - 4.96  (1.34) I
R28972 014 1.06 - 4.50  (2.24) I 1.00 - 2.24  (1.54) I
R29035 002 1.06 - 4.50  (2.09) I 0.98 - 2.24  (1.54) I
R29039 078 1.06 - 5.01  (2.30) I 4.51 (4.51) A
R29078 027 0.56 - 1.50  (0.83) I 0.74 - 1.50  (1.08) I
R31234 106 0.74 - 2.20  (1.40) I 0.74 - 2.50  (1.34) I
R31315 013 1.06 - 2.12  (1.43) I 1.25 - 1.50  (1.37) I
R31350 220 1.00 - 2.25  (1.28) I 0.75  (0.75) I
DS1447 081 1.50 - 4.20  (2.70) I 0.75 - 6.00  (2.23) I
DS1507 106 2.07 - 4.50  (3.41) I 0.75 - 4.96  (2.75) I
DS1859 001 2.01 - 4.50  (3.55) I 2.25 - 4.48  (3.37) I
DS2090 124 2.05 - 8.05  (3.03) I 2.07 - 4.21  (2.63) I
DS2205 001 0.31 - 1.25  (0.76) I 0.75 - 1.00  (0.87) I
DS2285 106 0.75 - 4.12  (1.66) I 0.75 - 6.00  (2.05) I
DS2305 174 0.56 - 4.02  (1.35) I 0.75 - 3.00  (1.65) I
DS2315 011 0.55 - 4.50  (1.98) I 0.74 - 4.24  (1.65) I
DS2335 027 0.56 - 1.50  (1.06) I 1.17 - 3.00  (1.17) I
DS2345 027 1.06 - 1.50  (1.22) I 1.12 - 3.00  (1.56) I
Vancomycin + Tea GP-2 Metronidazole + Tea GP-2
1Geometric mean of three repeats. 2Interpetation of FIC: S = synergy, I = indifference, A = antagonism. 
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Similarly, the predominant interaction between green tea GP-2 and metronidazole was 
indifferent (95%).  In 15 (34 %) strains, antagonism was observed in at least one 
combination of metronidazole and GP-2, however unlike with vancomycin, no synergy 
was observed.  
Again with strain R22888, the predominant interaction between GP-2 and 
metronidazole was antagonism. This was seen with metronidazole at 0.06 µg/mL in 
combination with GP-2 at 3.1 %(v/v), and with metronidazole 0.03 µg/mL at and GP-2 
at 12.5 %(v/v). Furthermore, antagonism was also the predominant interaction in strain 
R29039. In this strain antagonism was observed with metronidazole at 0.03 µg/mL and 
GP-2 at 6.1 %(v/v). 
The appearance of antagonism would appear to be strain specific, although it is unclear 
how this would occur. Previously, it was found that strain R22888 was less susceptible 
to the effects of tea and catechins than other strains. It is possible that this attribute may 
be linked to the antagonism seen in combination with antibiotics. However, this 
phenomenon was not observed with other less susceptible strains. Further investigation 
would be needed to clarify the nature of this antagonism.  
In summary, the interaction of combinations of green tea (GP-2) and the antibiotics to 
treat C. difficile appear to be predominately indifferent, suggesting that potential dosing 
of tea in vivo would not be affected by co-administration with these antibiotics. Yet, it 
does not rule out other potential interactions that might be found in  an in vivo model. 
5.4.3 Evaluation of the Effects of Tea GP-2 and EGCG Against C. difficile Using 
Scanning Electron Microscopy 
In figures 5.10a-h the effects of water, green tea (GP-2) and EGCG against C. difficile 
DS2335 can be seen over contact times of 1, 5 and 10 hrs. This strain was chosen as it 
represents one of the most prevalent clinical ribotypes (027) and its sensitivity to tea 
and EGCG was representative of all the strains in the study.  
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Fig 5.10a. Scanning electron images of C. difficile DS2335 treated with water (control) for 1h at 25 k and 
100 k magnification. Red box indicates area zoomed in at 100 k. 
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Fig 5.10b. Scanning electron images of C. difficile DS2335 treated with green tea (GP-2l) for 1h at 25 k 
and 100 k magnification. Red box indicates area zoomed in at 100 k. ‘A’ = potential blebbing 
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Fig 5.10c. Scanning electron images of C. difficile DS2335 treated with water (control) for 5 h at 25 k and 
100 k magnification. Red box indicates area zoomed in at 100 k. 
A 
Water 5 h 
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Fig 5.10d. Scanning electron images of C. difficile DS2335 treated with Tea (GP-2) for 5 h at 25 k and 100 
k magnification. Red box indicates area zoomed in at 100 k. A’ = potential blebbing 
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Fig 5.10e. Scanning electron images of C. difficile DS2335 treated with EGCG (0.5 mg/mL) for 5 h at 25 k 
and 100 k magnification. Red box indicates area zoomed in at 100 k.  
A 
EGCG 5 h 
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Fig 5.10f. Scanning electron images of C. difficile DS2335 treated with water for 10 h at 25 k and 100 k 
magnification. Red box indicates area zoomed in at 100 k.  
A 
Water 10 h 
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Fig 5.10g. Scanning electron images of C. difficile DS2335 treated with tea (GP-2) for 10 h at 25 k and 100 
k magnification. A’ = potential blebbing 
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Fig 5.10h. Scanning electron images of C. difficile DS2335 treated with EGCG (0.5 mg/mL) for 10 h at 25 k 
and 100 k magnification. Red box indicates area zoomed in at 100 k.  
A 
EGCG 10 h 
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It is evident that in all SEM images that the bacterial cells have collapsed, which is most 
likely an artefact of the air-drying process. Nonetheless, the integrity of the cell surface 
has been preserved, which allows comparison of treated and untreated cell surfaces 
without ambiguity. 
After one hour in contact with water the surface of the bacterial cells appear to be 
smooth (fig 5.10a). In contrast, round structures approximately 30 – 40 nm in diameter 
appeared on the surface of cells treated with tea (fig. 5.10b). These round structures 
were also present in the cells treated with tea after 5 h, where they were more abundant 
and larger in size (50 – 60 nm) than those present at 1 h (fig 5.10d).  
The presence of these round structures was even more extensive after exposure to tea 
for 10 h (fig 5.10g), although their size was similar to that observed at 5 h (fig 5.10d). In 
contrast the surface of EGCG treated bacteria after 5h and 10h remained smooth (fig 
5.10e + 5.10h). 
Although the surface of the cells remained smooth after treatment in water for 10 h it is 
evident that lysis of some cells has occurred (fig 5.10f). This is not apparent in cells 
treated with tea or EGCG, possibly due to the hypertonic nature of these solutions. 
 
Figure 5.11. Membrane blebbing on E. coli cells after treatment with antimicrobial peptides 
LL-37 and Alarin (Wada et al., 2013). 
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Current evidence suggests that tea polyphenols interact with bacterial cell membranes 
and cell walls (Yoda et al., 2004) (Ikigai et al 1993; Hashimoto et al., 1999; Taylor et 
al., 2009). Therefore, it is possible that these round structures represent blebbing of the 
cell membrane. Blebbing is thought to occur when the integrity of the outer cell 
structures are compromised causing the cell membrane to protrude through the cell wall 
due to the high internal pressure (Daly et al., 2011), as seen in some bacteria after 
treatment with antimicrobial peptides (Wada et al., 2013; fig 5.11) and the biguanide 
chlorhexidine (Vitkov et al., 2005). This is also similar to what was seen when S. 
aureus was treated with ECG (Taylor et al. 2009; fig 5.1).  
These images of C. difficile treated with green tea support the current theory that the 
antimicrobial mechanism of tea may involve some form of interaction with the bacterial 
cell wall and/or membrane.  Indeed, this activity has been linked to ECG and EGCG as 
it has been reported that exposure of S. aureus to these compounds also causes blebbing 
(Taylor et al. 2009; Cui et al., 2012; fig 5.1).  Interestingly we observed no visible 
changes when C. difficile was exposed to EGCG suggesting that that the mode of action 
of the compound may differ between the two bacteria. Assessing the viability of the 
cultures post treatment may help to determine if these structural changes have had an 
adverse effects on the viability of the bacteria. 
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5.5. Conclusions 
This study has shown that both green and black tea demonstrate inhibitory activity 
against a wide range of clinical isolates of C. difficile at concentrations lower than that 
found in a full cup of tea (200 mL). It has also shown that the common C. difficile 
ribotypes, 027, 001 and 106 are equally susceptible to the antibacterial activity of tea. 
Furthermore, in the 10 year period between 2000 – 2011, clinical isolates of the 
pathogen appear to have become more susceptible to the effects of tea highlighting the 
potential advantages of its use  in the treatment of CDI. The inhibitory activity of green 
tea appears to be closely related to catechin content while this relationship is not as clear 
for black tea.  
This chapter demonstrates that in vitro, tea infusions may be potentially beneficial in the 
treatment of CDI. Furthermore, as the interactions between tea and the antibiotics used 
to treat C. difficile are predominately indifferent, tea could be potentially used in 
combination with these antibiotics. 
A recent study has shown that C. difficile is particularly susceptible to the effect of 
antibiotics that target the cell membrane (Wu et al., 2012). This may explain why tea is 
effective against a wide range of C. difficile isolates and would support the findings of 
the SEM performed in this chapter, which suggest that tea interacts with this structure in 
in a manner that is yet to be determined. To help further understanding in this area, 
Transmission Electron Microscopy (TEM) may provide useful information into the 
structural changes to C. difficile after exposure to tea. In addition, further investigation 
of the strains in this study, which were consistently more or less susceptible to the 
effects of tea, may help in determining the mechanism of action of tea.  
To date, tea has been shown to selectively inhibit the Clostridia family of bacteria in the 
gut (Ahn et al., 1991; Lee et al., 2006), promote the growth of lactobacillus (Axling et 
al., 2012) and concentrate in the small and large intestine after consumption (Lee et al., 
1995). In combination with these attributes, this chapter has provided evidence to 
suggest that the consumption of tea or its components could make a positive impact on  
the treatment or prevention of CDI and provides a rational for extending this work to an 
in vivo model. 
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6. General Discussion 
6.1 Discussion 
While the antimicrobial activity of tea polyphenols, particularly catechins, has been 
extensively studied (Ahn et al., 1995; Hamilton-Miller et al., 2005; Lee et al., 2006; 
Freidman et al., 2006; Betts et al., 2011), a comparable and comprehensive 
characterisation of the activity of tea infusions has yet to be undertaken. Thus far,  
published studies investigating the antimicrobial activity of tea infusions employ a 
range of  non-standardised methods, which make the comparison of the results from 
different studies almost impossible (Ahn et al., 1991; Yi et al., 2010; Tariq and Reyaz 
2012). 
To address this issue we have quantified the inhibitory activity of a comprehensive 
collection of green and black tea infusions using an internationally recognised 
antimicrobial activity assay  (CLSI., 2003).   
During the optimisation of this assay it was discovered that different culture medium 
components such as casein hydrolysate and metal rich medias such as Iso-Sensitest® 
interfered with the antibacterial activity of both tea infusions and catechins. Other media 
supplements such as those used for testing anaerobic bacteria have also been shown to 
be incompatible when assessing the antibacterial activity of tea (CLSI. 2003).  These 
issues highlight the need to consider the role of the culture media when seeking to 
assess the antibacterial activity of tea and its derivatives. 
While we have not been able to define the precise mechanism by which tea inhibits 
bacteria, we have identified a link between the polyphenol content and antioxidant/pro-
oxidant properties of tea infusions and their antimicrobial properties. Teas infusions 
with higher catechin content were  shown to be the most  potent inhibitors of S. aureus 
and C. difficile achieving inhibition at concentrations as low as 3.1 %(v/v) of a cup of 
tea (1.25 %w/v, 5 min brew; green tea GP-2). However, it was observed that catechin 
content was not the best predictor of the antimicrobial activity of black teas, 
highlighting the need to further explore the antimicrobial activities of the black tea 
polyphenols.  
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In an attempt to determine if there was a direct correlation between antibacterial activity 
and a specific component present in tea we undertook a comprehensive chemical 
analysis of each tea sample using HPLC and HPCCC. Indeed, to our knowledge this is 
the first study, which has attempted to correlate the results of individual HPLC profiles 
of tea samples with antibacterial activity.  
Previous studies have shown that the inhibitory activity of catechins can be enhanced as 
a consequence of synergistic interactions with other catechins and polyphenols (Sasaki 
et al., 2004; Betts et al., 2004). However, it was unknown if these interactions 
contributed to the antimicrobial activity of tea infusions.  Our analysis  has revealed that 
the inhibitory activity of tea is indeed the result of the synergistic and/or additive effects 
of polyphenols rather than the action of individual antimicrobial compounds.   
Regrettably, statistical analysis failed to provide insight into the compounds that 
directly contribute to these interactions. However, by emulating the composition of 
green tea we have evidence to suggest that the components involved in these 
interactions are likely to be the 6 major  catechins, EGCG, EC, C, GCG, ECG, EGC and 
gallic acid. In combination with the long-standing safety profile of tea consumption, 
these results provide a rational for exploiting  the natural synergy of tea as a potential 
treatment for antimicrobial infections as apposed to employing  individual catechins.  
In addition to employing HPLC to identify the major catechins, we also used HPCCC to 
exclude the possibility that we had overlooked other antimicrobial factors.  Although 
our  findings are  limited to a single green tea, the data from our HPCCC analysis 
suggests that the vast majority of the detectable antibacterial activity is due to the 
catechins. However, future studies of multiple tea samples would be required to 
reinforce these findings. 
Moreover, this study has provided the first example of the use of antimicrobial 
screening as a tool for solvent selection in HPCCC. At present, solvent selection is the 
rate-limiting step when this technology is used to extract bioactive compounds 
(Ignatova et al., 2011). The inclusion of an antimicrobial screening step enabled us to 
rationally select the most appropriate solvent system and thus eliminate the trial and 
error elements of this process. This provided a novel and high-throughput solvent 
selection method for separating antimicrobial compounds from crude mixtures. 
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Considerable variations in the catechin content and associated antimicrobial activity of 
individual teas appear to be influenced by the country where the tea has been cultivated 
. This was demonstrated by the potent inhibitory activity of African green teas and the 
poor activity of both green and black teas from China. On reflection, it is clear that 
multiple factors could contribute to these differences such as variations in the local 
environment (Yao et al., 2005), the use of different variants of Camellia sinensis 
(Sabhapondit et al., 2012) and variations in the manner in which the tea leaves were 
processed once they have been harvested (Chou et al., 1999). Moving forward, these 
variables could be manipulated to create conditions that optimise the production of 
catechins and thus maximise the antimicrobial activity of tea.  
While catechins have been identified as the principal antibacterial compounds in tea 
their mode of action has yet to be fully understood. To date membrane disruption and 
the release of H2O2 are the two most heavily investigated theories (Ikigai et al., 2003; 
Nakayama et al., 2002; Arakawa et al., 2004; Bernal et al., 2010). Clearly tea has a 
pronounced effect on the outer structure of Gram-positive bacteria as shown against C. 
difficile in this study, however it is uncertain if these morphological changes are 
indicative of cell wall/membrane damage, other structural interactions or an unrelated 
stress response.  
Interestingly no evidence of cell wall damage/membrane perturbation was observed 
when C. difficile was exposed to EGCG suggesting that other compounds in tea acting 
alone or in combination with EGCG are required to disrupt the membrane. With S. 
aureus, it was shown that antimicrobial activity of tea infusions is most likely due to the 
sum of the synergistic/additive effects of the catechin polyphenols. It is possible that the 
antimicrobial mechanism of EGCG is different to the combined effect of the catechins 
in the tea infusion. This may explain the difference in the SEM observations, 
highlighting the need for further investigation in this area.  
With regards the role of hydrogen peroxide, we have shown a direct correlation between 
the levels of H2O2 produced and the inhibitory activity of tea infusions. We have also 
found that the order of antibacterial activity of catechins and gallic acid is similar to the 
order of H2O2 production of these compounds also reported by Arakawa et al. (2004). 
This supports the hypothesis that catechins, which are more readily converted to 
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benzoquinones and thus produce the highest levels of H2O2, are the most potent 
antimicrobials (Sahu et al., 2003). All withstanding, it is still uncertain if H2O2 is 
directly involved in the inhibitory activity or is simply intermediate in a more complex 
pathway. 
It is unfortunate that specific tea infusions did not show synergy with the antibiotics 
vancomycin and metronidazole against C. difficile, as tea synergistic properties with β-
lactams has proved to be an expanding area of interest for treating MRSA infections 
(Yiannakopoulou, 2012). Synergy with antibiotics used to treat C. difficile would 
undoubtedly increase the potential of taking tea forward as a complimentary treatment 
of CDI. Nevertheless, this study has shown that the interactions were largely indifferent 
which is an important outcome in its own right when considering combined therapy.   
Whilst the antibacterial properties of tea have been known for many years, its 
widespread use as an antimicrobial agent has yet to be realised. In part, this is due to the 
poor systemic bioavailability of tea (Lee et al., 1995) and the relatively modest 
inhibitory activities of individual catechins compared to traditional antibiotics. In spite 
of these concerns, this study provides a strong argument that tea infusions could 
potentially be used for the treatment of CDI.  We have shown that tea has uniform 
inhibitory activity against a collection of clinical isolates of C. difficile representing the 
major ribotypes seen over the last 11 years in the UK. In addition, tea compounds have 
been shown to have a positive effect on the gut flora (Lee et al., 2006; Axling et al., 
2012). Therefore they may also have potential use as supplements for prevention of C. 
difficile and maintenance of healthy gut function, much like that of probiotics. This 
could possibly be achieved by regular consumption of infusions with optimised catechin 
content. In addition, it is not subjected to the limitations of bioavailability faced when 
treating systemic infections, as it has been demonstrated that the green tea polyphenol 
EGCG, and most likely other tea catechins, concentrate in the small intestine and colon 
after consumption, which is where the C. difficile is found to colonise (Lee et al., 1995). 
Granted that there is evidence of partial biotransformation and metabolism of some 
catechins within the gut (Sang et al., 2011), it remains a valid hypothesis that tea 
infusions could potently be useful in treating CDI due to their low inhibitory 
concentrations.  
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6.2 Limitations and Future Work 
It is clear from this investigation that tea infusions, particularly green tea infusions, may 
be of benefit in the treatment of CDI. Our in vitro testing has demonstrated that tea is 
inhibitory across a wide range of clinical isolates of the pathogen.  Therefore, the next 
logical progression of this work would be to determine the effects of tea in vivo.  
Currently, probiotics such as lactobacillus are used in the treatment of C. difficile as it 
thought that they help replenish the gut flora (Lawrence et al., 2005). Recently it has 
been shown that green tea can help the growth of Lactobacillus in the gut (Axling et al., 
2012), which may provide an opportunity for tea to be employed in combined with 
probiotics in the treatment of CDI.  
Although this investigation has provided an extensive overview of the catechin content 
and antimicrobial activities of tea, there is still some ambiguity over the antimicrobial 
activities of black tea. It would appear that residual catechins in black tea contribute to 
the antimicrobial activity, although as demonstrated in this study, other interactions are 
clearly present. An investigation comparing the theaflavin and thearubigin content of 
black teas to their antimicrobial activity may help to provide a better understanding of 
how these groups contribute to activity. However, this endeavor is likely to be 
challenging due to the complex nature of these compounds. 
This study has shown that a synthetic tea was able to successfully replicate the 
antimicrobial activity of the green tea it was based on. Yet, it is unknown if any of the 
components of this mixture are superfluous.  To determine if each catechin is critical to 
this mixture, a subtractive approach should be taken to rule out redundant compounds 
and to quantify the contribution of each active component.  Ultimately, combining this 
approach for multiple tea samples may provide a powerful tool for selecting potent 
antimicrobial teas based on their HPLC profile or catechin ratio alone and will help 
further the understanding of the combinational effect of catechins. The use of HPCCC 
may also prove useful in this investigation, as with the right solvent selection it has the 
ability to pull out pure compounds from crude mixtures. Since this process is non-
destructive,  both the isolated compounds and remaining mixture can be tested for 
activity and therefore help to determine synergy. Furthermore, study into the nature of 
the synergistic interactions of the catechin polyphenols may help to elucidate their 
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antimicrobial mechanism or provide insight into other compatible antimicrobials that 
catechins may have a synergetic relationship with. 
Although the role of hydrogen peroxide production in the antibacterial action of tea 
infusions is clearly important, its specific function is as yet unknown, warranting further 
investigation into this area. Previously it has been reported that the production of H2O2 
by catechins is dependent on the pH of the testing environment (Arakawa et al., 2004) 
and that the antibacterial activity of tea increases with increasing pH (Liu et al., 2012). 
The pH of the small and large intestine is reported to be 7.5 and 6.4 – 7.0, respectively 
(Evans et al., 1988).  Therefore, it is important that future studies determine if the 
inhibitory activity of tea infusions against C. difficile varies over a broader pH range or 
in conditions simulating these environments. Not only will this help predict the 
potential activity of these compounds in vivo, but may provide further insight into the 
role of H2O2 in the antimicrobial mechanism of tea. It has been observed that only small 
amounts of H2O2 are produced by tea polyphenols at ranges between pH 5.5 – 6.5 
(Nakayama et al., 2002). Therefore, if reduced antimicrobial activity of tea infusions 
were observed at these lower pH ranges then it would strengthen the hypothesis of H2O2 
involvement in teas antimicrobial mechanism.  
The use of SEM in this study revealed gross structural changes to C. difficile when 
exposed to green tea. However, the observation of these changes was restricted to the 
outermost structures of the bacterial cell. The use of TEM, which looks at cross sections 
of cells, would provide much more detail into specific parts of the cell (i.e. cell wall, 
membrane, etc.) that have been affected and thus further understanding of the 
interaction. Moreover, since no obvious changes were apparent with bacteria treated 
with EGCG, it would be of interest to conduct SEM on cells treated with other tea 
catechins. In addition, as H2O2 is implied in the antimicrobial mechanism of tea, it 
would be of interest to compare its affect on the surface of C. difficile in comparison to 
tea infusions and tea polyphenols.  
Finally green teas from Kenya were found to possess potent inhibitory activity 
compared to other green teas. As previously mentioned, the diversity of tea plants may 
be caused by multiple variables. Environment (Yao et al., 2005), processing (Chou et 
al., 1999) and type of tea bush (Sabhapondit et al., 2012) are just some of factors shown 
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to affect the levels of polyphenols in tea leaves. Future work to identify these variables 
may provide a novel method for producing tea blends with exemplarity antimicrobial 
activity. 	  
6.3 Concluding Remarks 
In summary, this work has shown that tea infusions have inhibitory activity against one 
of the most prevalent hospital acquired infections in the UK. We have also provided 
evidence that green tea polyphenols, namely catechins are the dominant antimicrobial 
factors in green tea and they exert their antibacterial activity through synergetic or 
additive interactions. Albeit inconclusive, the work presented in this thesis supports the 
current hypothesis that the antimicrobial mechanism of tea involves H2O2 and that 
exposure to tea alters the structure of the bacterial cell in a manner which is yet to be 
determined. 
In conclusion, tea a drink consumed by millions worldwide has been shown to be a 
versatile antimicrobial against C. difficile in vitro and may prove to be a useful natural 
antimicrobial in an era were antibiotic resistance is becoming ever more prevalent. 
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